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ABSTRACT 
New strategies are urgently needed to increase physical activity participation in the 
increasingly sedentary population to combat the rising rates of obesity and 
metabolic disease. The aim of this thesis was to provide evidence that practical 
high-intensity interval training (HIT) strategies can remove many of the major 
exercise barriers for obese individuals and people with type 1 diabetes that could 
potentially increase physical activity participation. Secondly, this thesis aimed to 
provide mechanistic evidence to explain the physiological effectiveness of HIT as a 
means to reduce the risk of cardio-metabolic disease.  
In Chapters 4 and 5, 32 obese adults with at least 3 additional 
cardiovascular disease (CVD) risk factors completed one of three 12-week training 
programmes 3x/week: Home-HIT (n=9); Laboratory-based supervised HIT (Lab-HIT; 
n=10) or home-based moderate intensity continuous training (Home-MICT; n=13). 
Changes in !̇O2peak, insulin sensitivity, body composition, flow-mediated dilation 
(FMD) and aortic pulse wave velocity (PWV) were assessed. Muscle biopsies were 
taken to assess changes in capillarisation, mitochondrial density, intramuscular 
triglyceride (IMTG) content and eNOS and GLUT4 protein expression using 
quantitative immunofluorescence microscopy. Adherence and compliance (Home-
HIT 96±3% & 99±1%; Home-MICT 88±4% & 100±0%; Lab-HIT 97±1% & 100±0%, 
respectively) to training did not differ between groups. Training increased !̇O2peak 
and Matsuda insulin sensitivity index (P<0.05). BMI, body fat percentage and 
visceral fat decreased (P<0.05). FMD increased and aortic PWV decreased in each 
group (P<0.05). Immunofluorescence microscopy revealed increased capillarisation, 
mitochondrial density, IMTG content and eNOS and GLUT4 protein expression 
(P<0.05).  
In Chapter 6, 14 people with type 1 diabetes completed a randomised 
counterbalanced crossover design whereby continuous glucose monitoring was 
used to assess glycaemic control and risk of hypoglycaemia following a single bout 
of HIT and moderate-intensity continuous training (MICT) on separate days, 
compared to a non-exercise control day (CON). In Chapter 7, 14 people with type 1 
diabetes (n=7 per group) completed six weeks of HIT or MICT 3x/week and the 
effect on glucose control and markers of cardio-metabolic health were measured. 
Chapter 6 showed no difference in the time, incidence or severity of hypoglycaemia 
over the 24-hour or nocturnal period between the CON, HIT and MICT days. In 
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Chapter 7, six weeks of HIT or MICT improved !̇ O2max by 14% and 15%, 
respectively and aortic PWV by 12%, with no difference between groups. Therefore, 
Chapters 6 and 7 demonstrate that HIT is an effective exercise strategy for people 
with type 1 diabetes that reduces the two major barriers of lack of time and fear of 
hypoglycaemia. 
Finally, in Chapter 8, eleven previously sedentary individuals with type 1 
diabetes completed 6 weeks of Home-HIT. Blood glucose was monitored before, 
immediately and 1h after all of the exercise sessions. Perceptions of the program 
along with attitudes towards exercise, barriers to exercise and previous experiences 
of exercise were evaluated using an online survey. Training session adherence was 
93±2%, with participants achieving their target HR in 99±1% of sessions. Blood 
glucose was not different from baseline immediately or 1h post HIT exercise. 
Training increased !̇O2peak by 8% (P=0.015), but blood pressure was unchanged 
(P=0.445). The qualitative data showed that the Home-HIT programme was 
positively received with many benefits.  
In conclusion, this thesis provides strong evidence that HIT can reduce major 
barriers to exercise and potentially increase exercise participation in these at-risk 
populations. Furthermore, Home-HIT was shown to be an effective strategy to 
improve a wide range of physiological markers indicative of improved cardio-
metabolic health. Importantly, Home-HIT not only reduced traditional barriers to 
exercise, but also the key barrier in people with type 1 diabetes, fear of 
hypoglycaemia. As such, Home-HIT may represent an effective strategy to improve 
health in obese individuals with elevated CVD and people with type 1 diabetes by 
increasing exercise participation. Future research should investigate the effects of 
Home-HIT on a larger scale using larger cohorts and longer training periods using 
large-scale randomised controlled trials.  
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The overarching aim of the thesis is to investigate the cardio-metabolic benefits of a 
practical form of high-intensity interval training (HIT), home-based HIT (Home-HIT), 
in obese individuals with elevated cardiovascular disease (CVD) risk and people 
with type 1 diabetes. Secondly, this thesis aims to provide clear mechanistic 
evidence to explain the physiological effectiveness of home-based HIT as a means 
to reduce the risk of cardio-metabolic disease. It is envisioned that this thesis will 
provide the first evidence for a practical exercise strategy that reduces the major 
barriers to exercise in these at-risk populations.  
 
1.1. Objectives 
These aims will be achieved through completion of five studies with the following 
objectives:  
Study 1: 
1. To investigate the adherence and compliance to a novel 12-week Home-HIT 
programme in obese individuals with elevated CVD risk. 
2. To test whether Home-HIT improves markers of cardio-metabolic health 
including !̇O2peak, insulin sensitivity, blood lipid profile, arterial stiffness and 
body fat percentage.  
3. To use immunofluorescence microscopy to assess changes in GLUT4, 
mitochondrial density and intramuscular triglycerides following 12 weeks of 
Home-HIT. 
Study 2: 
1. To investigate the effect of a 12-week Home-HIT intervention on skeletal 
muscle capillary density and skeletal muscle microvascular enzymes 
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responsible for nitric oxide (NO) production and NO quenching in previously 
sedentary obese individuals with elevated CVD risk. 
Study 3: 
1. To examine the effects of a single bout of HIT and moderate-intensity 
continuous training (MICT) following an overnight fast on acute and 24 hour 
glucose concentrations in people with type 1 diabetes compared to a day 
without exercise.  
2. To assess the change in blood glucose concentrations during HIT and MICT 
in the fasted state using capillary blood sampling. 
Study 4: 
1. To investigate whether six weeks of HIT leads to similar improvements in 
cardio-metabolic health markers as MICT in people with type 1 diabetes. 
2. To investigate the acute change in blood glucose concentration during HIT 
and MICT in the fed state. 
Study 5: 
1. To investigate the adherence and compliance of Home-HIT in people with 
type 1 diabetes. 
2. To assess the effects of Home-HIT on !̇O2peak, insulin dose and glycaemic 
profile in people with type 1 diabetes. 
3. To assess the acute effects of Home-HIT on blood glucose concentration in 
people with type 1 diabetes. 
4. To use a qualitative survey to gain a greater understanding of the barriers to 
exercise that people with type 1 diabetes face and the participant 
experiences of Home-HIT. 
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1.2. Hypotheses 
The hypotheses for each study are as follows: 
Study 1: 
1. Home-HIT will have high adherence at the prescribed exercise intensity 
(compliance).  
2. Home-HIT will lead to comparable improvements in markers of cardio-
metabolic health and traditional skeletal muscle training markers to the fully 
supervised laboratory-based HIT group. 
Study 2: 
1. Microvascular density and eNOS content will increase with Home-HIT 
alongside an increase in !̇O2peak and insulin sensitivity.  
2. Home-HIT will reduce the protein content of NOX2 and its activator p47phox in 
the endothelial layer of the terminal arterioles and capillaries.  
Study 3: 
1. Blood glucose concentration would be maintained following HIT and that the 
incidence and time spent in hypoglycaemia would be lower compared to 
MICT over the 24-hour period. 
Study 4: 
1. Six weeks of HIT will improve markers of cardio-metabolic health including !̇O2peak, glycaemic control, blood lipid profile and vascular health in people 
with type 1 diabetes to a similar degree to MICT.  
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Study 5: 
1. Home-HIT will have high adherence and compliance in people with type 1 
diabetes.  
2. Six weeks of Home-HIT would increase !̇O2peak, reduce insulin requirements 
and improve glycaemic profile in people with type 1 diabetes. 
3. Blood glucose concentration would remain stable up to 1 hour post Home-
HIT sessions. 
 
Chapter 2 
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2.1. Introduction 
As early as ~600 BC, the ancient Indian physician Susruta advocated regular 
exercise to minimise the consequences of obesity and diabetes (Tipton, 2008), 
stating that medical practice should direct as much effort to prevention of disease as 
to curative remedies (Bhishagratna, 1963). In the 20th Century, Morris et al. (1953) 
observed in their landmark study that incidence of coronary heart disease in 
sedentary bus drivers was double that of the physically active conductors in London 
double-decker buses, suggesting a protective effect of physical activity. Since then, 
the association between physical inactivity and chronic diseases has been 
acknowledged by countless mechanistic and epidemiological studies and in their 
excellent review, Booth et al. (2017) highlight how physical inactivity directly 
increases the risk of disease leading to reduced quality of life and increased 
mortality risk.  
According to Neel’s (1962) ‘Thrifty Gene Hypothesis’, the human genome 
adapted to efficiently store and utilise food to optimise metabolism to support the 
physically active lifestyle of our hunter-gatherer ancestors, some 10,000 years ago 
(Eaton et al., 1988). Because the genetic makeup of Homo sapiens has hardly 
changed since the Late-Palaeolithic era (50,000–10,000 BC), the sedentary, food-
abundant state of the 21st Century is creating an abnormal phenotype which is 
associated with the increasing incidence of metabolic disease (Booth et al., 2012, 
Booth et al., 2017). Regular physical activity and/or aerobic training help preserve 
the normal, healthy human phenotype (Booth et al., 2017). Therefore, as suggested 
by Booth and Lees (2006), throughout this thesis the physically active, endurance 
trained phenotype will be referred to as the ‘normal’ or optimal state. 
Changing eating habits towards a diet comprising high fat and sugar 
convenience foods with low nutritional value combined with an increasingly 
sedentary lifestyle has led to a huge increase in the prevalence of obesity and type 
Chapter 2 
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2 diabetes. There are ~350 million cases of type 2 diabetes worldwide which is 
projected to increase to ~500 million by 2035 (IDF Diabetes Atlas 8th Edition, 2017). 
This is associated with a huge financial burden, as 12% of global health expenditure 
is spent on diabetes treatment, equating to £523 billion per annum (IDF Diabetes 
Atlas 8th Edition, 2017). Physical inactivity has been identified as one of the leading 
global risks for mortality, and obesity has been shown to double the risk of all-cause 
mortality due to its association with cardio-metabolic pathologies such as 
cardiovascular disease (CVD) and type 2 diabetes (Berrington de Gonzalez et al., 
2010, Kohl et al., 2012). However, the role of physical activity as a means to combat 
obesity and metabolic disease continues to be undervalued (Kohl et al., 2012). Low 
physical activity levels in the general population are largely due a number of 
exercise barriers, with the most common being a ‘lack of time’ (discussed in Section 
2.6 and throughout this thesis). Major culture shifts leading to increased physical 
activity and/or novel strategies to reduce the barriers to exercise are urgently 
needed to combat the obesity crisis.  
Type 1 diabetes is a chronic inflammatory autoimmune disease whereby the 
insulin-producing β-cells of the islets of Langerhans of the pancreas are destroyed 
(Atkinson and Eisenbarth, 2001). This leads to absolute insulin deficiency, making it 
a daily challenge to maintain euglycaemia (blood glucose 4-8 mmol/L) through self-
administration of exogenous insulin, regular glucose monitoring and diet control. As 
with the rest of the population, people with type 1 diabetes are recommended to 
exercise regularly to reduce the risk of micro- and macrovascular complications 
(Vestberg et al., 2013, Price et al., 2014). However, people with type 1 diabetes tend 
to be at least as inactive as the general population with a large proportion of patients 
not maintaining a healthy body mass as ~60% are overweight or obese (Makura et 
al., 2013, Bohn et al., 2015). In addition to the usual barriers to exercise cited by the 
Chapter 2 
9 
 
general population there are further barriers to exercise for people with type 1 
diabetes (Section 2.6.1.) that can reduce exercise participation.  
This introduction will start by outlining how glucose control is achieved in the 
healthy, physically active state before introducing how inactivity and obesity lead to 
an unhealthy phenotype and impaired glucose homeostasis. The following sections 
will describe how exercise training can be used to combat insulin resistance and 
metabolic disease to provide context for the physiological adaptations investigated 
during the experimental chapters. The introduction will continue by discussing 
barriers to exercise faced by the general population and people with type 1 diabetes 
before describing the exercise strategies that have been employed in the literature 
to combat physical inactivity and metabolic disease. 
 
2.2. Glucose Homeostasis 
In normal healthy individuals, tight control mechanisms exist so that glucose uptake 
into peripheral tissues is precisely matched by the rate of endogenous glucose 
production to maintain plasma glucose concentration between 3.9-5.5 mmol/L 
(Abdul-Ghani et al., 2006, Gagliardino, 2005). Glucose is the primary fuel source of 
the brain, so severe reductions in blood glucose concentration (<2 mmol/L) are 
deleterious to brain function (Wasserman, 2009). On the other hand, prolonged 
and/or recurrent increases in blood glucose concentration (hyperglycaemia) leads to 
tissue damage and secondary complications including CVD, microvascular damage, 
retinopathy and nephropathy.  
Blood glucose control is achieved by a number of hormones, of which insulin 
is possibly the most important and will be a large focus of this thesis. Insulin is a 
polypeptide hormone produced by the pancreatic β cells following a meal that 
regulates glucose homeostasis by promoting absorption of glucose from the blood 
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into skeletal muscle, liver and adipose tissue. In these tissues, the absorbed glucose 
is then either converted to glycogen via glycogenesis; converted to fatty acids 
through de novo lipogenesis; used to generate the glycerol backbone for 
triglycerides in adipose tissue; or used to provide energy through glycolysis. In the 
postabsorptive state, decreases in blood glucose concentration are sensed by α 
cells of the pancreas which secrete glucagon (Abdul-Ghani, 2006). Glucagon 
stimulates endogenous glucose output from the liver to maintain blood glucose 
concentration sufficient for normal brain function.  
 Skeletal muscle accounts for ~80% of glucose disposal during a 
hyperinsulinaemic-euglycaemic clamp (DeFronzo et al., 1981) and ~50% glucose 
disposal following ingestion of a mixed meal, with the splanchnic tissues accounting 
for the remaining 50% (Capaldo et al., 1999). Therefore, skeletal muscle glucose 
uptake is fundamental to the maintenance of glucose homeostasis following a meal 
or during exercise. Insulin-stimulated glucose uptake into skeletal muscle occurs 
primarily through facilitated diffusion via glucose transporters, of which glucose 
transporter 4 (GLUT4) is the predominant insulin-responsive isoform in human 
skeletal muscle (Watson and Pessin, 2001), although transendothelial glucose 
transport in skeletal muscle capillaries is mediated by GLUT1 (Wagenmakers et al., 
2016). Insulin also stimulates increased perfusion of the microvascular system to 
promote greater delivery of insulin and glucose to the myocyte. Therefore, a high 
level of insulin sensitivity is required for an optimal healthy phenotype to prevent 
substantial perturbations in blood glucose concentrations and the long-term 
complications that can accompany a persistent elevation in blood glucose 
concentration (Abdul-Ghani et al., 2006). The following sections will describe the 
effects of insulin on microvascular perfusion and skeletal muscle glucose uptake in 
normal healthy individuals to provide context for future sections that discuss obesity-
induced insulin resistance and type 1 diabetes. 
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2.2.1. Vascular Actions of Insulin 
Insulin has important vascular actions that act to increase delivery of glucose and 
insulin to the myocyte (see Muniyappa et al. (2007) and Younk et al. (2014) for 
detailed reviews). Baron et al. (1990) introduced the idea that insulin could regulate 
its own delivery and that of glucose after experiments in which they observed a 
strong correlation between leg blood flow and insulin-mediated glucose disposal 
(Laakso et al., 1990, Baron et al., 1990). In the study by Baron et al. (1990) they 
measured whole body glucose uptake, leg glucose uptake (using the leg balance 
technique), leg blood flow and cardiac index after an overnight fast and over 180 
minutes after an oral glucose load in lean and obese participants. In the lean group 
there was a 36% increase in peak leg blood flow over baseline while there was no 
change in the obese subjects. Consequently, leg glucose uptake was 44% lower in 
the obese than the lean group, suggesting that haemodynamics play an important 
role in glucose disposal and defects in blood flow response potentially contribute to 
decreased glucose tolerance and insulin resistance.  
Studies using contrast enhanced ultrasound have shown that in the normal, 
healthy state microvascular blood volume increases within 15-30 minutes during a 
hyperinsulinaemic-euglycaemic clamp and that this correlates with the rise in 
forearm glucose uptake (Bonner et al., 2013, Eggleston et al., 2013, Eggleston et al., 
2007). This is followed by relaxation of larger resistance vessels with increased 
overall limb blood flow after 90 minutes (Baron et al., 1996). Thus, insulin promotes 
its own delivery and the delivery of glucose to the skeletal muscle through nitric 
oxide (NO)-mediated dilation of the terminal arterioles leading to an increase in 
perfusion and expansion of the endothelial surface area to augment glucose uptake 
(Clerk et al., 2006, Vincent et al., 2004). Studies have shown that this response is 
related to insulin sensitivity, as obesity (Laakso et al., 1990), type 1 diabetes (Baron 
et al., 1991) and type 2 diabetes (Clark, 2008) have been shown to suppress insulin-
mediated blood flow and glucose disposal. The postprandial increases in skeletal 
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muscle microvascular perfusion are important for glucose and lipid homeostasis, 
and maintenance of long-term metabolic health. 
 
2.2.2. Mechanisms of Insulin on the Microvasculature 
Insulin directly influences vascular function through increases of NO production and 
endothelin-1 (ET-1) synthesis within the endothelium to induce vasodilation and 
vasoconstriction, respectively (Muniyappa et al., 2007). Under insulin-sensitive 
conditions, NO is the predominant factor resulting in the vasodilatory response to an 
increase in insulin (Steinberg et al., 1994). Increases in plasma insulin concentration 
following a meal activates an insulin signalling cascade that shares many of the 
steps of the myocyte insulin signalling pathway (Section 2.2.3.), suggesting a 
common function and link between these actions of insulin.  
Upon binding to insulin receptors on the vascular endothelium, insulin 
activates the IRS-1/PI3K/PDK-1/Akt signalling cascade (Montagnani et al., 2002b, 
Montagnani et al., 2002a, Montagnani et al., 2001) (Figure 2.1A.). First, insulin 
phosphorylates intracellular substrates including insulin receptor substrate (IRS) 
family members and the Shc that serve as docking proteins for downstream 
signalling molecules (White, 2002). Tyrosine phosphorylation of IRS creates Src 
homology 2 (SH2)-domain binding motifs for SH2-domain containing effectors 
including phosphatidylinositol 3-kinase (PI3K) and Grb-2. PI3K is a heterodimer 
composed of a regulatory p85 subunit and a catalytic p110 subunit. When SH2-
domains of p85 subunit bind to tyrosine-phosphorylated motifs on IRS-1 this 
activates the p110 catalytic subunit to generate phosphatidylinositol 3,4,5-
triphosphate (PIP3) from phosphatidylinositol 4,5-biphosphate (PIP2). PIP3 binds to 
the pleckstrin-homology domain in the 3-phosphoinositide-dependent protein 
kinase-1 (PDK-1) resulting in phosphorylation and activation to phosphorylate and 
activate Akt and atypical protein kinase C (PKC) (Vanhaesebroeck and Alessi, 
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2000). Akt activates endothelial nitric oxide synthase (eNOS) via phosphorylation of 
Ser1177 (Dimmeler et al., 1999) resulting in NO production through the conversion of 
ʟ-arginine to NO and ʟ-citrulline (Nathan and Xie, 1994).  
NO is a potent vasodilator that acts on the smooth muscle cell layer of the 
terminal arterioles leading to vasodilation and increased perfusion of the skeletal 
muscle to increase the surface area for the transport of insulin and glucose (Vincent 
et al., 2003). NO diffuses into the vascular smooth muscle cells (VSMC) to activate 
guanylate cyclase, driving relaxation of the VSMCs through an increase in cGMP 
(Fleming and Busse, 2003). Insulin at high concentrations also stimulates 
expression of ET-1 which is a potent vasoconstrictor that opposes the vasodilator 
action of NO (Marasciulo et al., 2006). The balance between NO and ET-1 protein 
synthesis is an important determinant of insulin’s ability to increase skeletal muscle 
perfusion after meal ingestion and during hyperinsulinaemic-euglycaemic clamps 
(Ergul, 2011).  
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Figure 2.1. Insulin signalling cascades in the normal healthy state 
A) Mechanisms of insulin on the microvasculature and B) myocyte in the normal 
insulin sensitive state. Adapted from Richter and Hargreaves (2013). 
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2.2.3. Insulin-Mediated Glucose Uptake into Skeletal Muscle  
Following a postprandial rise in plasma glucose concentration, insulin is secreted 
from the pancreatic β cells into the circulation to promote glucose uptake into insulin 
sensitive tissues (Fridlyand and Phillipson, 2011). Insulin binds to the insulin 
receptor located on the skeletal muscle plasma membrane and initiates glucose 
uptake. The insulin receptor is a heterotetramer with two extracellular insulin binding 
α subunits and two membrane spanning β subunits (Chang et al., 2004). Insulin 
binds to the extracellular α subunit of the insulin receptor which stimulates tyrosine 
autophosphorylation of the insulin receptor β subunit and activation of tyrosine 
kinase (Chang et al., 2004). This promotes autophosphorylation and subsequent 
activation of IRS-1 to provide docking sites for downstream signalling proteins 
containing SH2-domains. Activation of IRS-1 triggers activation of PI3K and 
subsequent interaction with p110 catalytic and p85 regulatory subunits through 
increased interaction with SH2-domains (O'Neill, 2013). The activated p110 subunit 
of PI3K phosphorylates the 3’-OH moiety of the plasma membrane, PIP2 to generate 
PIP3. Increases in PIP3 lead to activation of pleckstrin homology domain-containing 
proteins, such as PDK1, protein kinase B (Akt/PKB) and atypical PKC to localise 
these proteins to the plasma membrane (Chang et al., 2004). Akt is then 
phosphorylated by mammalian target of rapamycin complex 2 and Rictor protein 
complex on Ser473 and subsequently by PDK on Thr308 to achieve Akt activation 
(Sarbassov et al., 2005, Chang et al., 2004). Akt/PKB phosphorylates glycogen 
synthase kinase-3 (GSK-3), reducing the activity of this protein to subsequently 
increase the activity of glycogen synthase and thereby promote glycogen synthesis. 
Activated Akt/PKB also phosphorylates TBC1D4 (formally known as AS160). Under 
basal conditions, TBC1D4 retains Rab proteins in an inactive GDP-bound state 
thereby preventing GLUT4 translocation. In response to TBC1D4 phosphorylation, 
Rab proteins become GTP-loaded leading to a reorganisation of the cytoskeleton 
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that is required for GLUT4 mobilisation to the plasma membrane and glucose 
uptake. 
Insulin-mediated GLUT4 translocation also occurs through an IRS-PI3K-
independent pathway involving the APS-CAP-Cb1 complex. This pathway is centred 
on the lipid raft microdomain of the plasma membrane (see Figure 2.1B). The 
protein flotillin which is present in the lipid rafts interacts with CAP resulting in 
recruitment of the CAP/Cb1 so that it is incorporated within the lipid rafts (Chang et 
al., 2004). Tyrosine phosphorylation of Cb1 stimulates translocation of CrkII and 
C3G to the lipid rafts which activates the small G proteins TC10α and TC10β 
(Chiang et al., 2002). Upon activation, TC10 interacts with a number of effector 
molecules resulting in translocation of GLUT4.  
In the basal state, GLUT4 slowly cycles from the plasma membrane to 
vesicle storage sites within the cell (Chang et al., 2004) and the majority of GLUT4 
is located in intracellular storage clusters with a small proportion contained within 
the plasma membrane (Bryant and Gould, 2011). Following insulin stimulation, the 
slow cycling of GLUT4 between the plasma membrane and the intracellular storage 
membranes is interrupted and assumed to lead to increased GLUT4 at the plasma 
membrane through increased exocytosis of glucose storage vesicles and reduced 
endocytosis of GLUT4 (Kampmann et al., 2011, Richter and Hargreaves, 2013). 
During insulin-mediated glucose uptake, GLUT4 storage vesicles (GSV) containing 
1-25 GLUT4 molecules are inserted into the muscle cell surface membrane 
following formation of specific SNARE (Soluble N-ethylmaleimide Sensitive Factor 
Attachment Protein Receptor) protein complexes.  
Vesicle (v)-SNAREs are located in GLUT4 vesicles and target (t)-SNAREs 
are membrane proteins. A full overview of the role of SNAREs is beyond the focus 
of this introduction so readers are directed to reviews by Richter and Hargreaves 
(2013) and Bryant and Gould (2011). In brief, when v-SNAREs (e.g. VAMP2) 
interact with the relevant t-SNARE (e.g. SNAP23, syntaxin 4), a SNAREpin complex 
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is formed in which four SNARE motifs assemble to form a twisted parallel four helix 
bundle. This helical structure of the SNARE complex brings the lipid bilayer of the 
GLUT4 vesicle and plasma membrane into close proximity and then catalyses the 
fusion of vesicles so that GLUT4 can be incorporated within the plasma membrane. 
GLUT4 fusion is regulated through Munc18c which determines syntaxin 4 availability 
and SNARE complex formation. One model suggests that Munc18c is an inhibitory 
factor that under basal conditions is bound to syntaxin 4, which prevents VAMP2 
from binding to form the SNARE complex (Tellam et al., 1997). Insulin stimulation 
activates aPKC resulting in phosphorylation of Munc18c. This reduces the Munc18c-
syntaxin 4 interaction which allows the SNARE complex to assemble and then GSV 
fusion with the plasma membrane. 
  
2.2.4. Contraction-Stimulated Glucose Uptake into Skeletal Muscle 
Contraction-stimulated glucose uptake is preserved in people with insulin resistance 
and type 1 diabetes, emphasising the use of exercise as a therapeutic agent. This is 
because exercise-stimulated glucose transport does not rely on the proximal portion 
of the insulin signalling pathway (the insulin receptor, IRS and Akt) which is impaired 
with insulin resistance. An understanding of contraction-mediated glucose uptake is 
important for the purpose of this thesis because Chapters 6 and 7 focus on glucose 
control in response to an acute bout of exercise in people with type 1 diabetes. 
Exercise increases glucose uptake up to 50-fold through simultaneous stimulation of 
delivery to the skeletal muscle through increased skeletal muscle perfusion, 
recruitment of additional capillary endothelial surface area leading to increased 
transendothelial transport of glucose via GLUT1 present in the luminal and 
abluminal endothelial membrane (Wagenmakers et al., 2016), increased glucose 
transport from the interstitial fluid surrounding the muscle fibres across the plasma 
membrane via GLUT4, and increased  glycolysis and glucose oxidation in the 
muscle fibres. Studies using immuno-gold particle-labelling of GLUT4 combined with 
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electron microscopy have demonstrated that the effects of insulin and muscle 
contraction on GLUT4 redistribution are additive in rat skeletal muscle (Ploug et al., 
1998). The additive nature of insulin and muscle contraction on GLUT4 translocation 
suggests there may be two intracellular pools of GLUT4: one recruited by insulin 
and the other by muscle contractions (Richter and Hargreaves, 2013). This is 
important to acknowledge when working with people with type 1 diabetes because 
exercise combined with increased circulating (exogenous) insulin will increase the 
risk of hypoglycaemia. 
The molecular mechanisms leading to exercise-stimulated GLUT4 
translocation are complex and no single master signalling pathway has been 
identified (Richter and Hargreaves, 2013). Nonetheless, it has been suggested that 
this regulation can be divided into a calcium (Ca2+)/calmodulin (CaM)-dependent 
feedforward mechanism and an AMP-activated protein kinase (AMPK)-related 
feedback mechanism responsible for adjusting glucose uptake of the muscle 
according to the muscle’s energy needs. A thorough review of contraction-
stimulated glucose uptake is beyond the scope of this introduction; therefore, 
interested readers are referred to the following reviews by Richter and Hargreaves 
(2013), Sakamoto and Goodyear (2002), and Sylow et al. (2017). 
Evidence for a role of intracellular Ca2+ comes from early studies showing 
that Ca2+ is released from the sarcoplasmic reticulum of frog sartorius muscle 
incubated with caffeine which was associated with increased glucose transport 
(Holloszy and Narahara, 1965). Ca2+ release during muscle contractions is thought 
to increase glucose uptake via activation of other Ca2+-sensitive downstream 
signalling molecules including CaMKK, CaMKII and nPKC (Rose and Richter, 2005, 
Rose et al., 2006, Jensen et al., 2014a). CaMKII has been implicated in contraction-
induced glucose uptake because Jensen et al. (2007b) showed that unselective 
CaMKII blockers KN62 and KN93 decrease contraction-induced glucose uptake. 
Furthermore, inactivation of CaMK reduces glucose uptake in rat skeletal muscle 
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(Wright et al., 2005). However, it has since been shown that incubation with caffeine 
increases AMPK activation in mouse muscle, suggesting the increased cytosolic 
Ca2+ concentration in muscle is due to the increased energy demand of ion pumping 
even if the muscle is not contracting (Raney and Turcotte, 2008). It may therefore be 
that increased Ca2+ per se does not increase muscle glucose uptake but rather, the 
release of Ca2+ during muscle contractions and activation of the SERCA pump 
causes metabolic stress to muscle cells, and this stress by activation of AMPK 
causes an increase in muscle glucose uptake (Jensen et al., 2007a). This suggests 
an indirect effect of Ca2+ on muscle glucose uptake (Richter and Hargreaves, 2013). 
AMPK is a serine/threonine protein kinase that senses the energy status of 
the muscle cell based on the AMP:ATP and creatine:phosphocreatine ratios (Salt et 
al., 1998). Therefore, as muscle contractions lead to an increase in the AMP:ATP 
ratio this causes AMPK activation (Wojtaszewski et al, 2000). Pharmacological 
activation of AMPK through AMP analogue 5-aminoimidazole-4-caboxamide-1-β-D-
ribonucleoside (AICAR) in resting muscle has been shown to increase muscle 
glucose transport independently of insulin (Jorgensen et al., 2006). However, 
studies investigating the role of AMPK in contraction-mediated glucose uptake via 
AMPK knockout have proved inconclusive, as Mu et al. (2001) found that 60% of 
contraction-induced glucose uptake is maintained when AMPK is knocked out, 
suggesting other factors independent of AMPK may also stimulate glucose uptake. 
Therefore, the role of AMPK in contraction-induced glucose uptake is currently 
controversial, suggesting other factors are important. 
Mechanical stress is also a potent stimulus to increase glucose transport in 
muscle in addition to alterations in the intracellular metabolic milieu (Jensen et al., 
2014b, Sylow et al., 2015). Contraction-stimulated glucose uptake has been shown 
to be reduced when tension development is inhibited ex vivo (Jensen et al., 2014b, 
Sylow et al., 2015). Jensen et al. (2014b) found that a combination of passive 
stretch and AICAR-induced stimulation of AMPK promoted an additive effect on 
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glucose transport during co-stimulation with insulin but not muscle contraction. This 
suggests that passive stretch and AMPK recruit GLUT4 from the same pool. A 
number of stretch-activated pathways might be involved in glucose uptake including 
the Rho family GTPase RAC1 (Sylow et al., 2017). Pharmacological inhibition and 
gene knockout of RAC1 reduced stretch-induced glucose transport by 30-40% 
(Sylow et al., 2015). Mechanical stretch can be sensed by a number of proteins at 
the plasma membrane including dystrophin-glycoprotein complex, ion channels, 
integrins and focal adhesions which associate with and activate RAC1 (Sylow et al., 
2017). 
Muscle contractions also activate a number of mitogen-activated protein 
kinase (MAPK) isoforms; for example, extracellular related kinase 1 and 2 (ERK1/2), 
p38 and c-Jun N-terminal kinase (JNK) (Sakamoto and Goodyear, 2002). p38 
MAPK has been implicated in contraction-induced glucose uptake because the drug 
SB203580 (a p38 MAPK inhibitor) decreases glucose uptake in rat muscle (Somwar 
et al., 2000). However, as SB203580 directly binds to GLUT4 in adipocytes this may 
not provide conclusive evidence for a role of p38 MAPK (Richter and Hargreaves, 
2013). Further evidence is provided by the fact that activation of p38 MAPK in 
resting muscle using the drug animysin increases glucose uptake in rat muscle 
(Geiger et al., 2005). However, at present we do not have a complete understanding 
of the mechanisms through which p38 MAPK would lead to GLUT4 translocation.  
Convergence of insulin and contraction-induced signalling occurs 
downstream of Akt at TBC1D1 and TBC1D4 as AMPK and CAMKII have been 
shown to phosphorylate TBC1D4 (Richter and Hargreaves, 2013). Phosphorylation 
of TBC1D4 inhibits Rab-GAP function leading to GTP loading and activation of 
target Rabs to promote GLUT4 translocation.  
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2.3. Lifestyle Factors Leading to Impaired Glucose Homeostasis 
The previous sections focused on glucose delivery and uptake into the skeletal 
muscle to maintain glucose homeostasis in the normal insulin-sensitive state. The 
following sections will outline how insulin resistance impairs these actions resulting 
in impaired glucose homeostasis and eventually type 2 diabetes. Obesity and 
sedentary behaviour lead to structural and functional impairments in the skeletal 
muscle microvasculature that are associated with endothelial function loss and 
development of metabolic disease (Wasserman et al., 2018). Insulin resistance is 
also a common feature of type 1 diabetes (Kaul et al., 2015), which is exacerbated 
by the rising rates of obesity and physical inactivity in this population (Polsky and 
Ellis, 2015).  
The time course for the development of type 2 diabetes is relatively slow and 
the metabolic abnormalities are established long before overt diabetes develops 
(Abdul-Ghani et al., 2006). The state where abnormalities in glucose metabolism are 
present but blood glucose concentration is below the threshold for type 2 diabetes 
diagnosis is termed pre-diabetes (Vendrame and Gottlieb, 2004). The exact 
definition of pre-diabetes and type 2 diabetes are frequently debated and have been 
subject to constant revision over time (Genuth et al., 2003, Davidson et al., 2003, 
Schriger and Lorber, 2004). Pre-diabetes is defined as one of the following states: 
when the individual has high fasting plasma glucose concentration with a normal 
response to a glucose load; an abnormal postprandial glucose excursion but normal 
fasting glucose concentration; or a combination of high fasting glucose and 
abnormal response to a glucose load (Abdul-Ghani et al., 2006). Accordingly, the 
American Diabetes Association defines pre-diabetes based on any one of the 
following three criteria: an HbA1c of 5.7-6.4%, a fasting blood glucose concentration 
of 5.6-6.9 mmol/L and/or an oral glucose tolerance test of 7.8-11.0 mmol/L at 2 
hours (American Diabetes Association, 2011). In addition, many patients with 
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prediabetes also have the metabolic syndrome, which is characterised by 
hypertension, abdominal obesity and dyslipidaemia (Cornier et al., 2008). 
As insulin resistance develops, normally insulin sensitive tissues do not 
respond adequately to insulin (Shulman, 2000) and blood glucose concentration is 
not as tightly regulated. This results in large excursions in blood glucose following 
glucose ingestion due to a reduction in insulin-mediated glucose uptake in 
peripheral tissues and failure of insulin-mediated suppression of hepatic glucose 
production (Abdul-Ghani et al., 2006). In the initial period of pre-diabetes, the 
pancreatic β cells compensate for the peripheral insulin resistance by secreting 
more insulin, resulting in hyperinsulinaemia. Over time, the increased demand 
exerted on the β cells by the continuous hyperinsulinaemia leads to more severe 
insulin resistance and ultimately β cell failure and apoptosis. This causes plasma 
glucose concentrations to be chronically elevated, eventually leading to type 2 
diabetes. The American Diabetes Association (2011) diagnostic definition for type 2 
diabetes is a fasting plasma concentration of >7.0 mmol/L or a plasma concentration 
of >11.1 mmol/L post 2 hour 75g oral glucose tolerance test. Chronic 
hyperglycaemia is associated with macrovascular and microvascular complications 
including nephropathy, neuropathy, and retinopathy that over time can lead to 
severe outcomes including coronary heart disease, kidney failure, limb amputations 
and blindness. The following sections will now outline the mechanisms leading to 
the development of insulin resistance.  
 
2.3.1. Mechanisms of Insulin Resistance 
Skeletal muscle insulin resistance cannot be explained by a single 
pathophysiological mechanism as it involves dysregulation to numerous cellular and 
metabolic pathways which will be outlined below and summarised in Figure 2.2. Key 
features of insulin resistance include; 1) decreased delivery of insulin and glucose to 
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the myocyte due to impaired insulin-mediated dilation of the muscle 
microvasculature and decreased capillary density, 2) impaired lipid metabolism and 
accumulation of fatty acid metabolites, and 3) impaired insulin signalling at the 
myocyte leading to impaired GLUT4 translocation. 
 
2.3.1.1. Microvascular Insulin Resistance and Reduced Capillary Density 
Insulin exerts a physiological action at all levels of the arterial vascular tree and as 
such, insulin resistance is accompanied by dysfunction at each level (Barrett and Liu, 
2013). In the conduit arteries it accelerates atherosclerosis; in resistance vessels it 
enhances risk for hypertension and increases vascular stiffness; in small arterioles it 
can impair NO-mediated vasodilation; and capillary rarefaction diminishes the 
available surface for nutrient exchange, thereby limiting insulin access to the tissue 
and promoting metabolic insulin resistance (Chantler and Frisbee, 2015, Labazi and 
Trask, 2017, Muniyappa et al., 2007). Microvascular dysfunction may have effects 
on insulin-mediated changes in muscle perfusion and glucose metabolism which 
would lead to increased postprandial hyperglycaemia, hyperinsulinaemia and 
hypertriglycaemia, which eventually lead to type 2 diabetes (Wagenmakers et al., 
2016). 
The importance of insulin’s microvascular actions have been demonstrated 
in studies using animal models of chronic insulin resistance showing a reduced 
microvascular response during insulin infusion and impaired insulin-mediated 
glucose uptake (Clerk et al., 2007, Wallis et al., 2002, St-Pierre et al., 2010). de 
Jongh et al. (2004) examined skin microvascular function in 16 lean and 12 obese 
healthy women in the basal and hyperinsulinaemic state. Impaired microvascular 
function was associated with decreased insulin sensitivity and increased blood 
pressure. Therefore, it is anticipated that the blunted capillary perfusion seen in 
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obese individuals would contribute at least in part to the reduced insulin-mediated 
glucose disposal.  
Endothelial function is dependent on NO bioavailability (McAllister and 
Laughlin, 2006) which in turn is determined by the balance between NO synthesis 
and scavenging by superoxide anions and related reactive oxygen species (ROS). 
With insulin resistance, there is an altered balance between the formation and 
quenching of NO by superoxide anions and other ROS (Silver et al., 2007). High 
free fatty acid (FFA) levels associated with insulin resistance increase ROS 
production in the vasculature, with the two primary sources being NAD(P)Hoxidase 
(NAD(P)Hox) and the mitochondrial electron transport chain. Obesity also causes 
vascular inflammation leading to gene induction of NAD(P)Hox and activation of 
NOX2 by p47phox (Silver et al., 2007). This then leads to production of superoxide 
anions which will scavenge NO therefore reducing NO bioavailablity for vasodilation 
of the skeletal muscle microvasculature. This occurs by superoxide anions 
interacting with NO to generate peroxynitrite, which subsequently reduces NO 
bioavailability. Peroxynitrite can then oxidise tetrahydrobiopterin to inhibit PGI2 and 
alter NO-induced cGMP signalling in VSMCs (Munzel et al., 2005).  
With obesity, exposure of the vasculature to high levels of FFA initiates 
cellular processes including impaired insulin signalling (Belfort et al., 2005) and 
oxidative stress (Inoguchi et al., 2000) which lead to vascular insulin resistance. 
High FFA levels lead to accumulation of diacylglycerol (DAG), ceramides and long-
chain fatty acyl-CoAs (LCFACoA) in the endothelial cells of the skeletal muscle 
microvasculature (Rask-Madsen and King, 2005, Symons and Abel, 2013). These 
lipid metabolites activate serine kinases such as protein kinase C (PKC) and 
inhibitory kB kinase (IKKβ), that regulates nuclear factor-κB (NF-κB) which is a 
transcription factor associated with inflammation (Itani et al., 2002). Activation of 
PKCβ1 and β2 result in increased serine phosphorylation of IRS-1 leading to 
reduced insulin-stimulated Akt and eNOS (Naruse et al., 2006). 
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Insulin resistance, obesity and endothelial dysfunction are also characterised 
by increased inflammation (Fernandez-Real and Ricart, 2003). Visceral adipose 
tissue secretes a wide range of hormones including leptin, adiponectin, TNF-α, IL-6, 
resistin, angiotensinogen and plasminogen activator inhibitor-1 that affect vascular 
metabolism. A full overview of the effects of inflammation on vascular insulin 
resistance is beyond the scope of this introduction so interested readers are referred 
to a review by Muniyappa et al. (2007). Briefly, one key mechanism is that elevated 
plasma triglyceride (TG; chylomicron-TG and VLDL-TG) concentrations in the insulin 
resistant state leads to increased ROS production, which activates NF-κB to 
stimulate release of proinflammatory cytokines such as TNF-α and IL-6. TNF-α 
activates serine kinases including JNK, IKKβ and IL-Iβ receptor associated kinase 
(Nguyen et al., 2005). These directly or indirectly increase serine phosphorylation of 
IRS1/2 leading to decreased PI3K activity in response to insulin, ultimately leading 
to decreased NO bioavailability (Kim et al., 2001). 
 Under insulin resistant conditions, the PI3K pathway within the endothelium 
is selectively impaired, diminishing NO production (Cusi et al., 2000). However, the 
MAPK pathway remains intact so that ET-1 production is maintained and the 
balance between NO and ET-1 production becomes skewed (Potenza et al., 2005). 
The increased ET-1 production due to enhanced MAPK-dependent functions (Piatti 
et al., 1996) further promotes vasoconstriction and opposes residual NO activity 
(Younk et al., 2014). Therefore, the compensatory hyperinsulinaemic state 
associated with insulin resistance has important pathophysiological implications due 
to the increased ET-1 induced vasoconstriction. 
Obesity and inactivity are also associated with reduced skeletal muscle 
capillary density which limits skeletal muscle perfusion (Hoier and Hellsten, 2014). 
Microvascular density is important in determining insulin sensitivity and !̇O2max as it 
determines maximal capillary surface area available for exchange of insulin, oxygen 
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and nutrients (Frisbee, 2007). Capillary density is much higher in active than 
sedentary individuals (Blomqvist and Saltin, 1983) and there is a strong correlation 
between muscle capillary density with !̇O2max and insulin sensitivity (Lillioja et al., 
1987). In Chapter 5 of this thesis the adaptations to the skeletal muscle 
microvasculature during 12 weeks of Home-HIT will be investigated. This will 
provide information on the key mechanisms in the microvasculature underpinning 
the increased insulin sensitivity and aerobic capacity in obese individuals with 
elevated CVD risk. 
2.3.1.2. Lipid Induced Insulin Resistance and the Lipid Overflow Hypothesis 
The second major mechanism for obesity-related insulin resistance that will be 
discussed in this introduction is lipid induced insulin resistance in the skeletal 
muscle. Following a meal in normal healthy individuals, the rise in plasma glucose 
concentration is controlled through coordinated mechanisms that increase plasma 
glucose disposal and suppress endogenous glucose production. This glucose 
‘buffering’ minimises the exposure of tissues to the potentially damaging effects of 
hyperglycaemia that can lead to long-term vascular complications. In the same way, 
it has been argued that adipose tissue buffers the flux of fatty acids into the 
circulation during the postprandial period (Frayn, 2002). If this buffering process is 
impaired, as happens with obesity, tissues such as the liver, skeletal muscle and 
pancreatic β cells are exposed to excessive concentrations of TGs which can 
accumulate in the form of triacylglycerol (TAG), leading to insulin resistance via a 
complex array of metabolic abnormalities (Lewis et al., 2002, Frayn, 2002). The 
series of events by which failure of adipose tissue to buffer the influx of fatty acids 
leads to insulin resistance has been described by the “lipid overflow hypothesis” 
(Frayn, 2002). 
In the fasted state, insulin concentrations are low and plasma TG output from 
adipose tissue is high. Following a mixed meal, however, there is a rise in plasma 
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glucose concentrations resulting in insulin secretion from pancreatic β cells which 
has three main effects to buffer the FFA flux: 1) reduce the activity of hormone 
sensitive lipase (HSL) activity in the adipose tissue to suppress lipolysis and the 
release of FFAs into the circulation; 2) activation of lipoprotein lipase (LPL) in the 
capillary bed of adipose tissue, which stimulates FFA uptake into the adipose tissue 
for storage as TAG; 3) decreased LPL activity in the capillaries of skeletal muscle 
which reduces FFA uptake into the skeletal muscle. These mechanisms enable 
adipose tissue to buffer the lipid flux following a meal and protect non-adipose 
tissues such as the liver, skeletal muscle, heart and pancreatic β cells from the 
potentially damaging effects of elevated FFAs (Frayn, 2002).  
In obesity, the ability of adipose tissue to buffer the lipid flux is compromised 
(Frayn, 2002). The relative insulin resistance means that insulin does not increase 
LPL activity in adipose tissue following ingestion of a meal which reduces the 
capacity of adipose tissue to buffer the lipid flux causing FFAs to ‘spillover’ into non-
adipose tissues. In addition, there is a reduced capacity of insulin to suppress LPL 
activity in skeletal muscle leading to increased uptake of FFAs into this tissue. The 
accumulation of lipid in skeletal muscle (intramuscular triglyceride; IMTG) observed 
in obesity and type 2 diabetes is associated with insulin resistance (Goodpaster et 
al., 2001, Pan et al., 1997).  
At this point it is important to note that endurance-trained athletes have equal 
or even higher IMTG content than obese individuals or type 2 diabetes patients, 
despite being insulin sensitive (Goodpaster et al., 2001). This phenomenon has 
been termed the “athletes’ paradox” (Goodpaster et al., 2001). The elevated IMTG 
storage in endurance-trained individuals appears to represent an important 
metabolic adaptation to endurance training (van Loon, 2004, Amati et al., 2011). 
Indeed, the IMTG pool makes a significant contribution to total substrate oxidation 
during a bout of endurance exercise (van Loon et al., 2003). Research suggests that 
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skeletal muscle lipid oxidation is influenced by the spatial and functional interactions 
between mitochondria and lipid droplets. This appears to be an adaptation that 
occurs with training, as studies using electron microscopy have shown that the 
number of lipid droplets in contact with the mitochondria increases following SIT 
(Shepherd et al., 2017) and endurance training (Tarnopolsky et al., 2007). Therefore, 
in trained individuals with a high mitochondrial content, the capacity to oxidise 
plasma FFA and IMTG as a fuel source during exercise is high. Fundamentally, the 
regular breakdown and subsequent re-synthesis of IMTG in the post-exercise period 
in endurance-trained individuals means that the turnover rate of the IMTG pool is 
high, and this underpins the high insulin sensitivity in this population. 
Several experimental approaches have been taken to determine the 
mechanisms underpinning lipid-induced insulin resistance. Raising plasma FFA 
concentrations through infusion of intralipid and heparin or prolonged fasting (which 
is accompanied by an increased release of fatty acids from endogenous lipid stores) 
induces insulin resistance. Furthermore, cross-sectional studies comparing obese 
individuals and/or type 2 diabetes patients to healthy insulin-sensitive controls also 
offer insight into the mechanisms of lipid-induced insulin resistance. As a result of 
these studies, the current belief is that a functional imbalance exists between IMTG 
storage, lipolysis and fatty acid oxidation, leading to the accumulation of 
intramuscular lipid metabolites including LCFA-CoA, DAG and ceramides which are 
responsible for the impairment in insulin action (Amati et al., 2011, Itani et al., 2002). 
This imbalance is largely driven by a poor capacity of sedentary obese and/or type 2 
diabetic individuals to break down and oxidise IMTG during exercise (Moro et al., 
2008, Shaw et al., 2010). Indeed, studies using stable-isotope tracers have shown 
that IMTG contribute 40-50% of total fat oxidation during exercise in trained 
individuals, but IMTG makes a negligible contribution to fat oxidation in obese 
individuals and type 2 diabetes patients (van Loon et al., 2003, Blaak et al., 2000, 
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Schrauwen et al., 2002). In addition, a sedentary lifestyle leads to reduced 
mitochondria content and function which contributes to insulin resistance 
(Wagenmakers, 2005). Mitochondrial dysfunction is proposed to decrease the rate 
of β-oxidation, explaining the accumulation of intramuscular lipid metabolites that 
disrupt insulin signalling (Lowell and Shulman, 2005). However, it was also 
proposed by Koves et al. (2008) that lipid-induced insulin resistance may be due to 
excessive rather than reduced β-oxidation. This model suggested that oversupply of 
lipid to the mitochondria with obesity drives an increase in mitochondrial β-oxidation 
that exceeds the capacity of the Krebs cycle and electron transport chain leading to 
incomplete fatty acid oxidation and intra-mitochondrial accumulation of metabolites, 
mitochondrial stress and cellular dysfunction.  
The accumulation of fatty acid metabolites (including LCFA-CoA, DAGs and 
ceramides) is combined with increased plasma levels of inflammatory cytokines and 
local inflammation to inhibit the proximal insulin signalling cascade leading to 
reduced GLUT4 translocation to the plasma membrane (Hulver and Dohm, 2004). 
DAG is an intermediate of IMTG synthesis and hydrolysis and increases with insulin 
resistance in humans (Itani et al., 2002). However, there is also data showing that 
athletes have greater myocellular DAG than obese individuals (Amati et al., 2011), 
suggesting that the cellular localisation of DAG is more important in the 
development of insulin resistance with obesity. Indeed, Bergman et al. (2012b) 
found that only saturated DAG in skeletal muscle membranes was related to insulin 
resistance. DAG activates novel protein kinase C (PKC) isoforms (Itani et al., 2002, 
Bergman et al., 2012a) which inhibit the action of IRS-1 via serine phosphorylation 
leading to downstream inactivation of the insulin signalling cascade (Shaw et al., 
2010, Morino et al., 2006).  
With obesity and type 2 diabetes, ceramide concentration is elevated, and in 
particular, long-chain C18:0 and C16:0 ceramide species have been identified as 
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potentially critical in human insulin resistance (Tonks et al., 2016, Perreault et al., 
2018). Ceramide accumulation in the mitochondria is inversely related to insulin 
sensitivity as it may impede mitochondrial respiration (Perreault et al., 2018). 
Ceramide accumulation inhibits the insulin signalling pathway downstream of PI3K 
through the activation of protein phosphatase 2A which phosphorylates and 
inactivates Akt/PKB (Amati et al., 2011), meaning TBC1D4 and subsequently 
GLUT4 activation are inhibited (Mukhopadhyay et al., 2009). 
A full description of lipid induced insulin resistance is beyond the scope of 
this introduction; therefore, interested readers are referred to reviews by Shaw et al. 
(2010) and Tumova et al. (2016) for more information. Together it appears that the 
accumulation of IMTG and lipid metabolites per se do not cause insulin resistance. 
Rather, it is the reduced turnover of the IMTG pool due to inactivity and reduced 
access of the lipid droplets to the mitochondria for oxidation suggesting impaired 
metabolic flexibility. With exercise training there will be increased IMTG turnover 
resulting in a reduction in the accumulation of lipid metabolites such as ceramides, 
LCFA-CoA and DAG that can impair insulin signalling at the IRS-1 and Akt/PKB 
(Shulman, 2014, Amati et al., 2011, Shaw et al., 2010), eventually leading to 
improved insulin sensitivity (Shepherd et al., 2017). Exercise training should 
therefore be utilised as a strategy to improve insulin sensitivity.  
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Figure 2.2. Mechanisms of insulin resistance 
A) Shows the impaired insulin signalling in the vascular endothelial cell leading to 
impaired nitric oxide (NO)-mediated vasodilation and increased endothelin-1 (ET-1) 
induced vasoconstriction. Obesity increases NOX2 activation which leads to 
production of superoxide anions (O2¯) which in turn interact with NO to generate 
peroxynitrite (OON¯) which reduces NO bioavailability. B) Shows impairments in 
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insulin signalling at the myocyte resulting in impaired glucose uptake. Under insulin 
resistant conditions, the PI3K pathway within the vascular endothelium is selectively 
impaired, diminishing NO production. However, the MAPK pathway remains intact 
so that ET-1 production is maintained which further promotes vasoconstriction and 
opposes residual NO activity. In the skeletal muscle, an increased FFA flux leads to 
intramuscular triglyceride (IMTG) accumulation in this tissue. An imbalance in the 
storage, breakdown and oxidation of IMTG leads to accumulation of lipid 
metabolites which impair the insulin signalling cascade resulting in reduced GLUT4 
translocation. Excess lipid drives an increase in mitochondrial β oxidation which 
without an increase in energy demand leads to reactive oxygen species (ROS), 
inflammation and cell damage.  
 
2.4. Exercise Training as an Agent to Combat Metabolic Disease Risk 
A sedentary lifestyle is an important modifiable risk factor for the development of 
type 2 diabetes and CVD. Regular physical activity slows the progression of type 2 
diabetes and cardiovascular events due to the beneficial effects on body weight, 
insulin sensitivity, glycaemic control, lipid profile, endothelial function and aerobic 
capacity (see Section 2.4.2.). Large cohort studies consistently show that low 
aerobic fitness and physical activity levels predict an increased risk of 
cardiovascular mortality and type 2 diabetes (Kohl et al., 1992, Helmrich et al., 1991, 
Manson et al., 1991, Manson et al., 1992) and interested readers are directed to a 
review by Bassuk and Manson (2005) on epidemiological observations. For example, 
the Nurses’ Health Study showed that among 70,000 initially healthy women aged 
40-65 years that walking briskly for at least 2.5 hours per week (i.e. 30 minutes per 
day for 5 days a week) was associated with a 25% reduction in type 2 diabetes over 
an 8-year follow-up period compared to those reporting no vigorous exercise (Hu et 
al., 1999). 
Clinical trials using large cohorts have demonstrated that lifestyle 
interventions involving diet and exercise reduce the incidence of type 2 diabetes in 
people with impaired glucose tolerance (Tuomilehto et al., 2001, Lindstrom et al., 
2003, Eriksson and Lindgarde, 1991, Eriksson and Lindgarde, 1998). In the Finnish 
Diabetes Prevention Study (Lindstrom et al., 2003), 522 overweight individuals with 
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impaired glucose tolerance were randomly assigned to a lifestyle intervention or 
control condition. The intervention group aimed to perform moderate-intensity 
exercise at least 30 minutes per day alongside a diet intervention. Follow-up showed 
that incidence of type 2 diabetes in the intervention group was less than half that of 
the control group. Similarly, in the Malmo study (Eriksson and Lindgarde, 1991, 
Eriksson and Lindgarde, 1998), 161 people with impaired glucose tolerance 
participated in a diet and exercise intervention and were compared after 6 years with 
56 individuals that declined to take part in the same intervention. The incidence of 
type 2 diabetes after 6 years was 11% in the intervention group and 21% in the 
controls (Eriksson and Lindgarde, 1991). After 12 years of follow-up, mortality rate in 
the intervention group was less than half that of the control group (Eriksson and 
Lindgarde, 1998).  
Altogether, these large-scale studies provide strong evidence that regular, 
long term exercise reduces the risk of cardio-metabolic disease and mortality. 
Broadly speaking there are two aspects by which exercise enhances glucose 
homeostasis. First, the effects of an acute bout of exercise to enhance glucose 
uptake and improve post-exercise insulin sensitivity, and second, the longer term 
molecular adaptation with chronic exercise training leading to greater insulin 
sensitivity.  
 
2.4.1. Effect of an Acute Exercise Bout on Insulin Sensitivity 
Exercise (muscle contractions) has two main effects on muscle glucose metabolism. 
First, acute exercise stimulates increased glucose uptake via GLUT4 translocation, 
and second, a single bout of exercise increases insulin sensitivity for up to 48 hours 
to facilitate rapid glycogen resynthesis (Wojtaszewski et al., 1997, Richter et al., 
1984). From an evolutionary perspective, increased insulin sensitivity resulting in 
glycogen synthesis may be necessary to restore energy homeostasis (Jensen and 
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O'Rahilly, 2017), which would ultimately be beneficial during ‘fight-or-flight’ situations. 
However, in today’s obesogenic environment, exercise is an effective way to 
improve glycaemic control in insulin resistant individuals as blood glucose levels will 
be reduced after a bout of exercise (Wojtaszewski and Richter, 2006). This 
prolonged increase in insulin sensitivity following each exercise bout is a driver for 
the glucoregulatory benefits of regular endurance exercise (Morrison et al., 2017, 
Segal et al., 1991). Segal et al. (1991) investigated the effects of 12 weeks of 
exercise training (cycling at 70% !̇O2max 4 hours per week) on insulin action and 
glucose metabolism where bodyweight and body fat content were held constant in 
lean, obese and type 2 diabetic men. They found that despite the 27% increase in !̇O2max, the training had no effect on insulin-stimulated glucose disposal measured 
4-5 days after the last training session. More recently, Morrison et al. (2017) showed 
that postprandial glucose and insulin responses were reduced to the same extent 
following acute and chronic training. These observations suggest that the 
glucoregulatory benefits of endurance exercise are largely attributed to the residual 
effects of the last exercise bout.  
Establishing the mechanisms by which exercise improves muscle insulin 
sensitivity has proved difficult since Richter et al. (1984) first observed that exercise 
had an effect on muscle insulin sensitivity 36 years ago, and this is still not 
completely understood. Wojtaszewski et al. (2000) excluded the proximal portion of 
the insulin signalling cascade from contributing to the increase in muscle insulin 
sensitivity 4-48 hours after a single bout of one-legged knee extensor exercise. They 
found that insulin-stimulated glycogen synthase activity and glucose uptake in 
exercised muscle was not associated with upregulation of insulin signalling through 
the insulin receptor, Akt and GSK-3. A recent paper by Kjobsted et al. (2017) 
provided evidence the AMPK-TBC1D4 signalling axis is the likely mediating factor 
for improved insulin sensitivity up to 48 hours following muscle contractions. 
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Kjobsted et al. (2017) showed that AMPK activity is required for muscle contraction 
to increase insulin sensitivity as deletion of the two catalytic subunits (α1 and α2) 
prevented an exercise induced increase in insulin sensitivity. Kjobsted et al. (2017) 
also found that improved insulin sensitivity following contractions was not associated 
with enhanced glycogen synthase activity or proximal insulin signalling, which 
provides support for the study by Wojtaszewski et al. (2000).  
 
2.4.2. Adaptations Underpinning Exercise Training Induced Increases in &̇O2max and Insulin Sensitivity 
A high aerobic capacity (!̇O2max) and insulin sensitivity are key features of an 
optimal healthy phenotype so will be a major focus of this thesis. Aerobic exercise 
capacity is the strongest predictor of mortality risk even compared to more clinical 
variables or established risk factors such as hypertension, smoking or diabetes 
(Myers, 2003). Increasing !̇O2max through exercise training can reduce the risk of 
mortality by an equivalent (Paffenbarger et al., 1993) or greater magnitude (Blair et 
al., 1995) compared to modifying other risk factors such as giving up smoking. 
Insulin sensitivity is also important for reducing the risk of clinical events and the two 
factors are positively correlated (Goodpaster et al., 2001). This section will cover the 
effects of exercise training on mitochondrial density, capillary density, lipid 
metabolism and insulin signalling as these are key factors within the skeletal muscle 
that are associated with improvements in !̇O2max and insulin sensitivity. Other 
training induced adaptations in cardiac muscle, blood composition and arterial 
structure are also important. However, these cardiovascular adaptations are beyond 
the scope of this introduction so interested readers are referred to Hellsten and 
Nyberg (2015).  
Increased mitochondrial protein content is a major training adaptation that 
increases skeletal muscle oxidative potential (Holloszy, 1967, MacInnis and Gibala, 
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2017). Skeletal muscle mitochondria regulates substrate metabolism during 
submaximal exercise, with greater mitochondrial content promoting an increased 
reliance on fat oxidation and a proportional decrease in carbohydrate oxidation 
(Egan and Zierath, 2013). This results in reduced glycogen degradation and lactate 
production at a given exercise intensity, while increasing the lactate threshold and 
allowing individuals to exercise for longer and at greater intensities. Mitochondrial 
biogenesis reflects an increase in the abundance of proteins involved in 
mitochondrial ATP production, the Krebs cycle, mobilisation, transport and oxidation 
of fatty acids, glycolytic metabolism, antioxidant capacity, glucose transport and 
glycogen synthesis (Egan and Zierath, 2013). The increase in mitochondrial content 
appears to be a relatively short-term adaptation to training and the reader is directed 
to a paper by Egan and Zierath (2013) for a detailed review on the signalling 
pathways involved in mitochondrial biogenesis. Very briefly, a single bout of MICT 
activates signalling pathways to induce transient mRNA expression, and the 
repeated activation of these pathways leads to increases in mitochondrial protein 
content (Coffey and Hawley, 2007). Egan et al. (2013) investigated the time-course 
of adaptation of mitochondrial mRNA expression and protein content during aerobic 
training. They found that there was increased mRNA expression of genes including 
PGC1-α and EERα after one session which was proceeded by progressive 
increases in cytochrome oxidase IV (COX IV) expression after 2 weeks of training. 
Increased mitochondrial protein content is also important in regulation of fatty acid 
turnover with training which will reduce the accumulation of lipid metabolites that are 
implicated in impairment in the insulin signalling cascade (Shulman, 2000). 
Therefore, mitochondrial biogenesis with aerobic exercise training is associated with 
improved insulin sensitivity.  
Microvascular density has an important role in determining aerobic capacity 
and insulin sensitivity as it determines the maximal surface area available for 
exchange of insulin, nutrients and oxygen (Akerstrom et al., 2014, Hellsten and 
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Nyberg, 2015). Capillary density is higher in active individuals and there is a strong 
positive correlation between skeletal muscle capillary density and !̇O2max and insulin 
sensitivity. Exercise training increases skeletal muscle capillarisation in human 
skeletal muscle (Andersen and Henriksson, 1977, Wagenmakers, 2016) and the 
mechanisms are reviewed in detail by Hoier and Hellsten (2014).   
Endurance training increases microvascular eNOS content in lean sedentary 
and obese individuals (Cocks et al., 2013, Cocks et al., 2016), insulin induced 
ser1177 phosphorylation and vasodilatory response capacity of the skeletal muscle 
microvasculature to insulin. Oxidative stress is a systemic feature of obesity and 
excessive ROS production can result in apoptosis and increased cellular 
permeability which may promote inflammation, endothelial dysfunction and vascular 
remodelling. NAD(P)Hox is considered a prominent source of vascular derived ROS 
that promotes vascular dysfunction (Weseler and Bast, 2010). NOX2 which is a 
catalytic subunit of NAD(P)Hox and its activation by p47phox, has been suggested to 
be a major source of superoxide anion production in obese individuals (Silver et al., 
2007, La Favor et al., 2016). These superoxide anions will scavenge NO thereby 
reducing the bioavailability of NO for vasodilation of the skeletal muscle 
microvasculature. Four weeks of MICT increased capillarisation and 
eNOS/NAD(P)Hox balance in previously sedentary obese (Cocks et al., 2016) and 
lean (Cocks et al., 2013) males which was associated with improved insulin 
sensitivity and !̇O2max.  
Cross-sectional studies have shown that IMTG content is greater in trained 
compared to obese or type 2 diabetic individuals (Goodpaster et al., 2001) and 
endurance trained athletes have a higher IMTG fractional synthetic rate compared to 
sedentary individuals (Bergman et al., 2010). Exercise training increases the 
capacity to oxidise fat during exercise, which decreases reliance on carbohydrate 
(van Loon, 2004). Longitudinal training studies consistently show that there is an 
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increase in IMTG utilisation during moderate-intensity exercise with training 
(Schrauwen et al., 2002, De Bock et al., 2008, Van Proeyen et al., 2011, Phillips et 
al., 1996a) due to greater expression of enzymes responsible for IMTG hydrolysis. A 
single bout of endurance exercise has been shown to prevent fatty acid induced 
insulin resistance during lipid infusion on the following day (Schenk and Horowitz, 
2007). This was accompanied by increased expression of enzymes involved in 
triglyceride synthesis and reduced accumulation of fatty acid metabolites. Increased 
mitochondrial density combined with an increased IMTG content following training 
suggests an adaptation whereby IMTG-containing lipid droplets are in closer 
proximity to the mitochondrial reticulum, which underpins the training-induced 
increase in IMTG utilisation. Indeed, four weeks of MICT increased the number of 
lipid droplets in contact with the mitochondria in obese males (Shepherd et al., 
2017). This adaptation likely enhanced the capacity for IMTG utilisation during 
exercise, and will result in reduced accumulation of lipid metabolites such as 
ceramides, LCFA-CoA and DAGs that can impair insulin signalling (Shulman, 2014, 
Amati et al., 2011, Shaw et al., 2010), thereby contributing to improved insulin 
sensitivity. In support, Shepherd et al. (2017) also reported a reduction in muscle 
ceramide concentrations alongside an improvement in insulin sensitivity following 4 
weeks of MICT in obese individuals.  
Regular exercise training leads to increased expression and/or activity of key 
signalling proteins involved in the regulation of glucose uptake and metabolism 
(Hawley and Lessard, 2008). Part of the improved glycaemic control achieved 
through exercise training may be due to the cumulative effects of acute exercise 
bouts which firstly reduce plasma glucose concentration through contraction-
mediated glucose uptake and secondly improve insulin sensitivity of working muscle 
up to 48 hours after the exercise bout. With regular exercise training there are 
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adaptations that result in reduced basal and glucose-stimulated insulin levels, 
improved intracellular insulin signalling and increased GLUT4 protein content.  
Defects in insulin signal transduction through the IRS-1/PI3K pathway are 
associated with reduced GLUT4 translocation in insulin resistant skeletal muscle 
(Zierath et al., 1996, Bjornholm et al., 1997). Therefore, the metabolic adaptations 
with exercise training may involve changes in expression of proteins involved in 
glucose transport. Chronic exercise training has been shown to result in higher rates 
of tyrosine phosphorylation of molecules of the insulin signalling cascade in healthy 
and insulin-resistant humans (Frosig et al., 2007, Consitt et al., 2013). Exercise 
training has been shown to stimulate PI3K in skeletal muscle (Kirwan et al., 2000, 
Chibalin et al., 2000) and trained individuals have increased insulin-stimulated PI3K 
activation than untrained suggesting a positive association between PI3K activation 
and !̇O2max (Kirwan et al., 2000). As PI3K is an important step in insulin-stimulated 
GLUT4 translocation, this is likely to be one step that regular physical activity 
improves insulin signalling. Improvements in whole-body insulin-mediated glucose 
uptake after exercise have been attributed to an increase in intracellular signalling 
via PI3K activity (Houmard et al., 1999, Kirwan et al., 2000). This is clinically 
relevant because PI3K activity is decreased in skeletal muscle from insulin resistant 
participants and in those with type 2 diabetes (Goodyear et al. 1995). Frosig et al. 
(2007) investigated the effect of 3 weeks of leg extensor endurance exercise in 8 
healthy men. Training increased activity and phosphorylation of Akt1 and AS160 
alongside an increase in insulin sensitivity. However, in contrast to expectations, 
they did not find increased IRS-1 associated PI3K activity with training.  
Increased skeletal muscle GLUT4 content is associated with improved 
insulin action, as shown in animal models overexpressing GLUT 4 (Ren et al., 1995, 
Hansen et al., 1995). Increased GLUT4 levels is an adaptation to exercise training in 
humans leading to improved insulin sensitivity (Phillips et al., 1996b, Kraniou et al., 
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2004) and there is a rapid decline in GLUT4 with inactivity (McCoy et al., 1994). In 
humans, GLUT4 mRNA concentration increases in skeletal muscle within 3 hours 
after a single exercise bout (Neufer and Dohm, 1993) which is followed by increases 
in GLUT4 protein content after 16-24 hours (Ren et al., 1994). This will not lead to 
acute changes in insulin sensitivity, but with repeated exercise bouts over time 
(exercise training) adaptations to physical activity to include more long-lasting 
increases in insulin sensitivity (Ojuka et al., 2012). Bradley et al. (2014) showed that 
GLUT4 protein content increased following 6 weeks of SIT and endurance training in 
previously sedentary, lean males and this was associated with similar improvements 
in insulin sensitivity in both groups.  
The aforementioned markers of metabolic health are all important for a 
metabolically healthy, insulin-sensitive phenotype and are improved with regular 
exercise training. For this reason, Chapter 4 and 5 used a wide range of 
physiological tests to comprehensively establish the effectiveness of Home-HIT in 
obese individuals with elevated CVD. 
 
2.5. Type 1 Diabetes 
Unlike obesity-induced insulin resistance and type 2 diabetes which is largely driven 
by lifestyle factors, type 1 diabetes, previously known as insulin-dependent diabetes 
mellitus (IDDM) or juvenile diabetes, is a chronic inflammatory autoimmune disease 
whereby the insulin-producing β-cells of the islets of Langerhans of the pancreas 
are destroyed (Atkinson and Eisenbarth, 2001). Type 1 diabetes accounts for 10-15% 
of all cases of diabetes (>16 million cases worldwide), affecting ~400,000 people in 
the UK (jdrf.org.uk/about-type-1-diabetes) at a cost of ~£1.8 billion to the NHS per 
annum (Hex et al., 2012). The incidence of type 1 diabetes is increasing annually by 
3-5%, possibly due to environmental factors such as the obesity epidemic or 
increases in human hygiene (Peng and Hagopian, 2006, Chapman et al., 2012, 
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Bach and Chatenoud, 2012), although mechanisms for this are speculative at 
present. 
The classical symptoms of type 1 diabetes include weight loss due to 
uncontrolled glucose, protein and lipid metabolism, as well as glucose excretion in 
the urine; increased urination (polyuria) due to glucose in the urine; and increased 
thirst (polydipsia) due to increased urination and changes in the osmolality of 
extracellular fluid (Daneman, 2006). Type 1 diabetes increases the risk of numerous 
acute and long-term complications because of the lifetime exposure to erratic blood 
glucose levels (Chimen et al., 2012). Acute complications include diabetic 
ketoacidosis and hypoglycaemia, which can be potentially life threatening. Long-
term complications include neuropathy, nephropathy, retinopathy, heart disease, 
stroke and foot ulcers, which in severe cases may lead to amputation. Type 1 
diabetes shortens life expectancy by 15-20 years and risk of death is 3-4 times 
higher than for non-diabetics (Team, 2007, Dawson et al., 2008). This is particularly 
true in young females, mostly because their protection from CVD is lost and they 
have higher levels of centrally distributed obesity compared to non-diabetic females 
(Narendran et al., 2015, Krishnan et al., 2012).  
The following sections will discuss the importance of regular exercise for 
people with type 1 diabetes, as physical inactivity and obesity can also increase the 
risk of insulin resistance and vascular complications in this population. 
 
2.5.1. The Importance of Exercise for People with Type 1 Diabetes 
Regular exercise is recommended for those with type 1 diabetes for maintenance of 
overall health and prevention of macrovascular and microvascular complications, 
which are a major cause of mortality and morbidity (Chimen et al., 2012, Moy et al., 
1993, Wasserman and Zinman, 1994, Devaraj et al., 2007). However, people with 
type 1 diabetes tend to be at least as inactive as the general population, with a large 
Chapter 2 
42 
 
percentage of patients not maintaining a healthy body mass or meeting physical 
activity guidelines (Tielemans et al., 2013, Makura et al., 2013). The majority of 
patients living with type 1 diabetes do not have a healthy bodyweight as ~60% are 
overweight or obese (Bohn et al., 2015). Large scale studies such as the Swedish 
National Diabetes Registry found that among the 21,000 type 1 diabetic adults on 
their record, that obesity was significantly associated with increased risk for heart 
failure (Vestberg et al., 2013), and Price et al. (2014) found that obesity was 
associated with retinopathy and macrovascular disease in those with type 1 
diabetes. Inactive people with type 1 diabetes are also at risk of the metabolic 
syndrome, sometimes referred to as “double diabetes” (Cleland, 2012), as insulin 
resistance is common and inversely related to HbA1c (Yki-Jarvinen and Koivisto, 
1986). Data from the Finnish Diabetic Nephropathy study showed that the 
prevalence of the metabolic syndrome was 38% in men and 40% in women with 
type 1 diabetes (Thorn et al., 2005). Obesity and incidence of the metabolic 
syndrome is rising in the type 1 diabetic population (Chillaron et al., 2014), resulting 
in an increase in the incidence of cardiovascular events and diabetic complications.  
Insulin resistance is common in people with type 1 diabetes and the 
incidence is rising, mirroring the trend in the general population and reflecting the 
rising rates of obesity (Kilpatrick et al., 2007, McGill et al., 2008). This is important 
given that insulin resistance is an additional independent risk factor for micro- and 
macro-vascular complications in those with type 1 diabetes (Orchard et al., 2003). 
There is likely overlap in terms of the mechanisms for insulin resistance in type 1 
and 2 diabetes, including increased IMTG content (Perseghin et al., 2003) and 
mitochondrial dysfunction (Kacerovsky et al., 2011). However, hyperglycaemia 
alone is unable to explain the high prevalence of insulin resistance observed in 
those with type 1 diabetes (Fasching et al., 1993, Kacerovsky et al., 2011, Bergman 
et al., 2012a). It has been speculated that chronic exogenous insulin use is an 
important factor, as exposure to a long-acting human insulin analogue such as 
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insulin detemir has been shown to result in more significant insulin resistance, 
oxidative stress, skeletal muscle ectopic fat accumulation and mitochondrial 
impairments compared to hyperglycaemia alone (Liu et al., 2009). Studies 
consistently demonstrate that physical activity is associated with reduced insulin 
requirements in people with type 1 diabetes, which would therefore have positive 
effects on insulin sensitivity and cardiovascular health (Ramalho et al., 2006, Yki-
Jarvinen et al., 1984). Indeed, Muis et al. (2006) found in a cross-sectional study of 
416 patients that increased physical activity was associated with lower daily insulin 
needs, while increased body weight and triglyceride levels were associated with 
higher insulin doses. 
Skeletal muscle health is adversely affected in people with type 1 diabetes 
due to increased metabolic stress, vascular impairments and insulin resistance 
compared to non-diabetics (Coleman et al., 2015). Impaired skeletal muscle health 
may lead to a vicious cycle of insulin resistance, impaired glucose and lipid disposal, 
and reduced basal metabolic rate, which would affect an individual’s ability to 
manage their type 1 diabetes. In addition, impaired insulin-stimulated vasodilation 
can reduce blood flow and therefore glucose delivery for uptake into skeletal muscle 
(Makimattila et al., 1996, Baron et al., 1991). It is believed that maintaining or 
improving skeletal muscle health in individuals with type 1 diabetes, potentially 
through exercise, can contribute to delaying complications.  
People with type 1 diabetes have higher IMTG content than weight and 
activity matched non-diabetics, similar to type 2 diabetic individuals, which is 
associated with impaired insulin sensitivity (Perseghin et al., 2003, Dube et al., 
2006). It is assumed that as IMTG deposition increases, lipotoxicity ensues (van 
Herpen and Schrauwen-Hinderling, 2008), enhancing stress on the tissue. The 
chronic hyperglycaemic state may be a relevant mechanism of exaggerated IMTG 
accumulation in those with type 1 diabetes as Perseghin et al. (2003) found a 
relationship between IMTG and HbA1c. When Perseghin et al. (2003) separated 
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type 1 participants into good (HbA1c <7.5%) and poor (HbA1c >7.6%) metabolic 
control, those with good control showed higher insulin-stimulated glucose metabolic 
clearance rate in association with lower IMTG, suggesting that when good glucose 
homeostasis is achieved these abnormalities may be at least partially reversed. As 
exercise training is associated with greater IMTG turnover in people without type 1 
diabetes, exercise may improve insulin sensitivity through similar mechanisms in 
people with type 1 diabetes.  
Increased inflammation and oxidative stress is another characteristic of type 
1 diabetes due to the excessive plasma glucose (Brownlee, 2005, Coleman et al., 
2015, Russell et al., 2009). Oxidative stress likely contributes to diabetic myopathy 
through upregulation of atrophy-related genes (atrogenes) atrogin-1 and MuRF-1 
resulting in lower muscle mass (Mastrocola et al., 2008). In addition, the high 
oxidative stress can impair the transcription of glucose transporters which 
contributes to the development of insulin resistance (Bloch-Damti and Bashan, 
2005). A single bout of exercise elicits anti-inflammatory effects and exercise 
training may decrease basal levels of the pro-inflammatory cytokine IL-6 in people 
with type 1 diabetes (Fischer, 2006). The anti-inflammatory effects of exercise may 
also have a beneficial effect on β cell mass due to marked increases in circulating 
growth hormone, IGF-1, GLP-1 and IL-1 receptor agonist. For people recently 
diagnosed with type 1 diabetes, exercise training may have numerous positive 
effects that would reduce daily insulin needs and possibly preserve β cell function. 
Animal studies suggest that exercise preserves β cell mass (Coskun et al., 2004) 
and insulin secretion per β cell islet (Huang et al., 2011), possibly due to anti-
inflammatory effects of exercise. Preservation of β cell mass is clinically significant 
as it reduces the risk of retinopathy and neuropathy and reduces the incidence of 
hypoglycaemia (Narendran et al., 2015).  
The majority of the evidence used to create the physical activity guidelines 
(Colberg et al., 2016) applied to people with type 1 diabetes are based on studies on 
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healthy individuals and those with type 2 diabetes (Chimen et al., 2012). These are 
clearly different conditions, so it is important to establish the effects of exercise in 
people with type 1 diabetes in order to establish the most effective strategies. The 
number of exercise training studies conducted in people with type 1 diabetes is 
relatively small; however, it appears that so long as the appropriate precautions are 
made regarding blood glucose levels during and around exercise, people with type 1 
diabetes should take part in regular exercise (Riddell et al., 2017). Supervised 
exercise training has been shown to improve !̇O2max (Laaksonen et al., 2000, Yki-
Jarvinen et al., 1984), blood lipid profile (Laaksonen et al., 2000) and endothelial 
function (Fuchsjager-Mayrl et al., 2002). Regular exercise training has consistently 
been shown to reduce insulin requirements between 6 and 15% indicating improved 
insulin sensitivity (Ramalho et al., 2006, Fuchsjager-Mayrl et al., 2002, Yki-Jarvinen 
et al., 1984); however, studies investigating the effects of physical activity on 
glycaemic control in people with type 1 diabetes are less clear (Chimen et al., 2012). 
A number of factors may account for the difficulty in detecting a change in glycaemic 
control with training. For example, carbohydrate consumption often increases 
around the time of exercise in people with type 1 diabetes to reduce the risk of 
hypoglycaemia and this may counteract any improvement in glycaemia with training 
(Kennedy et al., 2013). Nonetheless, improvements in the above mentioned factors 
collectively reduce the risk of diabetic complications and increase life expectancy 
(Moy et al., 1993). Unfortunately, as discussed earlier, similarly to the rest of the UK 
population, many people with type 1 diabetes fail to reach the minimum physical 
activity guidelines (Brazeau et al., 2014, Bohn et al., 2015). The following sections 
will discuss the potential barriers that prevent such a large proportion of the general 
population from meeting the physical activity guidelines.  
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2.6. Barriers to Exercise 
As outlined above, regular exercise training is associated with greater !̇O2max and 
insulin sensitivity which reduce the risk of chronic disease and mortality (Booth et al., 
2017, Myers, 2003). However, the majority of the worldwide population fail to reach 
the physical activity guidelines of 150 minutes of accumulated moderate intensity or 
75 minutes of vigorous intensity exercise per week. Lack of time is cited as the main 
barrier to exercise (Trost et al., 2002) as many individuals feel that increasing work 
hours and family commitments mean they cannot achieve the physical activity 
guidelines. Other common barriers within the general population include limited 
access to facilities and appropriate equipment, difficulty with transportation, 
inadequate financial resources and lack of motivation (Trost et al., 2002).  
Additional exercise barriers have been identified in overweight individuals 
either at high risk or already with type 2 diabetes (Korkiakangas et al., 2009). 
Physically active adults have been shown to experience fewer exercise barriers 
compared with those leading more sedentary lives and adults of normal weight 
experience fewer barriers than overweight adults (Kowal and Fortier, 2007). The 
feeling of being too fat or embarrassed to exercise are common additional barriers 
among overweight adults, that tend to be higher in women than men (Ball et al., 
2000). However, in obese individuals, increases in weekly exercise and/or weight 
loss are associated with reduced barriers (Korkiakangas et al., 2009). This suggests 
that starting and maintaining an exercise programme for a sustained period (~3 
months) may reduce barriers and help to maintain adherence. The population has to 
be taken into account when designing exercise training programmes to overcome 
the major barriers to exercise, as will be covered in Chapter 4. People with type 1 
diabetes have additional, specific barriers to exercise that will be discussed below, 
and these are the focus of Chapters 6, 7 and 8. 
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2.6.1. Specific Exercise Barriers in People with Type 1 Diabetes 
As with the rest of the population, people with type 1 diabetes are recommended to 
do regular exercise (Colberg et al., 2016, Riddell et al., 2017). However, many fail to 
achieve the exercise guidelines and many programmes designed to increase 
physical activity in people with type 1 diabetes have failed (Brazeau et al., 2014). In 
addition to the usual barriers cited by the general population such as lack of time, 
work commitments and cost (Brazeau et al., 2008, Jabbour et al., 2016, Lascar et al., 
2014), additional barriers to exercise can exist for those with type 1 diabetes 
including fear of hypoglycaemia, loss of glycaemic control and inadequate 
knowledge around exercise management (Lascar et al., 2014). 
Iatrogenic hypoglycaemia is defined in patients with type 1 diabetes as all 
episodes of abnormally low plasma glucose concentration that expose the individual 
to potential harm (Seaquist et al., 2013). A specific glycaemic threshold value that 
defines hypoglycaemia cannot be assigned, as the thresholds are lower after recent 
antecedent hypoglycaemia or higher in poorly controlled type 1 diabetic patients. 
However, the International Hypoglycaemia Study Group have defined Level 1 
hypoglycaemia as a blood glucose concentration ≤3.9 mmol/L; Level 2 
hypoglycaemia as ≤2.9 mmol/L which indicates serious, clinically important 
hypoglycaemia; and Level 3 severe hypoglycaemia as when the patient requires 
assistance from another individual to treat the hypoglycaemia (International 
Hypoglycaemia Study Group, 2017). The symptoms of hypoglycaemia range in 
seriousness from loss of coordination and mental confusion to convulsions, 
unconsciousness, brain damage and even death (Becker and Ryan, 2000, Cryer et 
al., 2003). At the very least, an episode of hypoglycaemia is a nuisance and a 
distraction, but in extreme cases can be fatal; hypoglycaemia accounts for 2-4% of 
deaths in people with type 1 diabetes (Cryer et al., 2009). People with type 1 
diabetes suffer on average two episodes of symptomatic hypoglycaemia per week 
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(although studies using continuous glucose monitors show higher unnoticed 
incidences; (Kubiak et al., 2004)) and one severe, temporarily-disabling 
hypoglycaemic episode per year (MacLeod et al., 1993, Gubitosi-Klug et al., 2017). 
Hypoglycaemia is associated with cardiovascular, neurologic and 
psychological morbidities (Gill et al., 2009, Oyer, 2013). During hypoglycaemia there 
is a large autonomic stimulus which promotes haemodynamic changes and 
increases workload on the heart, which may have dangerous consequences in 
some patients. Hypoglycaemia also stimulates an increased pro-inflammatory 
cytokine response (Razavi Nematollahi et al., 2009), leading to elevated plasma 
viscosity because of an increase in erythrocyte concentration and coagulation, and 
potentially affecting plaque stability (Frier et al., 2011). These changes may promote 
intravascular coagulation and thrombosis, and encourage development of tissue 
ischaemia. Hypoglycaemic episodes also prolong cardiac repolarisation and can 
increase the risk of cardiac arrhythmias and sudden death (Frier et al., 2011, Cryer, 
2011). The longer term effects of repeated exposure to severe hypoglycaemia on 
cognitive function are less clear. Data from the diabetes control and compilations 
trial (DCCT) showed no differences in cognitive function between intensive 
treatment (strict avoidance of hypoglycaemia) and standard treatment arms over 20 
years (Frier, 2011). However, severe hypoglycaemia in children with type 1 diabetes 
has been associated with poorer cognitive development (Bjorgaas, 2012). 
Fear of hypoglycaemia is a major barrier to exercise in people with type 1 
diabetes (Lascar et al., 2014, Brazeau et al., 2008). Exercise generally increases 
the risk of hypoglycaemia in people with type 1 diabetes due to their inability to 
decrease endogenous circulating insulin, increases in exercise-induced insulin 
sensitivity and an exercise-induced mobilisation of insulin from the site of 
administration (Wasserman and Zinman, 1994). The current exercise guidelines 
recommend that people with type 1 diabetes should accumulate 150 minutes of 
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moderate-intensity exercise per week (Colberg et al., 2016). However, as a bout of 
moderate-intensity exercise is associated with a rapid decline in glycaemia (-4.43 
mmol/L h-1 on average; (Garcia-Garcia et al., 2015)), it is not surprising that many 
people with type 1 diabetes avoid exercise, especially if they have had a previous 
bad experience of exercise-related hypoglycaemia. However, because of their 
increased risk of macro-vascular disease, regular exercise should be encouraged as 
the overall cardio-metabolic benefits outweigh the immediate risks, provided certain 
precautions are taken (Codella et al., 2017, Riddell et al., 2017). Greater knowledge 
of the glucoregulatory responses to different types of exercise may enable 
precautions to be made to manage exogenous insulin and nutritional intake 
accordingly. This will be explored in Chapters 6, 7 and 8. 
Post-exercise, late-onset hypoglycaemia is also a common complaint and 
barrier to exercise for those with type 1 diabetes (MacDonald, 1987). The risk of 
hypoglycaemia has been shown to persist for up to 31 hours post exercise 
(MacDonald, 1987). Glucose requirements following moderate-intensity exercise 
exhibit a biphasic pattern with increases occurring both immediately post and 7-11 
hours post-exercise (McMahon et al., 2007, Tsalikian et al., 2005). The immediate 
effects of exercise on glucose uptake are mediated by the residual effects of 
contraction-stimulated glucose uptake which are independent of insulin. Beyond the 
first few hours, the increased risk of hypoglycaemia is primarily due to increased 
insulin sensitivity which can vary according to duration and intensity of exercise that 
was performed (Mikines et al., 1988). The increased insulin sensitivity and continued 
extraction of glucose from the circulation has been suggested to be due to increased 
glycogen synthase activity to replenish muscle glycogen stores (Teich and Riddell, 
2016). Deactivation of glycogen synthase kinase 3 is also thought to promote 
activation of glycogen synthase which will mean that glucose uptake is maintained 
(Cross et al., 1995). However, enhanced GLUT4 translocation and microvascular 
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perfusion are also important for the changes in glucose uptake. Special care may be 
required to prevent post-exercise hypoglycaemia after afternoon or evening exercise 
because there is a greater risk of nocturnal hypoglycaemia (Gomez et al., 2015). 
The risk of nocturnal hypoglycaemia following 45 minutes of moderate-intensity 
exercise in the day has been shown to be as high as 30-40% (Tsalikian et al., 2005, 
Maran et al., 2010, Iscoe et al., 2006). For these reasons, continuous glucose 
monitoring is used in Chapter 6 to assess the 24-hour glucose profiles in people 
with type 1 diabetes following exercise. 
Hyperglycaemia is another potential barrier for people with type 1 diabetes 
as certain types of exercise can cause an increase in blood glucose (Riddell et al., 
2017). High-intensity aerobic exercise tends to increase blood glucose 
concentrations because insulin levels do not rise in the portal circulation of someone 
with type 1 diabetes to compensate for the increase in catecholamines. In someone 
without type 1 diabetes, the increase in catecholamines and hyperglycaemia is 
compensated for by an increase in insulin secretion, usually at the end of the 
exercise session. Prolonged and severe hypoinsulinaemia (possibly due to missed 
insulin dose, removed insulin pump or illness) increases the risk of elevated 
circulating or urinary ketone bodies. In these situations, high intensity exercise can 
increase hyperglycaemia and lead to ketoacidosis. This is because in the absence 
of insulin, muscle cells may not be able to take up glucose to use as a fuel, so 
instead rely on fatty acids and ketones. Hyperglycaemia and ketoacidosis may 
cause dehydration and decrease blood pH resulting in impaired performance and 
severe illness. Rapid ketone production can lead to ketoacidotic abdominal pain and 
vomiting, and in some cases may require emergency assistance. Therefore, people 
with type 1 diabetes are recommended to delay an exercise session if blood glucose 
concentration is >14 mmol/L and blood or urinary ketones are elevated (Riddell et 
al., 2017, Narendran et al., 2017). 
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2.7. Using High-Intensity Interval Training to Overcome Barriers to Exercise 
2.7.1. Brief history of High-Intensity Interval Training 
After the Second World War, interval training became a widespread training method 
used by a number of European runners and was popularized by Emil Záptopek who 
won the 5,000 m, 10,000 m and marathon in the same Olympics. However, it wasn’t 
until the 1960s that the first scientific studies on interval training were conducted by 
the Swedish physiologist Per Oløf Astrand, who developed long interval training at a 
velocity between critical velocity and !̇O2max (Astrand et al., 1960). Shortly after, 
Christensen et al. (1960), from the same group, proposed very short interval training 
consisting of 10-second intervals at 100% !̇O2max interspersed with 10 seconds of 
recovery. This paper, involving two well trained male runners, was the first published 
paper to describe the metabolic response during interval training. This paper 
described how the two participants were able to achieve high oxygen uptake values 
during the intervals with a low increase in blood lactate as they were able to 
compensate for the oxygen deficits of each work interval during the rest periods. 
Around 10 years later, Karlsson and Saltin (1971) took biopsies at various points 
throughout an interval training protocol in three recreationally trained men which 
demonstrated that phosphocreatine was progressively depleted after each interval. 
Later, in the 1970s, Eddy et al. (1977) conducted a 7-week training intervention 
where one group did interval training (one minute on, one minute off at 100% !̇O2max) 
and the other did steady state cycling (70% !̇O2max). This study showed identical 
changes in !̇O2max following the 7 weeks. Together, this body of work provided the 
basis for the explosion in interval training-related research over the last 15 years.    
Today, high-intensity interval training (HIT) is defined as brief, intermittent 
periods of vigorous exercise, interspersed with periods of rest or active recovery. 
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When energy expenditure is matched to traditional MICT, HIT can induce similar or 
even superior improvements in performance and cardio-metabolic parameters in 
healthy and diseased populations (Wisloff et al., 2007, Tjonna et al., 2008). 
Furthermore, there is evidence that HIT may be more enjoyable than continuous 
exercise (Bartlett et al., 2011, Jung et al., 2014), unless the intervals are too 
strenuous or difficult to complete, and levels of enjoyment appear to increase with 
chronic training (Heisz et al., 2016). Therefore, HIT may offer an effective, 
alternative training strategy to traditional continuous aerobic exercise which currently 
forms the basis of the physical activity guidelines (Colberg et al., 2016). The main 
HIT protocols investigated in the literature are aerobic interval training (AIT) (Wisloff 
et al., 2007), sprint interval training (SIT) (Burgomaster et al., 2005) and constant 
load low-volume HIT (Little et al., 2011).  
The rationale for implementing AIT was derived from evidence that the 
interval design enables individual to exercise at higher intensities thereby 
challenging the pumping ability of the heart more than would be possible at lower 
intensities (Tjonna et al., 2008). Indeed, studies have shown that AIT induces 
superior benefits in !̇O2max to MICT in a number of at-risk populations (Molmen-
Hansen et al., 2012, Wisloff et al., 2007, Tjonna et al., 2008). A typical AIT session 
consists of 4 x 4 minute intervals of treadmill exercise at 90-95% of heart rate max 
(HRmax) interspersed with 4-minute recovery periods at 50-70% HRmax. Tjonna et al. 
(2008) found that 16 weeks of AIT improved endothelial function, insulin signalling in 
adipose tissue and skeletal muscle and blood pressure in metabolic syndrome 
patients. Wisloff et al. (2007) showed that 12 weeks of AIT induced superior 
cardiovascular effects to MICT in heart failure patients and Molmen-Hansen et al. 
(2012) found AIT to be effective in hypertensive patients. Although AIT is very 
effective even in these at-risk populations, it is still time consuming, as a typical 
session lasts 38 minutes including the warm up time. Furthermore, the exercise 
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intensity is very difficult to maintain throughout the session so requires high levels of 
motivation.  
As discussed in Section 2.6., many people cite ‘lack of time’ as the major 
barrier to achieving the physical activity guidelines (Trost et al., 2002). In an attempt 
to overcome this barrier, SIT was developed as a time-efficient alternative to AIT 
and MICT (Gibala et al., 2012). Typical SIT sessions involve 4-6 repeated Wingate 
tests (30-second supra-maximal ‘all-out’ sprints) interspersed with 4 to 4.5 minutes 
of recovery. The higher intensity of exercise during SIT elicits greater metabolic 
signalling than moderate-intensity exercise resulting in increased turnover of ATP 
(Howlett et al., 1998). The greater activation of kinases including AMPK, p38 MAPK 
and CaMKII during SIT are associated with greater expression of PGC-1α mRNA, 
which is a major regulator of mitochondrial biogenesis (Egan et al., 2010). For a 
more detailed description of the training adaptations with SIT readers are referred to 
reviews by Gibala et al. (2012) and MacInnis and Gibala (2017). Just six sessions of 
SIT, totalling ~15 minutes of all-out cycling over two weeks, has been shown to 
increase skeletal muscle oxidative capacity (Burgomaster et al., 2005). Other 
interventions lasting 4-6 weeks have shown that SIT induces comparable increases 
in !̇O2max, insulin sensitivity, oxidative capacity, vascular function and microvascular 
adaptations in comparison to a typical MICT programme consisting of 40-60 minutes 
moderate-intensity training 5 times per week (Burgomaster et al., 2005, 
Burgomaster et al., 2008, Shepherd et al., 2013a, Cocks et al., 2013). SIT is 
therefore a time-efficient training strategy as there is a weekly time commitment of 
just 1.5 hours compared to 4.5 hours with MICT. Furthermore, with just 2-3 minutes 
spent exercising per session there is a low training volume.  
Despite the effectiveness of SIT to stimulate metabolic adaptations, the 
supra-maximal Wingate-based protocol requires an ‘all out’ effort and therefore high 
levels of motivation to complete, and tend not to be well tolerated and as they often 
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cause nausea (Gibala et al., 2012). Furthermore, the total time commitment of a SIT 
session is still approximately 30 minutes because of the long rest periods, and 
performing Wingates requires expensive, specialised exercise equipment. As a 
result, Gibala’s laboratory subsequently developed a constant load low-volume HIT 
protocol whereby participants perform repeated 60-second bouts of cycling at a 
constant workload equating to ~90% HRmax interspersed with 60 seconds of 
recovery (Little et al., 2011). The reduced intensity during each interval allows for a 
reduced rest period, resulting in an overall reduction in the time commitment per 
session. In a small pilot study, Little et al. (2011) showed that six HIT sessions over 
2 weeks reduced average 24-hour blood glucose concentrations and post-prandial 
glucose excursions in people with type 2 diabetes. This mode of HIT has been 
shown to be effective at improving insulin sensitivity and GLUT4 protein content in 
lean males after just 2 weeks (Hood et al., 2011) and recently, Tan et al. (2018) 
found that 6 weeks of HIT three times per week increased microvascular density 
and oxidative capacity of type 1 and 2 muscle fibres in healthy sedentary young 
women. It therefore appears that constant load low-volume HIT provides a practical 
alternative to traditional MICT to improve physiological and metabolic health in both 
a healthy and a diseased population so will be the basis of all the studies in this 
thesis.  
 
2.7.2. Introducing HIT into the ‘Real World’ 
Although HIT is a time-efficient and effective means to improve cardio-metabolic 
health, exercise participation in the general population remains low and rates of 
obesity and type 2 diabetes continue to rise. Current evidence for the efficacy of HIT 
in comparison to traditional MICT originates from researcher led laboratory-based 
investigations involving relatively small participant numbers, on specialised 
equipment, under close supervision to ensure correct exercise intensities are 
Chapter 2 
55 
 
achieved (Gillen and Gibala, 2014, Weston et al., 2014). Whilst time-efficient, 
laboratory-based HIT does not address the other barriers to exercise including 
limited access to facilities and appropriate equipment, difficulty with transportation or 
inadequate financial resources (Korkiakangas et al., 2009). Furthermore, the 
feasibility of HIT has been questioned by public health researchers, citing the 
strenuous nature and high levels of motivation required to complete the exercises as 
barriers (Hardcastle et al., 2014, Biddle and Batterham, 2015, Courneya, 2010). 
Future studies should therefore focus on functional and practical forms of HIT that 
can be used in the ‘real world’. 
Two studies to date have attempted to apply HIT to a more ecologically valid 
environment (Shepherd et al., 2015, Lunt et al., 2014). Lunt et al. (2014) found 
modest improvements in cardiorespiratory fitness in a cohort of overweight/obese 
participants following a 12-week intervention of either AIT, MVIT (maximal volitional 
intensity training: repeated 30 second maximal walking or jogging up a slope 
interspersed with a 4-minute recovery period) or moderate intensity walking. The 
study was performed in a community park setting with the aim of making it more 
‘real world’. Following this, Shepherd et al. (2015) investigated HIT performed in a 
“real world” gym setting and found improved cardio-metabolic risk factors and 
psychological health in previously inactive adults. However, the latter intervention 
still relied on instructor led classes where participants were given verbal motivation 
throughout, which is not always available. These interventions also rely on exercise 
equipment and there is still the travel time needed to attend the sessions. An 
interesting finding from the study by Shepherd et al. (2015) was that adherence was 
greater in the HIT group than the MICT group, presumably because of the greater 
time commitment required in the MICT group (five sessions of 30-50 mins five times 
per week compared to three sessions of <25 mins for the HIT group), further 
supporting the use of HIT as a time efficient exercise strategy.  
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In an attempt to overcome the remaining barriers, home-based exercise 
interventions have been successfully introduced in various populations (Jaggers et 
al., 2013, Perri et al., 1997). Such studies based around traditional MICT have 
shown that home-based interventions can increase adherence, even over a 
supervised training programme (Perri et al., 1997). Therefore, low-volume HIT 
performed as a home-based intervention, using simple bodyweight exercises, may 
be particularly attractive as it would combine the time efficient nature of HIT with the 
ease and cost effectiveness of home-based interventions, minimising barriers to 
exercise. Recently, Blackwell et al. (2017) compared the efficacy of a 4-week 
unsupervised home-based HIT protocol to laboratory-based HIT in middle-aged 
individuals (Blackwell et al., 2017). The Home-HIT protocol consisted of 1 minute 
intervals involving three equipment-free exercises (star jumps, squat thrusts and 
static sprints) interspersed with 90 seconds of walking. Blackwell et al. (2017) 
reported that participants completed all training sessions in the home-based HIT 
group; however, this was only monitored using simple self-report diaries, which is 
not an objective measure. The use of HR monitors that would allow the research 
team to remotely monitor and record session completion rates, and that target 
training thresholds that are achievable with a completely unsupervised home-based 
training programme, has not been done. Furthermore, the study of Blackwell et al. 
(2017) was only 4 weeks in duration which may not be long enough to test the 
longer-term effectiveness of home-based HIT. Therefore, Chapter 4 will investigate 
the effects of a 12-week home-based HIT intervention in a previously sedentary, 
obese population with elevated CVD risk to test whether this programme can 
effectively reduce barriers to exercise in this at-risk population. 
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2.7.3. HIT and People with Type 1 Diabetes 
HIT may also have the potential to overcome the barrier of fear of hypoglycaemia in 
people with type 1 diabetes. A series of studies have shown that addition of a short 
sprint to a bout of moderate-intensity exercise can increase blood glucose 
concentration to provide a means to counter the fall in post exercise glycaemia 
(Fahey et al., 2012, Bussau et al., 2006, Bussau et al., 2007, Davey et al., 2013a). 
Bussau et al. (2006) investigated whether a short sprint can counter the rapid fall in 
glycaemia that occurs during moderate intensity exercise and decrease the risk of 
post exercise hypoglycaemia. Seven males with type 1 diabetes injected their 
normal insulin and ate their usual breakfast before performing a 20-minute cycle at 
40% !̇O2max followed immediately by a 10-second maximal sprint (sprint trial) or rest 
(control trial). The moderate-intensity exercise caused a significant drop in blood 
glucose in both trials. However, the 10-second sprint opposed a further fall in blood 
glucose for 120 minutes, whereas blood glucose fell by ~3.6 mmol/L in the control 
trial. The stabilisation of glycaemia following the sprint trial was associated with 
elevated catecholamines, growth hormone and cortisol. Therefore, HIT, which 
consists of high intensity bouts interspersed with low intensity recovery periods, may 
stabilise blood glucose and reduce the risk of hypoglycaemia both during exercise 
and in the post-exercise period. As such, HIT could lessen the fear of 
hypoglycaemia as a barrier to exercise in people with type 1 diabetes, as well as 
being a time-efficient and effective strategy for improving cardio-metabolic health. 
 
2.8. Thesis Overview 
The overarching aim of the thesis is to investigate the effects of practical forms of 
high-intensity interval training (HIT) in obese individuals with elevated cardiovascular 
disease (CVD) risk and people with type 1 diabetes. To realise this aim, a novel 
home-based HIT (Home-HIT) programme was developed with the intention of 
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reducing the major barriers to exercise. Five studies were subsequently conducted 
to examine the effects of HIT and Home-HIT in obese individuals with elevated CVD 
risk and people with type 1 diabetes.  
Section 2.6. described the major barriers to exercise that prevent a large 
proportion of the population from meeting physical activity guidelines and Section 
2.7.2. concluded that a home-based intervention based on the scientific principles of 
HIT represents a good strategy to increase exercise participation. Chapter 4 
investigated the effects of a novel Home-HIT intervention in obese individuals at 
elevated CVD risk designed to overcome these barriers. In Chapter 4 we used the 
principle of the low-volume HIT protocol developed by Little et al. (2011) to create a 
new Home-HIT intervention tailored to obese individuals with low fitness and 
mobility. During the 12-week intervention a novel HR monitoring system was used to 
remotely monitor adherence and compliance (ability to meet target HR thresholds). 
Changes in !̇O2peak, insulin sensitivity, body composition, flow-mediated dilation and 
aortic pulse wave velocity were assessed to determine the physiological 
effectiveness of Home-HIT in comparison to two control groups (laboratory-based 
HIT and home-based MICT). In addition, muscle biopsies were taken to assess 
changes in mitochondrial density, IMTG content and GLUT4 protein expression 
using quantitative immunofluorescence microscopy as these are classical 
adaptations associated with !̇O2peak and insulin sensitivity.  
Section 2.3.1.1. outlined the importance of microvascular health for an 
optimal insulin-sensitive phenotype and the impairments that occur with obesity and 
physical inactivity. Chapter 5 aimed to investigate whether Home-HIT was effective 
at improving microvascular density and enzymes controlling NO production and 
quenching, and whether these correlate with increases in !̇O2peak and insulin 
sensitivity. To achieve this, immunofluorescence microscopy was used to assess 
the protein content and phosphorylation status of the enzymes within the endothelial 
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layer of the skeletal muscle microvasculature as well as change in capillary density 
following 12 weeks of Home-HIT, laboratory-based HIT and home-based MICT. 
In Chapters 6, 7 and 8 the focus shifts to people with type 1 diabetes as the 
aim was to develop exercise strategies that reduce the major exercise barriers of 
“lack of time” and fear of hypoglycaemia (Section 2.6.1.). Chapter 6 aimed to 
investigate, for the first time, the effects of a single bout of HIT on risk of 
hypoglycaemia during exercise and in the subsequent 24-hour period in people with 
type 1 diabetes. To achieve this aim we examined the effects of a fasted bout of HIT 
and MICT in comparison to a control day with no exercise on 24-hour glucose levels 
using continuous glucose monitoring. Following this, in Chapter 7, we investigated 
whether 6 weeks of HIT improves markers of metabolic health, including !̇O2peak, 
glycaemic control, blood lipid profile and arterial stiffness in people with type 1 
diabetes in comparison to MICT. During this six-week training period, blood glucose 
concentrations were monitored before and after all exercise sessions that were 
performed in the fed state to provide further evidence that HIT could reduce the 
acute risk of hypoglycaemia compared to MICT.  
Finally, in Chapter 8 we investigated whether the Home-HIT programme 
introduced in Chapter 4 could remove the remaining exercise barriers in people with 
type 1 diabetes as an exercise strategy that is time-efficient, inexpensive, requires 
no equipment or travel time to “intimidating” gym environments and removes the 
barrier of fear of hypoglycaemia. In addition, to assessing the physiological 
effectiveness of Home-HIT, the participants that took part in the study in Chapter 8 
completed an online survey to qualitatively assess the effectiveness of Home-HIT. 
To date, no study has qualitatively explored the attitudes and barriers to exercise in 
people with type 1 diabetes in conjunction with an exercise programme specifically 
designed to remove barriers and increase exercise participation.  
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Over the course of the five studies, the aim was to provide evidence that 
practical HIT strategies can remove many of the major exercise barriers for obese 
individuals and people with type 1 diabetes that could potentially be used to improve 
population health by increasing physical activity participation. Secondly, this thesis 
aims to provide clear mechanistic evidence to explain the physiological 
effectiveness of Home-HIT as a means to reduce the risk of cardio-metabolic 
disease. 
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This General Methods chapter serves to outline the methods that are common 
across the experimental chapters, as well as describing in detail the staining 
procedures for the immunofluorescence microscopy work in Chapters 4 and 5.   
 
3.1. Incremental Exercise Test to Determine &̇O2peak and Wmax 
Throughout this thesis, the incremental exercise tests to volitional exhaustion were 
performed on an electromagnetically braked cycle ergometer (Corival, Lode, 
Groningen, The Netherlands) to determine maximal aerobic power output (Wmax) 
and !̇O2peak using an online gas collection system (MOXUS modular oxygen uptake 
system, AEI technologies, Pittsburgh, PA). The test consisted of 3-minute stages 
starting at 25 W, and the workload was increased by 35 W at each stage until 
subjects could not maintain a cadence of >50 rpm. !̇O2peak was taken as the highest 
value achieved over a 15-second recording period. Heart rate (HR) was measured 
throughout the tests using a Polar RS400 (Kempele, Finland) HR monitor.  
 
3.2. Flow Mediated Dilation  
Following 20 minutes supine rest, blood pressure measurements were made in 
triplicate using an automated sphygmomanometer (Dianamap; GE Pro 300V2, 
Tampa, Florida) on the contralateral arm. Endothelial function was measured using 
brachial artery flow-mediated dilation (FMD) in accordance with the current 
guidelines (Thijssen et al., 2011). Briefly, a 10 MHz multi-frequency linear probe 
attached to a high-resolution ultrasound machine (T3000, Terason, Burlington, MA) 
was used to image the brachial artery in upper arm and a rapid inflation/deflation 
pneumatic cuff was positioned on the imaged arm distal to the olecranon process. A 
one-minute baseline recording was made before the cuff was inflated to 220 mmHg 
for 5 minutes. The cuff was then deflated and the response monitored for 3 minutes. 
Chapter 3 
2 
 
The scans were performed by the same sonographer at each time point to reduce 
between scanner variation. 
Post-test analysis of the brachial artery was performed using custom-
designed edge-detection and wall-tracking software (Dicom Encoder), of which the 
reproducibility and validity have been demonstrated elsewhere (Woodman et al., 
2001). This software tracks the vessel walls and blood velocity trace in B-mode 
frames via pixel density and frequency distribution algorithm. First, regions of 
interest (ROI) on every individual study were identified by the sonographer. The 
ROIs allowed automated calibration for diameters on the B-mode image and 
velocities on the Doppler strip. A ROI was then manually drawn around the optimal 
area of the B-mode image and within this. Baseline diameter, flow and shear were 
calculated using continuous edge detection and wall tracking software. The peak 
artery FMD was defined as the peak percentage change in artery diameter from 
baseline to during the 3 minutes post cuff release. The software automatically 
calculated the relative diameter change, time to peak (following cuff release) and 
shear rate area-under-the-curve (SRAUC). Despite the initial region of interest 
selection being operator-determined, the remaining analysis was independent of 
operator bias. 
 
3.3. Arterial Stiffness 
Aortic pulse wave velocity (PWV) measurements were made in triplicate using a 
semi-automated device and software (SphygmoCor, AtCor Medical, Sydney, 
Australia). Carotid-femoral PWV measurements were performed to characterise the 
aortic stiffness in participants by placing a single high fidelity applanation tonometer 
at the proximal (carotid) and distal (femoral) pulse, to record sequentially over 10 
waveforms. The QRS complex was measured simultaneously using an ECG. The 
pulse transit time was calculated by subtracting the time between the R wave of the 
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ECG and the foot of the proximal waveform from the time between the R wave and 
the foot of the distal waveform. To determine the distance used for PWV, an 
anthropometric tape was used to determine the distance from the carotid 
measurement site to the suprasternal notch subtracted from the distance between 
the femoral measure and suprasternal notch. The day-to-day variability measured 
as the coefficient of variation for aortic PWV in our laboratory is 4%. 
 Obesity and sedentary behaviour are associated with increased arterial 
stiffness, which in turn is associated with an increased risk of cardiovascular events 
and mortality (Laurent et al., 2001, Vlachopoulos et al., 2010). Degenerative 
changes that occur in the walls of large arteries are thought to contribute to 
increased stiffening over time. Large artery stiffness increases left ventricular 
afterload (Laurent et al., 2006) and is associated with left ventricular hypertrophy 
(Toprak et al., 2009). Furthermore, increased arterial stiffness is associated with 
hypertension (Laurent et al., 2006, Vlachopoulos et al., 2010, Vlachopoulos et al., 
2006). Arterial stiffness is dependent on the dynamic and material properties of the 
artery (Zieman et al., 2005). For example, sympathetic activation of the vascular 
smooth muscle causes vasoconstriction, decreasing lumen diameter and increased 
arterial stiffness, and exercise training has been shown to improve autonomic 
control in obese women (Trombetta et al., 2003). Improved arterial stiffness with 
exercise training may also be due to improved endothelial function, a reduction in 
low-grade inflammation and a reduction in the wall-to-lumen ratio (Donley et al., 
2014).  
 
3.4. Blood Analysis 
Insulin sensitivity was measured using the oral glucose tolerance test (OGTT) 
procedure, as described by Matsuda and DeFronzo (1999). A cannula was inserted 
into an antecubital vein and a baseline 10 ml blood sample was taken before 
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consumption of a 25% glucose beverage containing 75g of glucose and 225 ml of 
water. Further 5 ml blood samples were collected at 30, 60, 90 and 120 minutes 
after glucose ingestion. Plasma was separated by centrifugation (10 min at 3000 
rpm at 4˚C) and stored at -80°C until analysis.  
Plasma glucose concentrations at each time point, as well as fasting plasma 
cholesterol and triglyceride concentrations, were analysed using a Randox 
chemistry analyser (Randox RX Series, the RX Daytona™). Plasma insulin 
concentrations were determined by commercially available enzyme linked immuno-
sorbent assay (ELISA) kit (Invitrogen, UK). Area under the curve (AUC) for insulin 
and glucose during the OGTT was calculated using the conventional trapezoid rule. 
Insulin sensitivity index (ISI) was calculated using the Matsuda index (Matsuda and 
DeFronzo, 1999) using the following equation: 
Matsuda ISI =  '(,(((*(,-.	0	,-1)0	(-.̅	0	-1)̅ 
Where FPG = fasting plasma glucose concentration, FPI = fasting plasma insulin 
concentration, P4̅ is mean plasma glucose concentration over 2 hour OGTT, P5 ̅is 
mean plasma insulin concentration. 
 
3.5. Muscle Biopsies 
Resting muscle biopsies were taken from the lateral portion of the m. vastus lateralis, 
approximately 25-50% of the distance from the lateral joint line and the greater 
trochanter under local anaesthesia (0.5% Marcaine), using the Weil-Blakesley 
conchotome technique as described previously (Baczynska et al., 2016). Excess 
blood and visible collagen or fat were removed before samples were embedded in 
Tissue-Tek OCT Compound (Sakura Finetek Europe, Zoeterwoude, Netherlands) 
and immediately frozen in liquid nitrogen cooled isopentane (Sigma-Aldrich, Dorset, 
UK). Samples were then stored at -80°C until analysis.   
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3.5.1. Quantitative Immunofluorescence 
Details of the specific quantification techniques used can be found in Table 3.1. and 
all techniques have been previously validated (Shepherd et al., 2013b, Cocks et al., 
2016, Bradley et al., 2014). GLUT4 content was assessed using the method 
described by (Bradley et al., 2014) which has previously been optimised for analysis 
of GLUT4 in human skeletal muscle using negative controls to conﬁrm there were 
no problems with antibody cross reactivity (Bradley et al., 2014). All techniques used 
frozen muscle biopsy samples cryosectioned to a thickness of 5µm onto uncoated 
glass microscope slides so that transverse orientated samples could be used for 
analysis.  
 Fibres were either fixed in 3.7% formaldehyde (IMTG, mitochondria) or 
acetone and ethanol (GLUT4). Where sections were fixed with formaldehyde, this 
was followed by a brief 30-second rinse in dH2O, followed by permeabilisation using 
0.5% triton X-100. Following three 5-minute washes with phosphate-buffered saline 
(PBS, 137 mmol/L sodium chloride, 3 mmol/L potassium chloride, 8 mmol/L sodium 
phosphate dibasic, 3 mmol/L potassium phosphate monobasic) sections were 
incubated overnight with appropriate primary antibodies. On day 2, slides were 
washed 3 times for 5 minutes in PBS before secondary antibodies were applied to 
sections for 1 hour at room temperature. Mitochondria and GLUT4 slides were 
washed a final 3 times in PBS before being mounted with Mowiol and a coverslip. 
IMTG slides were moved to a dark room after the secondary antibody incubation 
where they were incubated a final time in BODIPY for 20 minutes, followed by 3 x 5 
minute PBS washes before being mounted using Vectashield (Sigma-Aldrich, UK). 
  
 
Table 3.1. Staining protocol for GLUT4, mitochondria and intramuscular triglycerides 
Treatment GLUT4 Mitochondria IMTG 
Fixation Acetone:ethanol (3:1) for 5 mins Formaldehyde 3.7% for 1 hour Formaldehyde 3.7% for 1 hour 
Washes 3 x 5 min PBS washes 3 x 30 second dH2O washes 3 x 30 second dH2O washes 
Permeabilisation  0.5% Triton X-100 for 5 mins 0.5% Triton X-100 for 5 mins 
Washes 3 x 5 min PBS washes 3 x 5 min PBS washes 3 x 5 min PBS washes 
Incubation Primary antibodies overnight 
Dystrophin (1:400); MHCI (1:100); GLUT4 
(1:200) 
Primary antibodies 1 hour 
Dystrophin (1:400); MHCI 
(1:100); COX IV (1:100) 
Primary antibodies 45 mins 
Laminin (1:50); MHCI (1:100) 
Washes  3 x 5 min PBS washes 3 x 5 min PBS washes 
Incubation Secondary antibodies 1 hour 
GAMIgM 546 (1:100); GAMIgG2b 633 (1:100); 
GARIgG 488 (1:200) 
Secondary antibodies 1 hour 
GAMIgM 546 (1:250); GAMIgG2b 
633 (1:100); GAMIgG2a 488 
(1:250) 
Secondary antibodies 30 mins 
GAMIgM 546 (1:200); GARIgG 
633 (1:200) 
Washes 3 x 5 min PBS washes 3 x 5 min PBS washes 3 x 5 min PBS washes 
   Move to dark room 
Incubation   BODIPY for 20 mins (1:200) 
Mounting Mowiol Mowiol Vectashield 
 
MHCI = myosin heavy chain I; PBS = phosphate-buffered saline; COX IV = cytochrome c oxidase 
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Capillarisation  
Sections were fixed in acetone and ethanol (3:1) for 5 minutes before 3 x 5 minute 
PBS washes. Muscle sections were incubated overnight with anti-myosin type I 
(developed by Dr Blau DSHB). On day 2, sections were washed 3 times for 5 
minutes with PBS before incubation with UEA-I-FITC (Sigma-Aldrich) and WGA-633 
as markers of the endothelium and plasma membrane, respectively for 1 hour. 
Lastly, sections were washed 3 more times with PBS for 5 mins before being 
mounted using Mowiol.   
 
Vascular Enzymes 
NOX2 and p47phox protein content in the skeletal muscle microvascular endothelium 
and sarcolemma were assessed using the previously developed 
immunofluorescence staining protocol and quantification technique (Cocks et al., 
2012, Cocks et al., 2013), adapted to allow for differentiation between capillaries 
and terminal arterioles (Cocks et al., 2016). Capillary and terminal arteriole specific 
eNOS content and eNOS ser1177 phosphorylation were also assessed using 
previously established methods (Cocks et al., 2016); however, the method was 
adapted to allow for assessment of individual vessel eNOS ser1177/eNOS ratio to be 
calculated.  
First, sections were fixed in acetone and ethanol (3:1) for 5 minutes. For 
assessment of eNOS ser1177/eNOS ratio, sections were triple stained with antibodies 
against eNOS (Transduction Laboratories, Lexington, KY, USA), p-eNOS ser1177 
(Cell Signalling Technology, Beverly, MA, USA) and anti-α smooth muscle actin 
(αSMA; Abcam, Cambridge, UK). For assessment of NOX2 and p47phox content 
sections were double stained with either NOX2 or p47phox (kind gift from Prof Mark 
Quinn, Montana State University) and anti-αSMA. All sections were then incubated 
with appropriate secondary antibodies (Invitrogen, Paisley, UK) in combination with 
the endothelial marker Ulex Europaeus-FITC conjugated (UEA-I-FITC; Sigma-
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Aldrich, UK). A plasma membrane marker, wheat germ agglutinin-633 (WGA-633; 
Invitrogen, Paisley, UK), was also included when staining samples for NOX2 and 
p47phox. Between each incubation with antibodies, sections received 3 x 5 minute 
PBS washes. For image capture, sections were mounted using Mowiol. See Table 
3.2. for general staining protocol for the vascular enzymes.  
 
Table 3.2. Staining protocol for vascular enzymes 
Treatment  
Fixation Acetone:ethanol (3:1) for 5 mins 
Washes 3 x 5 min PBS washes 
Incubation Primary antibodies overnight 
Washes 3 x 5 min PBS washes 
Incubation Secondary antibodies 1 hour 
Washes 3 x 5 min PBS washes 
Mounting Mowiol 
 
PBS = phosphate-buffered saline 
 
 
3.5.2. Image Capture 
Images for mitochondrial density and capillarisation were acquired using a Lecia 
DM6000FS widefield microscope and 40x 0.6 numerical aperture objective. Images 
for GLUT4 and IMTG content were acquired using an inverted confocal microscope 
(Zeiss LSM-710, Carl Zeiss, Germany) with a 63x oil immersion objective and the 
images for the vascular enzymes were captured using a 40x oil immersion objective. 
Alexa Fluor 405 was excited using the 405 nm line of the diode laser and detected 
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with 371-422 nm emission. FITC fluorescence was excited with a 488nm multiline 
argon laser and detected with 493–557nm emission. DAPI fluorescence was excited 
with a 405nm diode laser and detected with 410-495nm emission. The images were 
acquired at a resolution of 1,024 X 1,024 pixels and stored in 24-bit tagged image 
format file format. No image processing was carried out prior to intensity analysis 
and identical settings were used for all image capture for each variable within each 
participant.  
 
3.5.3. Image Analysis 
All image analysis was performed using ImagePro Plus 5.1 (Media Cybernetics Inc, 
Bethesda, MD, USA).  
 
Mitochondrial density 
Mitochondrial density was assessed using the method described by Shepherd et al. 
(2013b). Briefly, fluorescence intensity of the mitochondrial stain was quantified by 
measuring the signal intensity within the intracellular regions of a mask created by 
the dystrophin-633 stain, in a fibre type specific manner.  
 
GLUT4 Content 
GLUT4 fluorescence intensity was quantified by measuring the signal intensity 
within the intracellular regions of a mask created by the dystrophin-633 stain in a 
fibre type specific manner determined by the MHCI stain. For each subject at least 
10 type I ﬁbre images and 10 type II ﬁbre images were captured per section pre and 
post training. Therefore, for each subject at least 20 images (10 type I ﬁbres and 10 
type II ﬁbres) were analysed for both pre- and post-training.  
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IMTG Analysis 
Fibre type specific IMTG analysis to assess peripheral and central regions of the 
myocyte was assessed using the method described in (Shepherd et al., 2017). This 
method was adapted in order to assess IMTG content, lipid droplet size and number 
in the peripheral and central regions of the myocyte. The peripheral region was 
defined as the 5µm below the plasma membrane. Briefly, an intensity threshold was 
uniformly selected to represent a positive signal for IMTG. IMTG content was 
expressed as the positively stained area fraction relative to the total area of each 
muscle ﬁbre. IMTG density was calculated as the number of IMTG objects relative to 
area. The mean area of individual IMTG (lipid droplets) objects was used as a 
measure of lipid droplet size. 
 
Capillarisation 
Capillaries were quantified in a fibre type specific manner manually, using the UEA-I, 
WGA-633 and myosin heavy chain images. The following indexes were measured 
(Hepple et al., 1997): 1) the number of capillaries around a fibre (capillary contacts), 
2) capillary-to-fibre ratio on an individual fibre basis and 3) capillary-fibre perimeter 
exchange (CFPE) index. In addition, overall capillary density was determined. 
Quantification of capillarisation was performed only on transverse fibres. In line with 
previous studies assessing capillarisation, at least 50 complete fibres were included 
in each analysis (Porter et al., 2002). Fibre cross-sectional area and perimeter were 
measured on calibrated images using ImagePro Plus 5.1 software. 
The indexes used to quantify capillarity include global indexes include 
capillary density and capillary-to-fibre ratio, while the individual fibre indexes include 
capillary contacts, capillary-fibre perimeter exchange and fibre perimeter per 
capillary (Latroche et al., 2015). The global indexes provide a global indication of 
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muscle blood supply but they assume regular distribution of capillaries and do not 
take fibre size and type into account. The individual fibre indexes allow evaluation of 
capillarity at the level of the individual myofibre. The individual indexes also provide 
more information on capillarity specific to fibre size and type, which will be important 
in Chapter 5 to provide information on adaptations to Home-HIT. Capillary density 
provides information on the number of capillaries per unit area; however, it gives 
little information on the capillary supply to individual fibres and is dependent on fibre 
size changes. Capillary-to-fibre ratio gives information on the number of fibres per 
unit area. However, there is little information on capillary supply to individual fibres. 
Capillary contacts provides information on the number of capillaries in contact with 
each fibre but without information on the effects of fibre size.  
 
Vascular Enzymes 
Blood vessels were divided into either capillaries or arterioles using the αSMA 
image. The endothelial (UEA-I-FITC) outline was then overlaid onto the 
corresponding vascular enzyme image. Fluorescence intensity of the vascular 
enzyme signal was then quantiﬁed within the endothelial speciﬁc area. Diameter of 
the arterioles was determined on calibrated images. Vessels larger than 20 µm in 
diameter were excluded to remove 3rd and 4th order arterioles (Wu et al., 2011) 
from the analysis, which rarely appear in muscle cross-sections. As eNOS and 
eNOS ser1177 phosphorylation had been stained on the same sections it was 
possible to establish eNOS ser1177/eNOS ratio on an individual vessel basis, as the 
same endothelial outline could be placed over both eNOS and eNOS ser1177 images. 
Cell membrane specific fluorescence for NOX2 and p47phox was determined using 
the WGA-633 stain to create an outline of the cell membrane. This mask was then 
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overlaid onto the corresponding image to determine membrane specific 
fluorescence intensity for NOX2 or P47phox.  
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Chapter 4 A Proof of Principle Study to Determine 
Adherence and Compliance to a 12-Week Home-
Based High-Intensity Interval Training Programme 
and the Effects on Markers of Cardio-Metabolic Health 
in Obese Individuals with Elevated Cardiovascular 
Disease Risk  
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4.1. ABSTRACT 
Objectives: To investigate the efficacy of a novel home-based high-intensity interval 
training (Home-HIT) intervention in obese individuals, with elevated cardiovascular 
disease (CVD) risk. It was hypothesised that Home-HIT would 1) have high 
adherence to the prescribed exercise intensity (compliance), 2) improve markers of 
CVD risk, and 3) lead to favourable skeletal muscle adaptations.  
Methods: Thirty-two obese adults with at least two additional CVD risk factors (age 
36±2y; BMI 34.3±0.8kg∙m-2), completed one of three 12-week interventions: Home-
HIT (n=9), laboratory-based supervised HIT (Lab-HIT; n=10) or home-based 
moderate-intensity continuous training (Home-MICT; n=13). Adherence and 
compliance were monitored online using a heart rate monitor and mobile app. 
Changes in !̇O2peak, insulin sensitivity, body composition, flow-mediated dilation 
(FMD) and aortic pulse wave velocity (PWV) were assessed. As classical training 
adaptation markers muscle mitochondrial density, intramuscular triglyceride (IMTG) 
content and GLUT4 protein expression were assessed.  
Results: Adherence and compliance did not differ between groups (P>0.05). 
Training increased !̇O2peak, Matsuda insulin sensitivity index and FMD (P<0.05). BMI, 
body fat percentage, visceral fat mass and aortic PWV all decreased (P<0.05). 
Training also increased muscle mitochondrial density, IMTG content and GLUT4 
protein expression (P<0.05). Between group differences were not significant for any 
of the variables.  
Conclusions: Despite having no supervision during exercise, Home-HIT had a high 
adherence at the prescribed exercise intensity, comparable to fully supervised Lab-
HIT, resulting in improved cardio-metabolic health. This study provides strong 
evidence that Home-HIT is an effective strategy to remove barriers to exercise and 
improve health in obese individuals with elevated CVD risk. 
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4.2. INTRODUCTION 
Despite overwhelming evidence that an inactive lifestyle leads to chronic disease 
and premature death (Booth et al., 2012), many people fail to meet public health 
physical activity guidelines (Earnest, 2009, Hallal et al., 2012). Part of the reason for 
the current apathy is that recommendations (at least 150 minutes of moderate-
intensity exercise per week) are difficult to attain for many, with “lack of time” the 
most commonly cited barrier (Trost et al., 2002). High-intensity interval training (HIT), 
involving repeated bouts of high-intensity exercise interspersed with periods of 
recovery, has been proposed as a time-efficient and effective strategy to improve 
cardio-metabolic health (Currie et al., 2013, Little et al., 2011, Hood et al., 2011, 
Gillen and Gibala, 2014). However, the applicability of current HIT programmes to 
the sedentary obese population has been disputed by public health experts (Biddle 
and Batterham, 2015, Courneya, 2010, Hardcastle et al., 2014), who cite the 
strenuous nature and complex protocols as major barriers in sedentary, exercise-
naïve individuals. Furthermore, most successful HIT interventions to date have been 
laboratory-based investigations under optimal conditions with continuous supervision 
and using specialised equipment (Little et al., 2011, Hood et al., 2011, Tjonna et al., 
2008). This creates additional barriers to exercise including difficulties with access to 
facilities (including travel distance and cost) and embarrassment due to negative 
body image (Korkiakangas et al., 2009). 
To eliminate many of the aforementioned barriers to exercise we developed a 
HIT intervention tailored to exercise-naïve individuals with low fitness and mobility. 
The programme used simple ‘on the spot’ movements using one's own body weight, 
creating an intervention that could be performed in the participant’s home without 
supervision or equipment. The following pilot study aimed to investigate the efficacy 
of this novel home-based HIT (Home-HIT) intervention in previously sedentary obese 
individuals, with elevated cardiovascular disease (CVD) risk. To achieve this aim, 
participants completed 12 weeks of Home-HIT and the following were investigated: 1) 
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adherence and compliance (defined as ability to meet prescribed heart rates), 2) 
changes in cardio-metabolic health markers, and 3) the change in classical markers 
of training adaptation within skeletal muscle. Two control groups were included to 
assess the effectiveness of Home-HIT. A fully supervised laboratory-based HIT (Lab-
HIT) group was employed to assess the effect of Home-HIT compared to HIT 
performed under optimal conditions. Secondly, a home-based moderate-intensity 
continuous training (Home-MICT) group was used to assess the effect of Home-HIT 
compared to a group advised to meet the recommended physical activity guidelines 
(Colberg et al., 2016). It was hypothesised that Home-HIT would 1) have high 
adherence at the prescribed exercise intensity (compliance), 2) improve markers of 
cardiovascular and metabolic health, and 3) lead to favourable skeletal muscle 
adaptations. 
 
4.3. METHODS 
 
Participants 
Thirty-two sedentary obese adults (BMI >30 kg·m2 or waist/hip ratio of >0.9 in men 
and >0.85 in women) with at least 2 further CVD risk factors, according to the 
American Heart Association criteria (Grundy et al., 1999), completed the study (for 
participant characteristics see Table 4.1.). Participants were allocated to one of three 
12-week exercise training groups: Home-HIT (n = 9); Home-MICT (n = 13); or Lab-
HIT (n = 10) matched for age, BMI and !̇O2peak. Participants were free of diagnosed 
CVD and other contraindications to participate in an exercise intervention. All 
participants provided written informed consent, and the study was approved by the 
Black Country NHS Research Ethics Committee (West Midlands, UK) and 
conformed to the Declaration of Helsinki.  
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Table 4.1. Participant characteristics and overview of the number of patients 
that met American Heart Association coronary heart disease risk factor 
thresholds 
 Home-HIT Home-MICT Lab-HIT 
Age (yrs) 32 ± 3 38 ± 3 37 ± 2 
Sex (male/female) 4/5 4/9 5/5 
Height (cm) 168 ± 4 172 ± 3 172 ± 2 
BMI (kg·min-2) 35.9 ± 1.4 33.3 ± 1.4 34.2 ± 1.3 
!̇O2peak (ml·kg-1·min-1) 25.9 ± 0.8 26.4 ± 1.8 24.8 ± 2.0 
!̇O2peak (L/min-1) 2.4 ± 0.2 2.5 ± 0.2 2.5 ± 0.2 
Medication 1/9 8/13 4/10 
Smoker/previous 
smoker 
1/9 3/13 5/10 
Family history 5/9 6/13 4/10 
Obesity 9/9 13/13 10/10 
Sedentary lifestyle 9/9 13/13 10/10 
Impaired fasting 
glucose 
1/9 1/13 1/10 
Dyslipidaemia 9/9 12/13 7/10 
Hypertension  4/9 7/13 1/10 
Mean number of risk 
factors per participant  
 
4 ± 0 
              
            4 ± 0 
               
           4 ± 0 
Range of risk factors 3-5              3-6             3-6 
 
Medication included blood pressure medication (e.g. ramipril, felodipine, losartan, 
amilodipine, indipamide), metformin or statins. Family history included diabetes 
and/or cardiovascular disease in an immediate family member. Obesity was 
classified as a BMI >30 kg·m2 or waist/hip ratio of >0.9 in men and >0.85 in women. 
Dyslipidaemia was defined as total cholesterol >11.1 mmol.L-1, HDL <2.2 mmol.L-1 or 
LDL >7.2 mmol.L-1. Hypertension was classified as >140/90 mmHg or on 
antihypertensive medication and impaired fasting glucose was defined as fasting 
blood glucose >6.1 mmol.L-1. Sedentary lifestyle was defined as persons not 
participating in a regular exercise programme or accumulating 30 minutes or more of 
moderate physical activity on most days of the week. Data are presented as 
mean±SEM when appropriate.  
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Pre-Training Testing 
Participants performed an incremental exercise test to volitional exhaustion on an 
electromagnetically-braked cycle ergometer (Corival, Lode, Groningen, The 
Netherlands) to determine maximal aerobic power output (Wmax) and !̇O2peak, using 
an online gas collection system (MOXUS, AEI technologies, Pittsburgh, PA) as 
described in Chapter 3. Waist-to-hip ratio was recorded and body composition was 
analysed using Dual-energy X-ray Absorptiometry (DXA). Finally, participants were 
provided with a physical activity monitor (ActiGraph GT3X+, Fort Walton Beach, FL) 
and diet diary so that habitual physical activity levels and diet could be assessed 
over 7 and 3 days, respectively.  
Three to seven days after the incremental exercise test participants attended 
the laboratory after an overnight fast for pre-training testing. Vascular measures, 
muscle biopsies and oral glucose tolerance tests were undertaken. Participants were 
instructed to abstain from caffeine, alcohol and vigorous exercise the day before 
testing.  
 
Vascular Measures 
Flow mediated dilation (FMD), resting blood pressure and arterial pulse wave 
velocity (PWV) were measured as described in Chapter 3.  
 
Muscle Biopsies 
A resting muscle biopsy was taken from the lateral portion of the m. vastus lateralis 
under local anaesthesia (0.5% Marcaine), using the Weil-Blakesley conchotome 
technique (Baczynska et al., 2016). Samples were embedded in Tissue-Tek OCT 
Compound (Sakura Finetek Europe, Zoeterwoude, Netherlands) and immediately 
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frozen in liquid nitrogen cooled isopentane (Sigma-Aldrich, Dorset, UK). See 
Chapter 3 for more information.  
 
Blood Analysis and Oral Glucose Tolerance Test 
Insulin sensitivity was measured using an oral glucose tolerance test (OGTT) as 
described in Chapter 3. 
 
Week 4 Testing 
A testing session took place during week 4 of the training programme instead of the 
12th training session. Participants attended the laboratory following an overnight fast. 
FMD and arterial stiffness were measured, followed by assessment of !̇O2peak. 
Procedures were identical to pre-training testing.  
 
Post-Training Testing 
Post-training assessment of !̇O2peak was performed instead of the 35th training 
session in the final week of training. Following the test all participants were provided 
with a physical activity monitor and diet diary. ~72h following the final training 
session post-training testing was conducted with procedures, methods and timings 
identical in all respects to the pre-training testing protocol.  
 
Training Protocols 
Training programmes started ~72h after pre-training testing. Participants trained for 
12 weeks in one of three groups: 
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1. Home-based HIT (Home-HIT): repeated 1-minute bouts of exercise 
interspersed with 1 minute of rest. Participants were advised to achieve ≥80% 
of their predicted heart rate maximum (HRmax; 220–age) during the intervals. 
The 1-minute intervals were composed of two different sequential 30-second 
body weight exercises with no rest in between. Participants were provided 
with 9 exercise pairs, detailed in an exercise pack, and were free to choose 
which pairs of exercises they completed during each session (see Appendix). 
During weeks 1-4 participants were advised to complete 4 intervals, this then 
increased by one session each fortnight up to 8 during weeks 11-12. 
 
2.  Home-based MICT (Home-MICT): participants performed continuous 
exercise of their choosing (swimming, cycling or walking/running). 
Participants were advised to exercise at ~65% of predicted HRmax throughout 
the sessions. During weeks 1-4 participants were asked to exercise for 30 
minutes which increased by 5 minutes each fortnight up to 50 minutes during 
weeks 11-12.  
3. Laboratory-based HIT (Lab-HIT): participants performed repeated 1 minute 
bouts of exercise on a cycle ergometer (Excalibur Sport V2.0, Lode, 
Groningen, The Netherlands), interspersed with 1 minute of rest. During the 
intervals, participants exercised at an intensity of 100% Wmax (Little et al., 
2011) in order to elicit a HR of ≥80% HRmax. The number of intervals was 
identical to the Home-HIT group.  
 
Participants in the Lab-HIT group attended the School of Sport and Exercise 
Sciences at Liverpool John Moores University (LJMU) to train 3x/week for 12 weeks. 
Participants in this group were excluded if ≥80% of sessions were not completed. To 
ensure adherence to training, the Lab-HIT sessions were scheduled at set times and 
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if participants did not attend a session, it was rescheduled for later that week. All the 
training sessions were supervised and participants were given strong verbal 
encouragement to ensure they met target HRs. Exercise intensity was monitored 
using a HR monitor (POLAR RS400, Kempele, Finland). 
The home-based interventions were completed by the participants in an 
unsupervised place of their choosing outside of LJMU. To monitor training 
compliance and exercise intensity achieved, participants were given a POLAR H7 
HR monitor and POLAR Beat mobile application (www.polar.com/beat/uk-en; Figure 
4.1.). Following each training session HR was automatically uploaded to a cloud 
storage site (www.flow.polar.com), which could be accessed by the researchers to 
check adherence and that the correct HR threshold was being achieved during each 
session (training compliance). Participants were aware that the research team were 
monitoring their adherence and compliance. They were advised to train 3x/week, but 
this was not enforced. In contrast to Lab-HIT, participants in the home-based groups 
were responsible for scheduling their own training sessions, with no input from the 
research team. Participants were contacted by text/email once every two weeks to 
enquire about progress and any general issues around training. If participants were 
observed to have missed consecutive training sessions their email enquired as to 
whether there was a specific reason, however no direct encouragement was given 
for them to re-engage with training. 
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Figure 4.1. Methods used to monitor adherence and training intensity 
A) Participants were provided with a Polar H7 heart rate (HR) monitor and mobile 
phone application Polar Beat. B) HR data from each session was downloaded to 
Polar Flow, a cloud based storage application so that adherence and compliance 
could be remotely recorded by the researchers. C) HR traces were analysed to 
provide information on adherence to the prescribed workload.  
 
Quantitative Immunofluorescence 
Quantitative immunofluorescence microscopy was used to investigate the effects of 
training on GLUT4 protein content, IMTG and mitochondria density. Details of the 
specific quantitative measurement methods and image analysis are described in 
detail in Chapter 3.   
 
 
A B 
C 
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Statistical Analysis 
The primary outcome variable was !̇ O2peak. Previous research in our group 
(Shepherd et al., 2015, Shepherd et al., 2013a) has suggested an SD of 2.7-3.2 
ml·kg-1·min-1 for the training response. Using this data 7-9 participants would be 
required to detect a clinically relevant within group difference in !̇O2peak of 3.5 ml·kg-
1·min-1 (Myers, 2003) with 80% power at a significance level of 5%. Differences in 
adherence and compliance between the three training protocols were assessed 
using a one-way ANOVA. Measures taken pre, mid and post-training were analysed 
using a two-way mixed design ANOVA with the within group factor ‘training status’ 
(pre vs. mid vs. post) and the between group factor ‘training group’ (Home-HIT vs. 
Home-MICT vs. Lab-HIT). Original data is presented for FMD as the same findings 
were reported when baseline diameter was analysed using allometric scaling 
(Atkinson and Batterham, 2013). Mitochondrial density, IMTG content, and GLUT4 
protein expression were analysed using a three-way mixed ANOVA, with the 
between-group factor being ‘training group’ and within-group factors ‘training status’ 
(pre vs. post) and ‘ﬁbre type’ (type I vs. type II). In the case of a significant interaction 
a Bonferroni post-hoc test was applied to locate the differences. Eight muscle 
biopsies were taken and analysed pre- and post-training in each group. Aortic PWV 
was recorded in 8 Home-HIT, 6 Home-MICT and 9 Lab-HIT participants due to 
difficulty scanning some participants. Matsuda Index values are reported for 9 Home-
HIT, 10 Home-MICT and 9 Lab-HIT participants as it was not possible to obtain 
blood from all participants. All analyses were performed using IBM SPSS Statistics 
for Windows, Version 22.0. Armonk, NY: IBM Corp. Significance was set at P≤0.05 
and data are presented as mean ± SEM.  
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4.4. RESULTS 
Adherence and Compliance to Training Protocols 
Although not significant, training adherence tended to be different between the 
groups (P=0.053; Figure 4.2A). Post-hoc analysis revealed a trend for greater 
adherence to Lab-HIT compared to Home-MICT (P=0.081), but no significant 
differences were observed between Home-HIT and Lab-HIT (P=1.000) or Home-
MICT (P=0.195). Training compliance, defined as the ability to meet target HR 
thresholds, showed no differences between the groups (P= 0.420; Figure 4.2B).   
 
Figure 4.2. Adherence and compliance to home-based high intensity interval 
training (Home-HIT), home-based moderate intensity continuous training 
(Home-MICT) and lab-based HIT (Lab-HIT). 
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Figure 4.3. Flow chart of study design 
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General Characteristics 
At baseline there were no differences in age, BMI or !̇O2peak between groups 
(P=0.369; 0.455 and 0.898, respectively). Training increased !̇O2peak (main effect of 
training, P<0.001), but no difference between groups was observed. Post-hoc 
analysis revealed that !̇O2peak increased following 4 weeks of training compared to 
pre-testing (Home-HIT 9%, Home-MICT 6%, Lab-HIT 8%; P<0.001) and continued to 
increase further after 12 weeks compared to 4 weeks (Home-HIT 16%, Home-MICT 
12%, Lab-HIT 20%; P<0.001). Training decreased body mass and BMI (main effect 
of training, P=0.003 and P=0.005, respectively), with no differences between groups. 
Post-hoc analysis revealed both body mass and BMI decreased following 4 weeks of 
training (P=0.004 and P=0.007, respectively). Although body mass and BMI were still 
significantly lower than pre-testing at 12 weeks (P=0.014 and P=0.022) no further 
reduction in either measure was observed compared to 4 weeks (P=0.439 and 
P=0.515, respectively). There was a 4% decrease in body fat percentage in all three 
groups (main effect, P<0.01), with no difference between groups (P=0.468). Visceral 
fat mass was also significantly reduced in all three groups (Home-HIT -27%; Home-
MICT -12%; Lab-HIT -3%; main effect, P=0.025), with no difference between groups 
(P=0.304). There was no change in lean mass following training (P>0.05). 
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Figure 4.4. Effect of Home-based high-intensity interval training (Home-HIT), 
home-based moderate intensity continuous training (Home-MICT) and lab-
based HIT (Lab-HIT) on #̇O2peak (A), Matsuda Index (C), body fat percentage (E) 
and visceral fat (G). 
B, D, F and H show the individual responses. *Indicates a significant difference from 
baseline (P<0.05) and #indicates a significant difference from week 4 (P<0.05). 
There were no significant differences in any of the variables between the groups. 
Data are presented as mean ± SEM. 
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Blood Variables 
Insulin AUC decreased with training (Home-HIT -24%, Home-MICT -20%, Lab-HIT -
18%; main effect, P<0.001) but there was no change in glucose AUC (P>0.05), with 
no difference between groups for either variable. The Matsuda ISI was significantly 
increased by 12 weeks of training (Home-HIT 39%, Home-MICT 8%, Lab-HIT 13%; 
main effect, P=0.033), with no difference between groups (P=0.609). There was no 
change in fasting plasma glucose, cholesterol, triglycerides, HDL or LDL (main effect, 
P>0.05). Data are presented in Table 4.2. 
 
Vascular Measures 
Baseline artery diameter was unchanged by training (P=0.334). There was a 
significant increase in FMD (main effect, P<0.001), with no difference between 
groups (P=0.246). Post-hoc analysis revealed that following 4 weeks of training FMD 
was not different from pre-training (P=1.000). However, FMD was significantly 
increased in all three groups following 12 weeks of training compared to pre-training 
(Home-HIT 30%, Home-MICT 43%, Lab-HIT 49%; P<0.001). Similarly, there was a 
significant effect of training on aortic PWV (main effect, P<0.001), but no difference 
between groups (P=0.417). Following post-hoc analysis there was no change in 
PWV following 4 weeks of training (P=1.000), but there was a significant decrease 
following 12 weeks of training compared to pre-training (Home-HIT -17%, Home-
MICT -14%, Lab-HIT -4%; P=0.04). There was no difference in any of the blood 
pressure variables following training (P>0.05). 
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Figure 4.5. Effect of Home-based high-intensity interval training (Home-HIT), 
home-based moderate-intensity continuous training (Home-MICT) and lab-
based HIT (Lab-HIT) on brachial artery flow mediated dilation (FMD) (A), resting 
brachial artery diameter (B) and aortic pulse wave velocity (PWV; C). 
B, D, F and H show the individual responses. *Indicates significant difference from 
baseline (P<0.05).  
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Muscle Adaptations  
COX IV protein expression (ﬂuorescence intensity), a marker of mitochondrial 
density, was greater in type I ﬁbres than type II ﬁbres (main effect of ﬁbre type 
P<0.001). Mitochondrial density increased in both type I (Home-HIT 14%, Home-
MICT 6%, Lab-HIT 22%) and type II fibres (Home-HIT 34%, Home-MICT 11%, Lab-
HIT 33%) following training (main effect; P<0.001), with no difference between 
groups.  
 
GLUT4 content was not different between fibre types (main effect of fibre type, 
P=0.221). GLUT4 content was increased by training (main effect of training, 
P=0.005), with no difference between groups. There was also a strong trend towards 
a significant training*fibre type interaction (P=0.061), although not significant this 
trend was explored further. This analysis revealed that training increased GLUT4 
content in type 2 fibres (P=0.005), but not type 1 fibres (P=0.089). Post-training 
GLUT4 content was higher in type 2 fibres than type 1 fibres (P=0.02), but not 
different pre-training (P=0.983). 
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Figure 4.6. Effect of 12 weeks of home-based high-intensity interval training 
(Home-HIT), home-based moderate-intensity continuous training (Home-MICT) 
and lab-based HIT (Lab-HIT) on mitochondria density, indicated by COX IV 
fluorescence intensity, and GLUT4 content. 
A) Representative confocal microscopy images of skeletal muscle GLUT4 
fluorescence intensity pre (a) and post-training (b) and widefield microscopy images 
of COX IV fluorescence intensity pre (c) and post-training (d). Change in GLUT4 pre-
post training is shown in type 1 fibres (B) and type 2 fibres (C). Change in COX 
expression pre-post training is shown in type 1 fibres (D) and type 2 fibres (E). 
*Indicates main effect of training (P<0.05); white bar = 50 µm. †Indicates a main 
effect of fibre type (P<0.05).   
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Total IMTG content was significantly greater in type 1 fibres than type 2 fibres 
(P<0.001) at baseline. Total IMTG content increased following 12 weeks of training 
(main effect, P=0.006), with no difference between groups. Region specific 
investigation of IMTG content (expressed as percentage area stained) revealed that 
central and peripheral IMTG content were also significantly greater in type 1 fibres 
than type 2 fibres at baseline (P<0.001). Central IMTG content increased following 
12 weeks of training (main effect, P=0.026) and there was a non-significant trend 
towards an increase in peripheral IMTG content (P=0.06). The increase in total IMTG 
content was due to an increase in IMTG density in the central region (P=0.034) 
following training. IMTG size was unchanged by training (P=1.000). 
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Figure 4.7. Effect of 12 weeks of home-based high-intensity interval training 
(Home-HIT), home-based moderate-intensity continuous training (Home-MICT) 
and lab-based HIT (Lab-HIT) on fibre type specific intramuscular triglyceride 
(IMTG) content. 
(A) Representative confocal microscope images of myosin heavy chain I fibre type 
stain (red), IMTG (green) and plasma membrane using laminin (purple) pre (a, c, e) 
and post (b, d, f) training. Analysis was performed in both the peripheral (5µm border 
from the plasma membrane) and central (remainder of the cell) regions of each fibre. 
White bar = 20 µm. B and C show change in IMTG content pre and post training in 
type 1 and type 2 fibres in the central and peripheral region of the cells.  *Indicates 
main effect of training in total IMTG content; **indicates a change in central IMTG 
content (P<0.05).  
  
 
Table 4.2. Participant characteristics at pre, week 4 and post training 
 Home-HIT  Home-MICT  Lab-HIT 
 Pre Week 4 Post  Pre Week 4 Post  Pre Week 4 Post 
Body mass (kg) 
 
101.5±7.2 100.2±7.3* 100.1±7.5*  98.3±4.4 96.7 ± 4.5* 95.5±4.6*  101.1±4.8 99.6±4.4* 99.2±4.6* 
BMI (m∙kg2) 
 
35.9±1.4 35.4±1.4* 35.4±1.5*  33.3±1.4 32.8 ± 1.4* 32.3±1.4*  34.2±1.3 33.7±1.1* 33.6±1.1* 
Body fat (%) 40.1±1.9 - 38.4±1.9*  35.8±2.3 - 34.4±2.4*  38.1±2.4 - 36.6±2.5* 
Visceral fat (g) 523.1±66.3 - 447.4±56.5*  645.4±69.6 - 557.2±53.3*  626.7±76.9 - 611.0±68.4* 
Lean mass (kg) 56.7±4.8 - 58.1±5.0  57.9±2.6 - 57.5±2.9  58.1±4.0 - 58.8±4.0 !̇O2peak (ml∙kg-
1∙min-1) 
23.8±0.8 25.9±0.8* 27.6±1.6*#  24.9±1.9 26.4±1.8* 28.0±2.3*#  24.8±2.0 26.9±2.2* 29.8±2.6*# 
!̇O2peak(L/min-1) 2.4 ± 0.2 2.6 ± 0.2* 2.8 ± 0.3*#  2.5 ± 0.2 2.5 ± 0.2* 2.7 ± 0.3*#  2.5 ± 0.2 2.7 ± 0.2* 3.0 ± 0.3*# 
Wmax (W) 180±11 202±12* 213±11*#  182±15 188±15* 208±17*#  174±14 198±17* 221±16*# 
W/H ratio 
 
0.93±0.04 0.92±0.04 0.92±0.05  0.92±0.03 0.92±0.03 0.92±0.02  0.94±0.03 0.92±0.03 0.91±0.03 
ISI Matsuda 
 
2.8±0.7 - 3.9±1.2*  3.2±0.5 - 3.3±0.5*  2.3±0.4 - 2.5±0.3* 
Glucose AUC 
(mmol.L-
1.120min-1) 
 
15551±521 - 15155±915  13979±969 - 14868±1474  18401±1351 - 17840±1255 
Insulin AUC 
(mmol.L-
1.120min-1) 
 
13740±2583 - 10442±1839
* 
 12556±211
9 
- 10043±1797*#  11914±1498 - 9723±1049* 
Fasting glucose 
(mmol.L-1) 
5.4±0.2 - 5.0±0.3  5.2±0.2 - 5.5±0.3  5.2±0.2 - 5.6±0.2 
  
 
 
Cholesterol 
(mmol.L-1) 
4.2±0.3 - 4.1±0.3  4.4±0.2 - 4.5±0.2  5.3±0.4 - 5.3±0.3 
Triglycerides 
(mmol.L-1) 
1.0±0.1 - 1.0±0.2  1.1±0.2 - 1.3±0.2  1.6±0.3 - 1.4±0.2 
HDL (mmol.L-1) 0.8±0.1 - 0.9±0.1  1.0±0.1 - 1.0±0.1  1.1±0.1 - 1.1±0.1 
LDL (mmol.L-1) 3.7±0.3 - 3.7±0.3  3.7±0.4 - 3.8±0.3  4.4±0.5 - 4.4±0.5 
MAP (mmHg) 
 
86±3 82±3 83±3  86±2 90±3 85±2  91±3 87±1 90±3 
SBP (mmHg) 
 
119±4 115±4 115±4  127±5 124±4 125±4  122±3 123±2 121±3 
DBP (mmHg) 70±3 66±3 66±3  73±3 73±3 72±3  68±2 69±1 67±3 
Calorie intake 
(kcal) 
1838±214 - 2216±196  1952±157 - 2043±112  1849±105 - 1696±150 
Energy 
expenditure 
(kcal) 
447±73 - 499±79  471±51 - 538±77  304±52 - 339±70 
 
Values are means ± SEM. #Denotes a significant differences with training from baseline and *indicates a difference between week 4 and 12 
(P<0.05). At baseline there were no differences in age, BMI or !̇O2peak between groups (P>0.05). 
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4.5. DISCUSSION 
This is the first study to successfully implement an unsupervised Home-HIT 
intervention in sedentary obese individuals with elevated CVD risk. Participants in 
the Home-HIT group had high adherence, which was similar to fully supervised Lab-
HIT. Furthermore, the Home-HIT participants were able to meet the prescribed HR 
thresholds despite being completely unsupervised during exercise. All three exercise 
modes produced comparable improvements in markers of cardio-metabolic disease 
risk. Finally, the immunofluorescence microscopy data revealed skeletal muscle 
adaptations typically observed following endurance exercise training in all three 
groups. These pilot data provide strong evidence that our novel Home-HIT 
intervention is an effective strategy that removes many of the major barriers to 
exercise, and therefore may be an effective public health intervention for the 
sedentary obese population. 
 
An Effective Training Programme with High Adherence and Compliance  
A number of groups have shown HIT to be an effective training intervention (Cocks 
et al., 2013, Cocks et al., 2016, Little et al., 2011, Hood et al., 2011). However, to 
date most of the data has come from highly controlled laboratory-based studies 
(Weston et al., 2014), or field-based work with high levels of participant supervision 
(Shepherd et al., 2015, Lunt et al., 2014, Ong et al., 2009). As such, public health 
researchers have argued that although effective under optimal controlled conditions, 
HIT cannot become an effective public health intervention, when targeted at 
sedentary, exercise-naïve populations most in need (Biddle and Batterham, 2015, 
Courneya, 2010, Hardcastle et al., 2014). Here, we report high adherence rates 
(96%) to a novel Home-HIT programme in a sedentary obese group with elevated 
CVD risk, despite training sessions being unsupervised and self-scheduled at home. 
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Adherence to Home-HIT was in fact higher than two recent studies investigating 
supervised field-based HIT interventions (Lunt et al., 2014, Shepherd et al., 2015). 
Indeed, we (Shepherd et al., 2015) previously reported 83% adherence to an 
instructor-led HIT class in sedentary but otherwise healthy individuals over a 10-
week programme, and in another study adherence to supervised outdoor sprint 
interval training (SIT) and aerobic interval training for 12 weeks was 75% and 55%, 
respectively, in overweight inactive adults (Lunt et al., 2014).  
Moreover, despite previous concerns (Frazao et al., 2016), our data suggests 
obese participants with elevated CVD risk were able to exercise at sufficiently-high 
exercise intensities to elicit the benefits of HIT without close supervision. The Home-
HIT intervention was designed for individuals with low fitness and mobility. Creating 
a personalised exercise service tailored to the user’s needs is important as ability 
and health status has been shown to be a critical factor in maximising adherence to 
exercise (Morgan et al., 2016). One way in which current fitness level and mobility 
were taken into account was in the design of the exercises which ranged from, 
simple low-impact exercises to complex movements with higher impact. This allowed 
participants to modify exercise sessions, choosing exercises which elicited the 
desired HR response, but were suitable for their level of mobility and fitness. Unlike 
previous low-volume HIT studies (Little et al., 2011, Tan et al., 2018), the current 
protocol increased the number of intervals as participants progressed through the 
12-week intervention, from 4 to 8 intervals. This may have influenced adherence to 
the programme as sedentary individuals have been shown to report pleasant 
feelings during the first 3-4 bouts of low-volume HIT, with the affective responses 
becoming more unpleasant with a higher number of intervals (Frazao et al., 2016). 
Importantly, enjoyment of HIT has been shown to increase with training (Heisz et al., 
2016).  
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The Home-HIT protocol was designed to overcome the major barriers 
reported to prevent many people exercising as it was performed within the 
participant’s home without any equipment. As such, significant barriers to exercise 
uptake and adherence like “intimidating” gym environments, difficulties with access 
to facilities, travel time and financial constraints (Trost et al., 2002, Morgan et al., 
2016) were eliminated. Finally, the Home-HIT intervention was time-efficient. 
Training sessions lasted between 8 and 16 minutes and weekly time commitment in 
the Home-HIT group was 24-48 minutes compared to 90-150 minutes in the Home-
MICT group. Moreover, as the exercise could be performed at home, further time 
was likely saved by not having to travel to the gym or other exercise locations.  
A major strength of this study was the use of remote HR monitoring and 
mobile app to provide an objective measure of adherence and compliance. This is 
the first home-based investigation to use this technology, as other studies tend to 
rely on self-report (Blackwell et al., 2017, Halse et al., 2014). The novel exercise 
monitoring system may have positively influenced the findings of the current study, 
contributing to the high adherence observed in both home-based HIT (96%) and 
MICT (88%). Whilst home-based exercise programmes have a number of benefits, 
lack of support and supervision from exercise professionals may present a significant 
barrier. Indeed, a recent meta-analysis of barriers and facilitators to adherence in 
exercise referral schemes suggested that supervision from exercise professionals 
was needed to build and maintain motivation to exercise, and that lack of supervision 
induced negative opinions which are likely to reduce future adherence (Morgan et al., 
2016). In the current study participants were aware that the research team was 
monitoring their adherence and received regular personalised emails (once every 2 
weeks) asking how training was progressing. Although these emails did not explicitly 
instruct participants to train they may have led to a supportive environment (Morgan 
et al., 2016), contributing to the high adherence and compliance observed in both 
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home-based groups which were higher than previous field-based exercise 
interventions (Shepherd et al., 2015, Lunt et al., 2014). Importantly, such monitoring 
systems may provide a relatively inexpensive (approx. £40 per HR monitor and app) 
strategy to engage with participants and improve uptake, adherence, compliance 
and ultimately health outcomes. 
 
Home-based HIT Effectively Improved Cardio-Metabolic Disease Risk Factors  
Aerobic Capacity 
There were similar improvements in !̇O2peak in all three training groups despite the 
weekly time commitment in the Home-HIT group being 66-102 minutes less than 
Home-MICT, and having no supervision or encouragement as in the Lab-HIT group. 
The 16% increase in !̇O2peak after 12 weeks of Home-HIT is similar to that reported 
in two recent meta-analyses investigating laboratory-based HIT in patients with 
lifestyle-induced cardio-metabolic disease (Weston et al., 2014) and SIT in sedentary 
individuals (Sloth et al., 2013). The findings from these pilot data have clinical 
importance given that training induced improvement in	!̇O2peak is associated with 
reduced risk of all-cause mortality (Lee et al., 2010). Moreover, our increase of 3.8 
ml∙kg-1∙min-1 (~1 MET) after 12 weeks of Home-HIT is reported to be associated with 
a clinically meaningful 8-17% reduction in all-cause mortality24. 
!̇O2peak was increased significantly by 9% following 4 weeks of Home-HIT, 
suggesting that despite having fewer intervals than previous low-volume HIT studies 
(Little et al., 2011) (4 vs 10), the intervention induces meaningful improvements that 
are similar to previous low-volume HIT interventions of similar duration (Hood et al., 
2011, Gillen et al., 2012). Moreover, !̇O2peak continued to increase by a further 7% 
between weeks 4 and 12 in the Home-HIT group, in line with the 6% increase in the 
MICT group and 12% increase in the Lab-HIT group. This is only the second study to 
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report physiological adaptations at two time points during a HIT intervention, 
supporting the previous work (Gillen et al., 2016) evidencing that !̇O2peak does not 
plateau for at least 12 weeks of HIT.  
 
Vascular Measures 
On average, FMD increased by 2% after 12 weeks of Home-HIT. Brachial artery 
FMD is an independent predictor of CVD risk (Gokce et al., 2002, Green et al., 2011) 
and is a surrogate of coronary artery endothelial function (Anderson et al., 1995). 
Indeed, there is a 9% decrease in the future risk of cardiovascular events with each 
1% increase in FMD (Green et al., 2011). Improved FMD has been suggested to be 
the result of elevated nitric oxide (NO) bioavailability following training (McAllister 
and Laughlin, 2006).  
This is the first study to investigate the time course of FMD response with 
training in obese individuals with elevated CVD risk. Studies in healthy young 
volunteers have demonstrated that endothelial function (measured using FMD) is 
increased following 2-4 weeks of training, and that function is normalised after 
prolonged training (>6 weeks) due to structural adaptation i.e. increased brachial 
artery diameter (Green et al., 2017). The current results differ from this paradigm as 
increased endothelial function was observed only after 12 weeks, and there was no 
suggestion of arterial remodelling. These data are in line with previous work that has 
shown there is a different time-course of arterial adaptation in individuals with 
chronic heart failure and coronary artery disease (Maiorana et al., 2000, Walsh et al., 
2003) compared to asymptomatic healthy individuals (Maiorana et al., 2001). This 
may be due to the impact of oxidative stress or inflammation on NO bioavailability 
which are known to be elevated in obese individuals with increased CVD risk (Silver 
et al., 2007, La Favor et al., 2016).  
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This is the first investigation to study the effects of exercise training on aortic 
PWV over 12 weeks in obese individuals with elevated CVD risk. The results mirror 
the changes in FMD with no change in aortic PWV following 4 weeks of training, but 
a significant improvement after 12 weeks. Obesity results in increased central artery 
stiffness even in young individuals, with subsequent negative cardiovascular 
outcomes (Zebekakis et al., 2005). Therefore, the improved PWV in this study may 
be related to improved cardiovascular risk. 
 
Body Composition 
The data demonstrate that Home-HIT is effective at improving body composition, 
with a reduction in whole body and visceral adiposity after 12 weeks. This was the 
first study to our knowledge to investigate the effect of Home-HIT on visceral fat 
mass following training in obese individuals. The present data are consistent with the 
findings of Gillen et al. (2016) who found low-volume Lab-HIT to be effective at 
reducing whole body and abdominal adiposity in obese/overweight women. 
Accumulation of whole body adipose tissue, and visceral adipose tissue in particular, 
is strongly associated with increased cardio-metabolic disease risk and all-cause 
morbidity (Poirier et al., 2006, Bogers et al., 2007), and these changes in the longer 
term may lead to a clinically-meaningful reduction in CVD risk and improvement in 
metabolic health. Interestingly, Home-HIT induced the highest mean reduction in 
visceral adiposity and although no statistical difference between groups was 
observed in the current study future work should investigate if the whole body nature 
of Home-HIT induces favourable reductions in visceral adiposity compared to other 
training methods.  
 
Insulin Sensitivity 
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Home-HIT improved whole body insulin sensitivity to a similar extent as Lab-HIT and 
Home-MICT, and is in agreement with previous laboratory-based HIT programmes 
conducted in overweight/obese individuals (Cocks et al., 2016, Hood et al., 2011). 
The benefits of improved insulin sensitivity through Home-HIT are relevant for 
reducing the risk of progression to type 2 diabetes which is a major risk for 
macrovascular and microvascular complications that over time can lead to severe 
outcomes including coronary heart disease, kidney failure, limb amputations and 
blindness (Hellgren et al., 2015). Therefore, a high insulin-sensing capacity of 
skeletal muscle is required for an optimal healthy phenotype to prevent substantial 
perturbations in blood glucose concentrations and the long-term complications that 
can accompany a persistent elevation in blood glucose concentration (Abdul-Ghani 
et al., 2006). 
 
Myocyte Adaptations 
The myocyte adaptations investigated were selected because they are classical 
markers of skeletal muscle adaptation to exercise training potentially associated with 
improvements in health (Hawley and Lessard, 2008). Previous research has shown 
that HIT increases GLUT4 protein expression (Bradley et al., 2014), IMTG content 
(Shepherd et al., 2013a, Shepherd et al., 2017) and mitochondrial density (Shepherd 
et al., 2017, Tan et al., 2018). The increase in mitochondria likely underpins the 
improved !̇O2peak as mitochondrial biogenesis is a major training adaptation that 
increases lipid and glucose fuel handling. High IMTG content is associated with 
insulin resistance in sedentary individuals, but athletes combine high IMTG with high 
insulin sensitivity (Goodpaster et al., 2001). This is explained by their greater 
capacity to oxidise IMTG. Therefore, the increase in mitochondria alongside 
increased IMTG will lead to greater IMTG oxidation during exercise and this may be 
linked to the improved insulin sensitivity. GLUT4 is the primary insulin-responsive 
Chapter 4 
103 
 
glucose transporter in skeletal muscle, and experimental increases in skeletal 
muscle GLUT4 expression in animal models have been shown to increase whole 
body insulin sensitivity (Tsao et al., 1996, Ren et al., 1995, Hansen et al., 1995). As 
such, the increase in GLUT4 expression likely contributed to the increased insulin 
sensitivity observed in the present study. 
 
Limitations 
The current pilot investigation was designed as a proof of concept study, and as 
such the sample size was small, providing sufficient power to detect a meaningful 
within group difference in !̇O2peak. Using the data generated in this study a formal 
power calculation suggests 69 participants per group would be required to detect a 
between group difference in !̇O2peak of 1.5 ml·kg-1·min-1 between Home-HIT and 
Home-MICT. Therefore, based on this promising pilot data, future trials should 
investigate Home-HIT in larger cohorts to investigate its true effectiveness compared 
to traditional training interventions.    
 
Conclusions 
This is the first study to successfully implement an unsupervised 12-week Home-HIT 
training programme in previously sedentary obese individuals with elevated CVD risk. 
Despite being unsupervised and having no encouragement during the exercise, the 
Home-HIT group had high adherence rates at the prescribed exercise intensity, 
comparable with fully supervised Lab-HIT. Home-HIT was similarly effective at 
increasing a range of physiological measures to a fully supervised Lab-HIT and 
Home-MICT, including !̇O2peak, body mass, body fat percentage, measures of 
vascular function, visceral fat mass and insulin sensitivity, and markers of muscle 
training status all of which are indicative of a lower CVD risk. These pilot data 
therefore provide strong evidence that our novel Home-HIT intervention is an 
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effective strategy to improve cardio-metabolic health by increasing physical activity 
participation in the obese population most in need. 
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5.1. ABSTRACT  
Obesity and inactivity lead to structural and functional muscle microvascular 
impairments associated with development of chronic disease. This study is the first 
to investigate the effect of a novel home-based high-intensity interval training (HIT) 
(Home-HT) intervention in obese individuals with elevated cardiovascular disease 
(CVD) risk on capillarisation and muscle microvascular eNOS/NAD(P)Hoxidase ratio. 
Comparisons were made with home-based moderate-intensity continuous training 
(Home-MICT) and supervised laboratory-based low-volume HIT (Lab-HIT) as control 
groups. Thirty-two sedentary obese adults (age 36±2 years; BMI 34.3±0.8 kg∙m-2; V̇O2peak 2.5±0.2 L/min-1) were allocated to 12 weeks of Home-HIT (n=9), Home-MICT 
(n=13) or Lab-HIT (n=10). Muscle biopsies were taken pre- and post-training to 
assess specifically in the endothelial layer of muscle arterioles and capillaries the 
protein content of eNOS, serine1177 phosphorylated eNOS, NOX2 and p47phox and 
various capillarisation measures using quantitative immunofluorescence microscopy. 
All interventions induced comparable increases in total eNOS content in terminal 
arterioles and capillaries (P<0.001). There was no change in ser1177 phosphorylated 
eNOS (arterioles P=0.802; capillaries P=0.311), but eNOS ser1177/eNOS ratio 
significantly decreased following training in arterioles and capillaries (P<0.001). 
Training decreased NOX2 content (arterioles P<0.001; capillaries P<0.001), but 
there was no change in p47phox content (arterioles P=0.101; capillaries P=0.345). All 
measures of capillarisation increased (P<0.05). These adaptations occurred 
alongside increased !̇O2peak (P<0.001) and whole-body insulin sensitivity (P=0.033). 
There were no significant differences between training programmes. Therefore, the 
training effects of Home-HIT are comparable to those of traditional training methods, 
with the advantage that Home-HIT reduces barriers to exercise in obese individuals 
with elevated CVD risk. 
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5.2. INTRODUCTION 
With obesity and sedentary behaviour there are structural and functional 
impairments in the skeletal muscle microvasculature that significantly reduce the 
ability of the skeletal muscle to meet its metabolic demands and contribute to the 
development of insulin resistance and chronic diseases (Wallis et al., 2002, Clerk et 
al., 2006, Vincent et al., 2003). This decline in skeletal muscle microvascular function 
has been proposed to precede macrovascular impairments (Krentz et al., 2009). 
Together these observations suggest that the skeletal muscle microvasculature 
should be regarded as a primary target for intervention in the increasingly obese 
population.  
Reduced skeletal muscle microvascular nitric oxide (NO) bioavailability is a 
central factor contributing to capillary rarefaction and the impaired vasodilatory 
response seen in obesity (McAllister and Laughlin, 2006, Frisbee, 2007, Olver and 
Laughlin, 2016). Endothelial nitric oxide synthase (eNOS) is the rate limiting enzyme 
responsible for NO synthesis, with the ability of eNOS to synthesise NO being 
determined by its protein content and activity in the endothelial layer of the muscle 
microvasculature (Cocks and Wagenmakers, 2016). eNOS activation is determined 
by phosphorylation on multiple sites, with increases in insulin, shear stress and 
VEGFA leading to eNOS serine1177 phosphorylation and vasodilation of the muscle 
microvasculature (Hoier et al., 2013, Hellsten et al., 2008, Mount et al., 2007, Cocks 
and Wagenmakers, 2016). Obesity and inactivity have been shown to alter the 
balance between NO production by eNOS and increase NO quenching by 
superoxide anions and other reactive oxygen species (ROS) (McAllister and 
Laughlin, 2006, Frisbee, 2005). The enzyme complex NAD(P)Hoxidase (NAD(P)Hox) 
has been shown to be a major source of superoxide anion production in obese 
individuals (Silver et al., 2007, La Favor et al., 2016). As such, the eNOS to 
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NAD(P)Hox protein ratio has been suggested to be a key marker of microvascular 
function in skeletal muscle (Cocks and Wagenmakers, 2016).  
Recent work has demonstrated that 4 weeks of sprint interval training (SIT) 
leads to similar improvements in capillarisation and eNOS/NAD(P)Hox protein ratio 
as traditional moderate-intensity continuous training (MICT) in obese males (Cocks 
et al., 2016). Although the SIT protocol used by Cocks et al. (2016) offers a time-
efficient alternative to MICT, the suitability of SIT as a safe and tolerable exercise 
strategy in obese individuals with elevated cardiovascular disease (CVD) risk has 
been questioned (Levinger et al., 2015). As such, low-volume high-intensity interval 
training (HIT) protocols, consisting of 60 seconds of intense constant-load cycling 
interspersed with 60 seconds of active recovery, have been developed as a safe and 
tolerable alternative (Little et al., 2011), capable of  inducing similar adaptations to 
MICT in a number of health-related variables, including aerobic capacity (!̇O2max) 
and insulin sensitivity (Hood et al., 2011).  
However, public health experts have questioned the applicability of current 
HIT interventions (Hardcastle et al., 2014, Biddle and Batterham, 2015, Courneya, 
2010), arguing that although effective under optimal conditions in the laboratory 
(continuous supervision and specialised equipment) HIT creates a number of 
additional barriers to exercise in sedentary, exercise-naïve individuals in the “real 
world”. Common barriers to current HIT protocols include difficulties with access to 
facilities (including travel distance and cost), expensive exercise equipment and 
embarrassment due to negative body image (Korkiakangas et al., 2009). To 
eliminate many of these barriers we recently developed a new home-based HIT 
(Home-HIT) intervention (Chapter 4) tailored to sedentary obese individuals with low 
fitness and mobility that could be performed in the participant’s own home without 
supervision or equipment. In Chapter 4 we have shown that Home-HIT was effective 
at overcoming many of the major barriers to exercise, offering a time-efficient, low-
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cost and effective means to improve markers of cardio-metabolic health including !̇O2peak, insulin sensitivity, vascular stiffness and endothelial function. The aim of the 
present study was to investigate the effect of a 12-week Home-HIT intervention on 
skeletal muscle capillary density and skeletal muscle microvascular enzymes 
responsible for NO production (eNOS content and ser1177 phosphorylation) and NO 
quenching (NOX2 and p47phox content) in previously sedentary obese individuals 
with elevated CVD risk. Comparisons were made with the effects of home-based 
MICT (Home-MICT) and supervised low-volume laboratory-based HIT (Lab-HIT) as 
control groups. We employed quantitative immunofluorescence microscopy, to 
assess the protein content and phosphorylation status of the indicated enzymes 
within the endothelial layer of the skeletal muscle microvasculature. The hypothesis 
was that microvascular density and eNOS content would increase to a similar extent 
in all three groups alongside an increase in !̇O2peak and insulin sensitivity. The 
secondary hypothesis was that the three training programmes would reduce the 
protein content of NOX2 and its activator p47phox to a similar degree in the 
endothelial layer of terminal arterioles and capillaries. 
 
5.3. METHODS 
The participants described in this study have been used in a previous chapter that 
focused on adherence and compliance to the three exercise interventions and the 
subsequent effect on cardio-metabolic disease risk (Chapter 4). Basic subject 
characteristics are described in Chapter 4, Table 4.2. The effect of the interventions 
on aerobic capacity and insulin sensitivity are also presented in both chapters 
because they are relevant for the interpretation of both studies. 
 
Participants 
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Thirty-two sedentary obese adults (BMI >30 kg·m2 or waist/hip ratio of >0.9 in men 
and >0.85 in women) with at least 2 further CVD risk factors, according to the 
American Heart Association criteria (Grundy et al., 1999), (see Table 4.1. for 
participant characteristics) were allocated to one of three 12-week exercise training 
groups: Home-HIT (n = 9); Home-MICT (n = 13); or Lab-HIT (n = 10) matched for 
age, BMI and !̇ O2peak. Participants were free of diagnosed CVD and other 
contraindications to participate in an exercise intervention, ascertained through a 
medical screening process, and after completing the International Physical Activity 
Questionnaire all participants were deemed to have a sedentary lifestyle. All 
participants provided written informed consent, and the study was approved by the 
Black Country NHS Research Ethics Committee (West Midlands, UK) and 
conformed to the Declaration of Helsinki.  
 
Pre- and Post-Training Experimental Procedures  
Experimental procedures, including measures of !̇O2peak, body composition and 
insulin sensitivity, were undertaken before and after training (>48 h following the ﬁnal 
exercise training session and identical in all respects to pre-training) as previously 
described (Chapter 4). Muscle samples were obtained from the vastus lateralis 
under local anaesthesia using the Bergström technique (Bergstrom, 1975) following 
an overnight fast. Finally, participants were provided with a physical activity monitor 
(ActiGraph GT3X+, Fort Walton Beach, FL) and diet diary so that habitual physical 
activity levels and diet could be assessed over 7 and 3 days, respectively. 
 
Training  
The 12-week training interventions started ~72 h after pre-training testing. Full details 
of the three training interventions (Home-HIT, Home-MICT, Lab-HIT) are described 
in Chapter 4. In brief, participants in the Home-HIT group completed repeated 1-
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minute intervals composed of simple body weight exercises interspersed with 1 
minute of recovery. Participants were advised to achieve ≥80% of their predicted 
heart rate maximum (HRmax; 220–age) during the intervals. During weeks 1-4 
participants were advised to complete 4 intervals, this then increased by one interval 
per session each fortnight up to 8 intervals during weeks 11-12. In the Home-MICT 
group, participants performed continuous exercise of their choosing (swimming, 
cycling or walking/running). Participants were advised to exercise at ~65% of 
predicted HRmax throughout the sessions. During weeks 1-4 participants were asked 
to exercise for 30 minutes which increased by 5 minutes each fortnight up to 50 
minutes during weeks 11-12. The home-based interventions were completed by the 
participants in an unsupervised place of their choosing outside Liverpool John 
Moores University (LJMU). Participants in both home-based groups were advised to 
train 3 times per week, but this was not enforced. To monitor the number of training 
sessions completed (adherence) and exercise intensity achieved (compliance), 
participants were given a HR monitor which was able to connect via Bluetooth to the 
participant’s smart phone (Polar Beat; www.polar.com/beat/uk-en). 
Participants in the Lab-HIT group attended the School of Sport and Exercise 
Sciences at LJMU to train 3 times per week under researcher supervision where 
they performed repeated 1-minute bouts of exercise on a cycle ergometer (Excalibur 
Sport V2.0, Lode, Groningen, The Netherlands), interspersed with 1 minute of active 
recovery. During the intervals, participants exercised at an intensity of 100% Wmax 
(Little et al., 2011) in order to elicit a HR of ≥80% HRmax. The number of intervals 
were identical to the Home-HIT group. 
 
Quantitative Immunofluorescence 
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NOX2 and p47phox protein content in the skeletal muscle microvascular endothelium 
and sarcolemma were assessed using the previously developed 
immunofluorescence staining protocol and quantification technique as described in 
Chapter 3 to allow for differentiation between capillaries and terminal arterioles. 
Capillary and terminal arteriole specific eNOS content and eNOS ser1177 
phosphorylation were also assessed using previously established methods (Cocks et 
al., 2016); however, the method was adapted to allow for assessment of individual 
vessel eNOS ser1177/eNOS ratio to be calculated as described in Chapter 3.  
 
Capillarisation  
Immunofluorescence microscopy was used as described in Chapter 3 to assess the 
following indexes were measured (Hepple et al., 1997): 1) the number of capillaries 
around a fibre (capillary contacts), 2) capillary-to-fibre ratio on an individual fibre 
basis and 3) capillary-fibre perimeter exchange (CFPE) index. In addition, overall 
capillary density was determined. Quantification of capillarisation was performed only 
on transverse fibres. In line with previous studies assessing capillarisation, at least 
50 complete fibres were included in each analysis (Porter et al., 2002). Fibre cross-
sectional area and perimeter were measured on calibrated images using ImagePro 
Plus 5.1 software. 
 
Statistical Analysis 
The primary aim of the study was to compare the effects of training on muscle 
microvascular eNOS protein content. The study was powered to detect between-
group differences in these variables in response to training. G*Power 3.1 software 
(G*Power Software Inc., Kiel, Germany) was used to calculate the required sample 
size. The study was designed to detect a between-group effect of f = 0.35, 
representative of a medium-sized effect (Cohen, 1992), adopting an alpha of 0.05 
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and power of 0.80. This was deemed to be a physiologically relevant difference, as 
the authors have previously observed a medium effect size difference following 6 
weeks of SIT and MICT in sedentary individuals (Cocks et al., 2013). As such, 
muscle biopsies were taken and analysed pre and post-training from 8 participants in 
each group. Capillary contacts, capillary-to-fibre ratio on an individual fibre basis, 
capillary-fibre perimeter exchange, fibre cross-sectional area and perimeter were 
analysed using a three-way mixed ANOVA, with the between group factor ‘group’ 
(Home-HIT vs. Home-MICT vs. Lab-HIT) and within group factors ‘training status’ 
(pre vs. post) and ‘fibre type’ (type 1 vs. type 2). All other variables taken pre and 
post-training were analysed using a 2-way mixed design ANOVA with between factor 
‘group’ (Home-HIT vs. Home-MICT vs. Lab-HIT) and within group factor ‘training 
status’ (pre vs. post). Matsuda Index values are missing in one Lab-HIT participant 
and three Home-MICT participants because it was not possible to get blood samples. 
All analyses were performed using IBM SPSS Statistics for Windows, Version 22.0. 
Armonk, NY: IBM Corp. Significance was set at P≤0.05 and data are presented as 
mean ± SEM.  
 
5.4. RESULTS 
General Characteristics 
At baseline there were no differences in age, BMI or !̇O2peak between groups 
(P=0.369; 0.455 and 0.898, respectively). Adherence and compliance (Home-HIT 96 
± 3% & 99 ± 1%; Home-MICT 88 ± 4% & 100 ± 0%; Lab-HIT 97 ± 1% & 100 ± 0%, 
respectively) to training did not differ between groups (see Chapter 4 for more 
details). Training increased !̇O2peak (Home-HIT 16%, Home-MICT 12%, Lab-HIT 
20%) with a main effect of training (P<0.001) and no difference between groups 
(Table 4.2.). The Matsuda insulin sensitivity index was significantly increased after 
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12 weeks of training (Home-HIT 39%, Home-MICT 8%, Lab-HIT 13%; main effect of 
training, P=0.033; Table 3.1.) with no difference between groups.  
 
Quantitative Immunofluorescence  
Mean diameter of arterioles assessed were 10.2 ± 0.2 µm which is consistent with 
the interpretation that only terminal or 5th order arterioles were analysed (Wu et al., 
2011). The mean number of arterioles analysed was 9 ± 1 at each time point per 
participant. 
 
eNOS Content and Phosphorylation 
Terminal arteriole eNOS content increased with training (Home-HIT = 20%; Home-
MICT = 18%; Lab-HIT = 15%; main effect of training, P<0.001; Fig. 5.1.). There was 
also an increase in capillary eNOS content (Home-HIT = 21%; Home-MICT = 7%; 
Lab-HIT = 9%; main effect of training, P=0.001; Fig 5.1.). Training did not change 
eNOS ser1177 phosphorylation in the terminal arterioles (training effect, P=0.802) or 
capillaries (training effect, P=0.311; Fig. 3.1.). When eNOS ser1177 phosphorylation 
was normalised to eNOS content (eNOS ser117/eNOS ratio) on an individual vessel 
basis there were significant decreases with training in the arterioles and capillaries 
(main effect of training, P=0.001 and P<0.001, respectively; Fig 5.1.). There were no 
between group differences for any of the variables. 
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Figure 5.1. Effect of 12 weeks of home-based high-intensity interval training 
(Home-HIT), home-based moderate-intensity continuous training (Home-MICT) 
and lab-based HIT (Lab-HIT) on eNOS content and eNOS ser1177 
phosphorylation in capillaries and terminal arterioles. 
(A) Representative confocal microscopy images of skeletal muscle from pre (top) 
and post (bottom). The skeletal muscle microvascular endothelium was revealed 
using Ulex europaeus-FITC conjugated lectin (green). Arterioles and capillaries were 
differentiated using anti-α-smooth muscle actin (αSMA) in combination with Alexa 
Fluor 405 conjugated secondary antibody (blue). Skeletal muscle eNOS ser1177 
phosphorylation was revealed using Alexa Fluor 633 conjugated secondary antibody 
(purple). Skeletal muscle eNOS expression was revealed using Alexa Fluor 546 
conjugated secondary antibody (red). (B) and (C) show mean fold change in eNOS 
content in capillaries and arterioles with training; (D) and (E) show mean fold change 
in eNOS ser1177 phosphorylation  in capillaries and arterioles with training and (F) 
and (G) show change in eNOS/PeNOS ser1177 ratio with training. *Indicates a 
significant main effect of training (P<0.05). White bar = 50 µm. 
 
NAD(P)Hox Subunits  
Terminal arteriole NOX2 content was significantly reduced with training (Home-HIT = 
-22%; Home-MICT = -21%; Lab-HIT = -24%; main effect of training, P<0.001). 
Training also reduced skeletal muscle capillary NOX2 content (Home-HIT = -18%; 
Home-MICT = -14%; Lab-HIT = -24%; main effect of training, P<0.001; Fig. 3.2.). 
There was no change in p47phox content in the terminal arterioles (P=0.101) or 
capillaries (P=0.345) following training. Sarcolemma-associated NOX2 and p47phox 
content were unaltered by training (main effect of training, P=0.897 and P=0.561, 
respectively). There were no between group differences in any of the variables 
(P<0.05). 
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Figure 5.2. Effect of 12 weeks of home-based high-intensity interval training 
(Home-HIT), home-based moderate-intensity continuous training (Home-MICT) 
and lab-based HIT (Lab-HIT) on NOX2 and p47phox content. 
(A) Representative confocal microscopy images of skeletal muscle from pre (top) 
and post (bottom) training on NOX2 content. The skeletal muscle microvascular 
endothelium was revealed using Ulex europaeus-FITC conjugated lectin (green). 
Arterioles and capillaries were differentiated using anti-α-smooth muscle actin 
(αSMA) in combination with Alexa Fluor 405 conjugated secondary antibody 
(greyscale). Wheat germ agglutinin-633 (WGA-633; Invitrogen, Paisley, UK) was 
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used as a plasma marker membrane (pink). Skeletal muscle NOX2 expression was 
revealed using Alexa Fluor 546 conjugated secondary antibody (red). White bar = 50 
µm. (B) and (C) show mean fold change in NOX2 content in arterioles and capillaries 
with training; (D) and (E) show mean fold change in p47phox expression in arterioles 
and capillaries with training. *Indicates a significant main effect of training (P<0.05). 
White bar = 50 µm.  
 
 
Capillarisation 
Capillary density was increased by training (Home-HIT = 15%; Home-MICT = 33%; 
Lab-HIT = 16%; main effect of training P<0.001), with no differences between groups 
(P=0.850). Capillary-to-fibre ratio, capillary-fibre perimeter exchange index and 
capillary contacts were all higher in type I fibres than type II fibres irrespective of 
training status (main effect of fibre type, P<0.05). Capillary-to-fibre ratio on an 
individual fibre basis (C/Fı) increased with training (Home-HIT = 16%; Home-MICT = 
25%; Lab-HIT = 10%; main effect of training, P<0.001), with no difference between 
groups (P=0.774). Capillary-fibre perimeter exchange increased with training (Home-
HIT = 14%; Home-MICT = 19%; Lab-HIT = 5%; main effect of training, P<0.001), 
with no differences between groups (P=0.378). Capillary contacts increased with 
training (Home-HIT = 15%; Home-MICT = 33%; Lab-HIT = 16%; main effect of 
training, P<0.001), with no difference between groups (P=0.706). There was a trend 
towards an effect of fibre type on fibre cross-sectional area (P=0.077), but there was 
no effect of fibre type on fibre perimeter (P=0.242). Training had no effect on fibre 
cross-sectional area (P=0.190) or perimeter (P=0.394).   
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Figure 5.3. Effect of 12 weeks of home-based high intensity interval training 
(Home-HIT), home-based moderate intensity continuous training (Home-MICT) 
and lab-based HIT (Lab-HIT) on skeletal muscle capillarisation. 
Representative widefield microscopy images of skeletal muscle pre (top) and post 
(bottom) training. Capillarisation was revealed using Ulex europaeus-FITC 
conjugated lectin (UEA-I, green). The skeletal muscle membrane was revealed using 
wheat germ agglutinin-633 (WGA, blue). Fibre type was revealed using anti-myosin I 
(MHC-I, red). White bar = 50 µm. 
  
 
Table 5.1. Capillarisation pre- and post-training 
 Home-HIT  Home-MICT  Lab-HIT 
Variable Pre Post  Pre Post  Pre Post 
Overall FA (mm2) 3732 ± 458 4758 ± 1231  3054 ± 342 3210 ± 342  3912 ± 716 4569 ± 1206 
Type 1 FA (mm2) 4041 ± 512 5658 ± 2065  3397 ± 286 3180 ± 266  4061 ± 761 4698 ± 1289 
Type II FA (mm2) 3550 ± 466 4277 ± 880  2852 ± 406 3192 ± 434  3901 ± 754 4509 ± 1194 
Overall perimeter (mm2) 292.2 ± 28.8 307.5 ± 33.1  253.0 ± 19.8 263.7 ± 22.5  324.7 ± 37.1 333.2 ± 41.7 
Type 1 perimeter (mm2) 300.9 ± 30.8 318.0 ± 42.7  261.4 ± 16.4 267.7 ± 26.1  329.3 ± 36.4 327.1 ± 37.5 
Type II perimeter (mm2) 287.2 ± 28.9 301.3 ± 31.5  249.1 ± 23.4 259.9 ± 23.8   323.1 ± 38.5 334.4 ± 43.4 
Overall CC* 3.97 ± 0.22 4.56 ± 0.30  3.52 ± 0.42 4.68 ± 0.16  3.93 ± 0.29 4.56 ± 0.33 
Type I CC* 4.33 ± 0.35 4.84 ± 0.40  3.78 ± 0.42 4.99 ± 0.20  4.35 ± 0.21 4.76 ± 0.35 
Type II CC* 3.70 ± 0.20 4.27 ± 0.24  3.38 ± 0.42 4.48 ± 0.25  3.69 ± 0.36 4.44 ± 0.34 
Overall C/Fı* 1.54 ± 0.11 1.79 ± 0.12  1.41 ± 0.13 1.77 ± 0.09  1.66 ± 0.15 1.83 ± 0.17 
Type I C/Fı* 1.63 ± 0.15 1.86 ± 0.14  1.57 ± 0.13 1.89 ± 0.12  1.85 ± 0.15 1.92 ± 0.17 
Type II C/Fı* 1.47 ± 0.12 1.70 ± 0.13  1.30 ± 0.11 1.69 ± 0.12  1.54 ± 0.15 1.76 ± 0.17 
Overall CFPE* 5.60 ± 0.39 6.38 ± 0.68  5.79 ± 0.53 6.90 ± 0.39  5.63 ± 0.67 5.92 ± 0.44 
Type I CFPE* 5.80 ± 0.48 6.60 ± 0.79  6.20 ± 0.57 7.25 ± 0.48  6.39 ± 0.81 6.42 ± 0.64 
Type II CFPE* 5.38 ± 0.33 6.10 ± 0.79  5.52 ± 0.50 6.68 ± 0.38  5.10 ± 0.55 5.65 ± 0.33 
CD (caps mm-2)* 682.6 ± 64.9 812.7 ± 80.2  806.4 ± 78.9 955.7 ± 67.9  675.8 ± 84.2 836.6 ± 51.1 
Values are mean ± SEM. *Indicates P<0.05, main effect of training. FA = fibre cross-sectional area, CD = capillary density, CC = capillary 
contacts, C/Fı = capillary-to-fibre ratio on an individual fibre basis, CFPE = capillary-fibre perimeter exchange.
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5.5. DISCUSSION 
This is the first study to demonstrate that Home-HIT, Home-MICT and low-
volume Lab-HIT in obese individuals with elevated CVD risk lead to 1) increased 
endothelial eNOS protein content in both terminal arterioles and capillaries, 2) 
reduced eNOS ser1177 phosphorylation when normalised to the increase in eNOS 
content, 3) decreased endothelial NOX2 protein content in terminal arterioles and 
capillaries, and 4) increased skeletal muscle capillarisation. No significant 
differences existed between the three groups. There were also significant increases 
in the eNOS/NAD(P)Hox protein ratio, whole body insulin sensitivity and !̇O2peak. 
Importantly, Home-HIT, which has been shown to reduce the major barriers to 
exercise (Chapter 4), resulted in equal adaptations to fully supervised Lab-HIT for all 
these outcome measures. Therefore, Home-HIT in obese individuals with elevated 
CVD risk is an effective and practical training strategy capable of producing 
metabolic and functional adaptations in the skeletal muscle microvasculature in a 
direction consistent with substantial health benefits.  
 
Skeletal Muscle Endothelial Enzymes Regulating NO Bioavailability  
This is the first study to demonstrate that low-volume Lab-HIT increased terminal 
arteriole and capillary eNOS expression. These findings are similar to previous work 
from our group demonstrating that lab-based SIT increased skeletal muscle 
microvascular eNOS content in lean (Cocks et al., 2013) and obese (Cocks et al., 
2016) individuals. However, the low-volume HIT protocol used in the current study 
was developed as a more suitable training method than SIT for the obese population 
studied due to the lower workload (Gibala et al., 2012). This study is also the first to 
demonstrate that the two "real world" home-based exercise programmes, performed 
without supervision, produced similar increases in eNOS content as the highly 
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controlled Lab-HIT protocol. The advantage of the Home-HIT intervention is that it 
simultaneously reduces many of the barriers to exercise experienced by obese 
exercise naïve individuals (Trost et al., 2002, Korkiakangas et al., 2009), suggesting 
it may be an effective alternative exercise intervention in the growing obese 
population. The current study found comparable increases in eNOS content in the 
two HIT groups and the MICT group, confirming our observations in a previous study 
comparing SIT and MICT in obese individuals (Cocks et al., 2016). However, an 
earlier study in sedentary young lean men demonstrated that the increase in eNOS 
was significantly greater following six weeks of “all-out” SIT than MICT (Cocks et al., 
2013). This difference may have been due to variations in the training stimulus (30-
second “all out” sprints vs. 1-minute submaximal exercise in the current study) and 
fitness differences between the studied populations.     
In this chapter, eNOS ser1177 phosphorylation and total eNOS protein content 
were quantified for each microvessel in view on the same image set. This is unlike 
the previous publication (Cocks et al., 2012) that assessed these variables on 
separate muscle sections and, therefore, calculated the eNOS ser1177/eNOS ratio 
without taking the variation in eNOS content (up to 3-fold) or phosphorylation status 
(up to 2-fold) between individual terminal arterioles and capillaries into account. As 
such, this study provides an improved quantitative assessment of these variables to 
training. Future studies should use this advance of the imaging method to deepen 
mechanistic insight in the role played by these variables and the eNOS ser1177/eNOS 
ratio in the metabolic adaptation of the muscle microvasculature to acute stimuli (e.g. 
exercise, insulin and VEGF) and the training adaptations seen in trained, sedentary, 
obese and insulin resistant individuals. 
There was no change in basal eNOS ser1177 phosphorylation in the 
microvascular endothelium following 12 weeks of training in all three groups. 
However, when normalised to eNOS content, eNOS ser1177 phosphorylation was 
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reduced. This is different to previous studies investigating the effect of training on 
basal eNOS ser1177 phosphorylation. Our group has previously found that 6 weeks of 
SIT or MICT in sedentary lean individuals reduced eNOS ser1177 phosphorylation 
expressed by itself and when normalised to eNOS content (Cocks et al., 2013). 
However, eNOS ser1177 phosphorylation was shown to increase and eNOS 
ser1177/eNOS content ratio was unchanged in obese individuals following 4 weeks or 
SIT or MICT (Cocks et al., 2016). The data produced by these studies indicate that 
the response of eNOS ser1177 phosphorylation to training is affected by obesity and 
temporal differences. In combination, the studies suggest that in obesity eNOS 
ser1177 phosphorylation initially increases in response to training before reducing over 
time. This reduction in obese individuals may continue with training to eventually 
reduce eNOS ser1177 phosphorylation irrespective of eNOS content as observed in 
the lean individuals (Cocks et al., 2013). The decrease in eNOS ser1177 
phosphorylation following training has been attributed to a decrease in shear stress 
due to the increased capillary density (Cocks et al., 2013), however Gliemann et al. 
(2014) suggested it may be a reflection of increased NO bioavailability as a result of 
less NO being scavenged by NOX2 and therefore less activation of eNOS is needed. 
Expression of the catalytic subunit of the NAD(P)Hox complex NOX2 was 
reduced in terminal arterioles and capillaries following Home-HIT to a similar degree 
as Home-MICT and Lab-HIT. This adds to previous work that found 4 weeks of 
laboratory-based SIT and MICT reduced mixed microvascular NOX2 content in 
obese individuals (Cocks et al., 2016). Conversely, when investigating sedentary 
lean individuals, Cocks et al. (2013) found no change in mixed microvascular NOX2 
protein content following SIT or MICT, presumably because the lean individuals have 
a very low NOX2 protein content at baseline. There was no change in arteriole or 
capillary content of the regulatory and assembly subunit of the NAD(P)Hox complex 
p47phox following training. These findings agree with those of La Favor et al. (2016), 
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who used Western blots on whole tissue homogenates to show that 8 weeks of 
aerobic interval training did not alter the expression of p47phox in obese individuals, 
despite elevated baseline levels. Together the current study and that of La Favor et 
al. (2016) demonstrate the importance of measuring multiple NAD(P)Hox subunits to 
gain full insight into the effect of training on O2¯ production.  
The increase in eNOS content and reduced NOX2 content following training 
indicates an altered balance between NO formation and quenching by O2¯ anions 
and other ROS leading to increased skeletal muscle microvascular NO bioavailability. 
Previous work has shown that NO-mediated increases in skeletal muscle perfusion 
are essential for optimal glucose uptake (Vincent et al., 2003, Vincent et al., 2004) 
and that this mechanism is impaired in obesity, contributing to impaired glucose 
disposal in this population (Clerk et al., 2006, Keske et al., 2009). As such, the 
improved eNOS/NAD(P)Hox ratio observed in the current study likely contributed to 
the improved insulin sensitivity observed following training. The metabolic 
importance of elevated eNOS content was highlighted by Kubota et al. (2011) who 
observed that an increase in eNOS content, through administration of bera-prost 
sodium (a prostaglandin I2 analogue that stimulates eNOS mRNA expression and 
protein synthesis), increased skeletal muscle capillary perfusion and glucose uptake 
in IRS-2 knockout and high-fat fed mice. In addition, obesity is associated with 
elevated oxidative stress in skeletal muscle due to elevated NOX-mediated ROS 
production, which leads to microvascular endothelial dysfunction (Weseler and Bast, 
2010, La Favor et al., 2016). La Favor et al. (2016) found that 8 weeks of aerobic 
interval training in obese individuals decreased expression of NAD(P)Hox subunits 
which coincided with reduced ROS production and reversed microvascular 
endothelial dysfunction. The observations from these previous studies combined with 
the results of the present study suggest that the increased eNOS/NAD(P)Hox ratio in 
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obese individuals following exercise training will result in increased NO bioavailability 
upon insulin stimulation and a more metabolically healthy phenotype.    
 
Capillarisation 
This is the first study to demonstrate that two home-based exercise interventions 
performed without supervision or equipment improve capillary density, capillary 
contacts and capillary-fibre perimeter exchange index. The findings also extend the 
recent work of Tan et al. (2018), which demonstrated that 6 weeks of low-volume 
HIT increased capillary contacts in overweight/obese women, while we show that 12 
weeks of low-volume HIT increased capillary density and capillary-fibre perimeter 
exchange index. The similar increases in capillarisation with Home-HIT and 
supervised Lab-HIT suggest Home-HIT is an effective strategy to increase 
capillarisation while simultaneously reducing the major barriers to exercise. The 
findings also provide support for previous shorter duration SIT (Cocks et al., 2013, 
Cocks et al., 2016) and HIT studies (Tan et al., 2018), which show no difference in 
fibre type specific angiogenesis in response to interval training, which is in contrast 
to previous work in rats showing fibre type difference in response to interval training 
and MICT (Gute et al., 1994).   
The increase in skeletal muscle capillarisation, as shown here, is an 
established adaptation to exercise training that is likely to be a key contributing factor 
to improved !̇ O2peak (Bassett and Howley, 2000, Saltin, 1988, Andersen and 
Henriksson, 1977, Hellsten and Nyberg, 2015) due to prolonged mean erythrocyte 
transit time and decreased diffusion distance to allow increased delivery and 
extraction of oxygen. Increased capillarisation is also likely to contribute to the 
improved insulin sensitivity observed, which would improve glucose tolerance and 
delay progression to type 2 diabetes in obese individuals with elevated metabolic 
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disease risk. This is supported by Akerstrom et al. (2014), who directly investigated 
the effects of capillarisation on insulin sensitivity by treating sedentary rats with 
Prazosin (an α1-adrenergic receptor antagonist). The ~20% increase in capillary 
density following 3 weeks of Prazosin treatment resulted in a ~30% increase in 
insulin-stimulated skeletal muscle glucose disposal, despite no change in skeletal 
muscle insulin signalling. This suggests that increased capillarisation with exercise 
training has a direct effect on insulin sensitivity, independent of other metabolic 
adaptations.  
 
Conclusions 
This study provides novel evidence that 12 weeks of Home-HIT, Home-MICT and 
Lab-HIT in obese individuals with elevated CVD risk leads to skeletal muscle 
microvascular adaptations that underpin the functional improvements in insulin 
sensitivity and !̇O2peak. All three training interventions induced similar improvements 
in endothelial enzyme balance as indicated by increased eNOS protein content, 
reduced eNOS ser1177/eNOS ratio and reduced expression of the catalytic subunit of 
the NAD(P)Hox subunit NOX2. There was also increased capillarisation and these 
adaptations occurred alongside increased !̇O2peak and whole-body insulin sensitivity. 
Importantly, Home-HIT induced comparable improvements in skeletal muscle 
capillarisation and endothelial eNOS/NAD(P)Hox balance to Lab-HIT, despite having 
no supervision during training. Therefore, we conclude that Home-HIT is a time-
efficient and effective strategy to remove barriers to exercise and improve skeletal 
muscle microvascular health in the obese population most in need.
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6.1. ABSTRACT 
OBJECTIVE: To compare the effect of a bout of high-intensity interval training (HIT) 
with a bout of moderate-intensity continuous training (MICT) on glucose 
concentrations over the subsequent 24h period. 
RESEARCH DESIGN AND METHODS: Fourteen people with type 1 diabetes 
(duration of type 1 diabetes 8.2±1.4 years), all on basal-bolus regimen, completed a 
randomised, counterbalanced, crossover study. Continuous glucose monitoring was 
used to assess glycaemic control following a single bout of HIT (6 x 1min intervals) 
and 30 mins of moderate-intensity continuous training (MICT) on separate days, 
compared to a non-exercise control day (CON). Exercise was undertaken following 
an overnight fast with omission of short-acting insulin. Capillary blood glucose 
samples were recorded pre and post-exercise to assess the acute changes in 
glycaemia during HIT and MICT. 
RESULTS: There was no difference in the incidence of or percentage time spent in 
hypoglycaemia, hyperglycaemia or target glucose range over the 24h and nocturnal 
period (24:00-06:00h) between CON, HIT and MICT (P>0.05). Blood glucose 
concentrations were not significantly (P=0.49) different from pre to post-exercise with 
HIT (+0.39±0.42 mmol/L) or MICT (-0.39±0.66 mmol/L), with no difference between 
exercise modes (P=1.00). 
CONCLUSIONS: HIT or 30 mins of MICT can be carried out after an overnight fast 
with no increased risk of hypoglycaemia or hyperglycaemia, and provided the pre-
exercise glucose concentration is 7-14 mmol/L, no additional carbohydrate ingestion 
is necessary to undertake these exercises. As HIT is a time-efficient form of exercise, 
the efficacy and safety of long-term HIT should now be explored.  
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6.2. INTRODUCTION 
Clinical guidelines recommend that people with type 1 diabetes perform at least 150 
minutes of moderate-intensity physical activity per week (Colberg et al., 2016). 
However, a single bout of moderate-intensity exercise in people with type 1 diabetes 
is associated with marked decreases in blood glucose concentrations and thus an 
increased risk of hypoglycaemia (Ertl and Davis, 2004, Garcia-Garcia et al., 2015). 
The potentially large drop in blood glucose during exercise and associated fear of 
acute and nocturnal hypoglycaemia means that many patients avoid exercise 
(Lascar et al., 2014), with long-tern cardio-metabolic health consequences. Clearly, 
safe and effective alternative forms of exercise that minimise the perceived barriers 
to exercise are needed for people with type 1 diabetes. 
Lack of time has also been cited as an important barrier to exercise in people 
with type 1 diabetes (Lascar et al., 2014). High intensity interval training (HIT), 
consisting of repeated bouts of high intensity exercise interspersed with low-intensity 
recovery, is purported as a time-efficient alternative to traditional moderate-intensity 
continuous training (MICT) in various groups without type 1 diabetes (Little et al., 
2011). Indeed, because the typical weekly training volume during a HIT programme 
is approximately one third of the time commitment required for MICT (Gibala et al., 
2012), HIT is able to minimise a perceived “lack of time” as a barrier to exercise. 
Importantly for people with type 1 diabetes, the addition of short bursts of high 
intensity exercise at regular intervals during a bout of MICT has been shown to 
assist in stabilising blood glucose concentration during exercise, and can prevent 
hypoglycaemia during and up to 2 hours post exercise (Guelfi et al., 2007b, Sills and 
Cerny, 1983). It is proposed that the increase in plasma catecholamines, growth 
hormone and cortisol during vigorous exercise (>80% !̇O2max) helps stabilise the 
glucose lowering effect of MICT (Marliss and Vranic, 2002). Therefore, in people with 
type 1 diabetes HIT may maintain blood glucose concentrations and reduce the risk 
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of hypoglycaemia both during exercise and overnight. To date, however, this has not 
been investigated.  
The current investigation aimed to determine whether HIT maintained 
normoglyccaemia both during exercise and in the 24 hours following exercise. To 
achieve this aim, we examined the effects of a single bout of HIT and MICT following 
an overnight fast on acute and 24h glucose concentrations in people with type 1 
diabetes, compared to a control day without exercise. Continuous glucose monitor 
data were analysed to assess 24h glycaemic control following exercise under 
controlled diet conditions using the most recent guidelines (Danne et al., 2017). 
Capillary blood sampling was used to assess change in blood glucose 
concentrations during the exercise bouts. We hypothesised that blood glucose 
concentrations would be maintained following HIT and that the incidence and time 
spent in hypoglycaemia would be lower, compared to MICT. 
 
6.3. METHODS  
Fourteen sedentary people with type 1 diabetes (6 men/8 women; age 26 ± 3 years; 
BMI 27.6 ± 1.3 kg·m-2; !̇O2peak 2.4 ± 0.2 L/min-1; duration of type 1 diabetes 8.2 ± 1.4 
years) on a basal-bolus insulin regimen completed the study. Exclusion criteria were 
duration of type 1 diabetes <6 months, insulin pump therapy, significant history of 
hyper- or hypoglycaemia (determined from medical history), obesity (BMI >30 kg∙m-2), 
pregnancy or planning pregnancy, uncontrolled hypertension (>180/100 mmHg), 
angina, autonomic neuropathy, taking any medication that affects heart rate, major 
surgery planned within 6 weeks of the study, severe nonproliferative and unstable 
proliferative retinopathy. Testing took place in the laboratory of the School of Sport 
and Exercise Sciences at Liverpool John Moores University. The study was 
approved by the Black Country NHS Research Ethics Committee (West Midlands, 
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UK) and all participants gave written informed consent to a protocol conforming to 
the Declaration of Helsinki.  
 
Pre-Experimental Procedures 
Participants first performed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, 
The Netherlands) to determine maximal aerobic power output (Wmax) and !̇O2peak 
using an online gas collection system (MOXUS modular oxygen uptake system, AEI 
technologies, Pittsburgh, PA). This information was used to determine appropriate 
workloads for subsequent exercise trials. The test consisted of 3-minute stages 
starting at 60 W, and the workload was increased by 35 W at each stage until 
subjects could not maintain a cadence of >50 rpm. !̇O2peak was taken as the highest 
value achieved over a 15 second recording period. Participants also completed a 
food diary over a minimum of three days in order to calculate their habitual caloric 
and macronutrient intake. 
 
Study Design and Experimental Protocol 
Participants completed a randomised, counterbalanced, crossover experiment, 
consisting of 3 intervention periods: control day with no exercise (CON), HIT and 
MICT (see Fig. 6.1. for protocol overview). Each intervention period lasted 24h 
during which the effect of a single session of exercise on subsequent 24h glycaemic 
control and risk of hypoglycaemia were assessed under standardised dietary, but 
otherwise free living conditions. Periods were identical except for the exercise 
performed. Prior to the intervention periods participants had a Dexcom G4 Platinum 
CGMS (Dexcom, San Diego, CA, USA) inserted subcutaneously on the abdomen. 
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Participants were trained on how to use the CGMS and instructed to calibrate the 
device a minimum of four times daily using capillary blood tests. Participants were 
not blinded to the CGMS meaning they could see their glucose values. Twenty-four 
hours after the CGMS was inserted participants completed the control intervention. 
Participants did not attend the laboratory on the control day, but were provided with a 
standardised diet to consume while going about their normal daily activities.  
 
 
Figure 6.1. Study protocol 
24h after the CGMS was inserted participants completed the control day. 
Participants did not attend the laboratory on the control day, but were provided with a 
standardised diet to consume while going about their normal daily activities. 
Following the control day, participants completed the two exercise intervention 
periods in a randomised order separated by at least 48h. The exercise intervention 
periods were identical to the control intervention except participants attended the 
laboratory following an overnight fast and having omitted their short-acting insulin to 
perform a bout of either high intensity interval training (HIT) or moderate intensity 
continuous training (MICT).  
 
 
The standardised diet was matched to each participant’s habitual energy intake and 
consisted of three meals (breakfast, lunch and dinner; 50% CHO; 30% fat; 20% 
protein). Participants were instructed to consume these meals at pre-determined 
time-points throughout the day. Participants only consumed the food provided by the 
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research team during this period. Additional snacks were only permitted to prevent 
hypoglycaemia. The diet was a 2-day rolling diet, matched for macronutrient and 
energy content between days, which ensured that participants consumed exactly the 
same food on the experimental days. Participants were also instructed to abstain 
from caffeine, alcohol and vigorous exercise. Participants completed a food diary to 
confirm that they had eaten the prescribed food at the correct times.  
Following the control day participants completed the 2 exercise intervention 
periods in a randomised order separated by at least 48h. The exercise intervention 
periods were identical to the control intervention except participants attended the 
laboratory following an overnight fast and having omitted their short-acting insulin to 
perform a bout of either HIT or MICT. Following the exercise, participants left the 
laboratory and returned to their normal daily activities. As on the control day 
participants were provided with a standardised diet to consume. This diet was 
identical to the control day and participants consumed each meal at the same pre-
determined time-points throughout the day. Insulin dosage was not recorded. 
 
Exercise Protocols 
Both exercise protocols were conducted on a stationary cycle ergometer (Excalibur 
Sport V2.0, Lode, Groningen, The Netherlands), and were preceded by a 
standardised 5 min warm-up at 50W. MICT consisted of 30 minutes continuous 
cycling at a workload equivalent to 65% !̇O2peak. HIT consisted of 6 x 1 minute 
intervals at a workload equivalent to 100% !̇O2peak, interspersed with 1 minute of rest. 
As such, the total time commitment of the HIT protocol (17 min) was ~half of that of 
the MICT protocol (35 min).  
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Acute Change in Blood Glucose with Exercise 
Blood glucose concentration was recorded before and after exercise through 
capillary fingertip sampling. This was to ensure that blood glucose levels were 
between 7-14 mmol/L, in accordance with the guidelines we developed in the 
Exercising for Type 1 Diabetes (EXTOD) study (Narendran et al., 2017), meaning 
participants were safe to commence exercise and also safe to leave following 
exercise. If blood glucose was <7 mmol/L before exercise, 20g of glucose was 
ingested. If >14 mmol/L, a light walk or insulin was advised, as well as checking 
blood ketones (Riddell et al., 2017).  
 
Statistical Analyses 
Continuous glucose monitor data were downloaded from the device using Dexcom 
Studioᵀᴹ software (12.0.4.6). Data from the CGMS were analysed in accordance to 
the International Consensus on Use of Continuous Glucose monitoring guidelines 
(Danne et al., 2017). A one-way ANOVA with repeated measures was used to 
assess glycaemic control between the three conditions using the following metrics: 
percentage of time in level 1 hypoglycaemia (≤3.9 mmol/L), level 2 hypoglycaemia 
(≤2.9 mmol/L), time in target range (3.9-10 mmol/L) and hyperglycaemia (≥10 
mmol/L). Mean glucose and glycaemic variability using coefficient of variation were 
compared between conditions. Episodes of level 1 and 2 hypoglycaemia and 
hyperglycaemia were compared between conditions. The 24h period was defined as 
08:00-08:00h and the nocturnal period was defined as 24:00-06:00h. A two factor 
repeated measures ANOVA was used to assess whether there was an acute change 
in blood glucose concentration following HIT and MICT in the fasted state with the 
within-subject factors ‘training mode’ and ‘time point’. All analyses were performed 
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using IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. Data 
are presented as mean ± SEM and significance was set at P≤0.05. 
6.4. RESULTS 
24h Glycaemic Control 
Glucose data from the CGMS are presented in Table 6.1 and mean continuous 
glucose monitor traces over the 24h period in each condition are shown in Figure 6.2. 
The CGMS data revealed no differences in the time spent in level 1 hypoglycaemia 
(≤3.9 mmol/L) over the 24h period (P=0.446) or nocturnal period (P=0.944) between 
the CON, HIT and MICT conditions. Similarly, there were no differences in the time 
spent in level 2 hypoglycaemia (≤2.9 mmol/L) between the three conditions over the 
24h period (P=0.518) or nocturnal period (P=0.969). There were also no differences 
in the time spent in target range or hyperglycaemia between the three conditions in 
the 24h or nocturnal periods (P>0.05). 
The incidence of level 1 hypoglycaemia over the 24h period (P=0.266) and 
nocturnal period (P=0.522) was no different between CON, HIT and MICT. There 
were no differences in the incidence of level 2 hypoglycaemia over the 24h (P=0.837) 
or nocturnal (P=0.703) period between conditions.  
There was no report of different levels of snacking between the conditions 
during the CGMS period. Three participants arrived to the laboratory with a blood 
glucose of <7 mmol/L on one trial so consumed ~200ml of Lucozade Sport Orange 
(20g CHO) and no participants arrived with a blood glucose >14 mmol/L.  
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Figure 6.2. Continuous glucose monitor traces 
Mean ± SEM continuous glucose monitor traces over the 24h period (08:00-08:00h) 
on the day of no exercise (Control), HIT and MICT. The thick lines represent the 
mean of all the participants’ glucose traces. Exercise was performed at 
approximately 8:30am. The shaded grey area represents the nocturnal period 
(24:00-06:00h).  
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Table 6.1. Summary of continuous glucose monitor data 
 CON         HIT         MICT 
24-hr period    
Mean glucose (mmol/L) 9.2 ± 0.6 9.0 ± 0.4 9.5 ± 0.5 
CV (%) 39 ± 2 39 ± 3 38 ± 3 
Time in level 1 
hypoglycaemia (%) 
5.7 ± 1.4 7.5 ± 3.2 4.9 ± 2.0 
Time in level 2 
hypoglycaemia (%) 
1.1 ± 0.5 3.1 ± 1.9 1.4 ± 0.7 
Time in range (%) 60.5 ± 5.0 58.1 ± 3.6 59.3 ± 4.8 
Time in hyperglycaemia  (%) 33.7 ± 5.4 34.2 ± 3.6 35.8 ± 5.4 
Incidence of level 1 
hypoglycaemia 
1.8 ± 0.4 2.2 ± 0.6 1.6 ± 0.5 
Incidence of level 2 
hypoglycaemia 
0.6 ± 0.3 0.8 ± 0.4 0.6 ± 0.2 
Incidence of hyperglycaemia 2.7 ± 0.3 3.1 ± 0.3 2.9 ± 0.3 
Nocturnal period    
Mean glucose (mmol/L) 9.0 ± 1.0 9.0 ± 0.7 9.3 ± 0.9 
CV (%) 25 ± 4 28 ± 5 19 ± 4 
Time in level 1 
hypoglycaemia (%) 
8.9 ± 4.8 8.0 ± 3.6 7.9 ± 4.7 
Time in level 2 
hypoglycaemia (%) 
1.5 ± 1.0 3.8 ± 2.4 4.0 ± 2.7 
Time in range (%) 59.5 ± 9.7 56.8 ± 8.2 58.5 ± 8.8 
Time in hyperglycaemia (%) 31.3 ± 10.2 35.1 ± 8.7 33.3 ± 9.8 
Incidence of level 1 
hypoglycaemia 
0.4 ± 0.2 0.5 ± 0.3 0.4 ± 0.2 
Incidence of level 2 
hypoglycaemia 
0.1 ± 0.1 0.3 ± 0.2 0.2 ± 0.2 
Incidence of hyperglycaemia 0.6 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 
 
Summary of continuous glucose monitor data for the 24h period (08:00-08:00h) and 
nocturnal period (24:00-06:00h) for the control day with no exercise (CON) and the 
days on which HIT and MICT were performed. Level 1 hypoglycaemia (≤3.9 mmol/L), 
level 2 (severe) hypoglycaemia (≤2.9 mmol/L), target range (4-10 mmol/L) and 
hyperglycaemia (≥10 mmol/L). Data are presented as mean ± SEM. There were no 
differences in any of the factors between the conditions (P<0.05). 
  
Chapter 6 
138 
 
Acute Change in Blood Glucose Concentration 
Blood glucose concentrations did not drop during HIT (+0.39 ± 0.42 mmol/L) or MICT 
(-0.39 ± 0.66 mmol/L) undertaken in the fasted state (P=0.493), with no difference 
between groups (P=1.00; Fig. 6.3).  
 
 
Figure 6.3. Blood glucose concentrations during HIT and MICT 
Mean (±SEM) blood glucose concentrations pre and post exercise (A) and individual 
responses (B) to HIT and MICT sessions where the participants were overnight 
fasted and had omitted their fast-acting insulin. 
 
6.5. DISCUSSION 
This study examined the effects of a fasted bout of HIT and MICT on acute and 24h 
glucose levels in people with type 1 diabetes. The most important novel findings are 
that 1) there was no difference in the effect of HIT on 24h glucose compared to MICT, 
2) both HIT and MICT performed following an overnight fast do not increase the 
incidence or time spent in hypoglycaemia over the 24h or nocturnal period in 
comparison to a day of no exercise, and 3) blood glucose concentration remained 
stable during a bout of fasted HIT and MICT. This suggests that, a single bout of HIT 
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or 30 minutes of MICT can be carried out after an overnight fast in people with type 1 
diabetes with no increased risk of hypo- or hyperglycaemia. In addition, provided the 
starting glucose is between 7-14 mmol/L, our data suggest that there is no need to 
ingest carbohydrate during and following HIT and MICT in the fasted state. 
The current exercise guidelines for people with type 1 diabetes report that 
aerobic exercise decreases blood glucose levels if performed during the postprandial 
period with insulin administration (Colberg et al., 2016). This is supported by a 
systematic review and meta-analysis (Garcia-Garcia et al., 2015) that aggregated 
the results from 10 studies to estimate rate of change in glucose concentration in 
response to different types of exercise in people with type 1 diabetes. Garcia-Garcia 
et al. (2015) reported that individuals typically experience a rapid decline in 
glycaemia during continuous exercise (-4.43 mmol/L h-1 on average), whereas the 
response to intermittent high intensity exercise is more varied and dependent on the 
protocol. In contrast, our results showed that blood glucose concentration remained 
stable during both HIT and MICT, and the CGMS data showed no increased risk of 
hypoglycaemia over the 24h period. It is likely that our results do not agree with the 
findings of Garcia-Garcia et al. (2015) because our study was performed in the 
morning following an overnight fast whereas their analysis did not control for time of 
day or nutritional status. Indeed, the most marked drop in blood glucose among the 
publications included in their meta-analysis was by Yamanouchi et al. (2002) who 
reported a mean drop of 4.3 mmol/L following a 30 minute walk at <50% !̇O2max 
after breakfast.  
The exercise guidelines published by Colberg et al. (2016) recommend that 
exercising while fasted may produce a lesser decrease or even a small increase in 
blood glucose concentration. The evidence to support this recommendation, 
however, is based on only one study that investigated the effects of fasted resistance 
training on glycaemia with no control day as a comparison (Turner et al., 2016). We 
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now provide the first evidence that blood glucose concentrations are stable following 
both HIT and MICT when undertaken after an overnight fast. The findings of the 
current investigation should therefore be used to inform future exercise guidelines.  
The use of CGMS allowed us to compare the complete 24h glucose profiles 
under dietary standardisation but otherwise free-living conditions to assess whether 
there is a delayed response in the risk of hypoglycaemia following HIT. Fear of 
hypoglycaemia during and after exercise, as well as during the nocturnal period, is a 
major barrier to exercise for people with type 1 diabetes, so it is essential to 
objectively establish whether exercise increases the hypoglycaemia risk. Here we 
found no differences in the time spent in level 1 (≤3.9 mmol/L) or 2 (≤2.9 mmol/L) 
hypoglycaemia in both the nocturnal and 24h period following either HIT or MICT 
compared to a day of no exercise. The food diaries that participants completed 
indicated that they consumed the correct food and there was no difference in the 
amount of additional carbohydrate consumed to prevent hypoglycaemia between the 
conditions. 
Based on our findings it appears that exercising following an overnight fast 
before using short-acting insulin helps to maintain blood glucose stability, 
irrespective of the mode or intensity of the exercise, which means that patients do 
not need to consume carbohydrate to avoid hypoglycaemia during exercise. 
However, the effects of longer duration MICT sessions will have to be tested. Future 
research should also investigate whether exercising regularly in the fasted state 
improves long-term glycaemic control. Indeed, Kennedy et al. (2013) suggested that 
previous research may have failed to show glycaemic benefits of exercise because 
calorie intake and insulin dose around the time of exercise has not been controlled. 
Future research which examines how exercise of different type, intensity and 
duration carried out in the fasted state affects 24h glucose control are needed to help 
to produce more flexible exercise guidelines for people with type 1 diabetes.  
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This is the first study to investigate the effects of HIT on glycaemia in people 
with type 1 diabetes. The results suggest that HIT in the fasted state offers a time-
efficient exercise mode that does not increase the risk of hypoglycaemia, thus, 
potentially overcoming two major barriers to exercise. As typical low-volume HIT 
protocols require 47-60% lower time commitment to MICT sessions, this may make 
HIT a more attractive training strategy to potentially increase exercise uptake and 
adherence in people with type 1 diabetes. The efficacy of long-term HIT programmes 
will have to be explored in people with type 1 diabetes to determine whether this is 
an effective and time-efficient strategy to improve health. Furthermore, the effects of 
HIT in the non-fasted state have not been investigated. 
The major strength of this investigation lies in the strict dietary 
standardisation during the CGMS period and the fact that the exercise sessions were 
performed at the same time of day, in the same nutritional state. Another strength is 
that by using CGMS we were able to study the individuals under free-living 
conditions, and thereby take an ecologically valid approach to investigate glucose 
levels following exercise. We also acknowledge that there are some limitations that 
will need to be addressed with further research. Firstly, we did not record insulin 
dose during the CGMS period and participants were not blinded to the CGMS so 
they may have corrected their insulin dosage or taken carbohydrate to prevent lows 
if they felt it was necessary. The fact that there were no differences in food intake 
between the days lessens the chances that change in intake could be the cause. 
Secondly, the small sample size makes it difficult to draw conclusions that can be 
applied to the wider type 1 diabetes community. However, the sample size is in line 
with previous investigations that have compared the glycaemic effects of different 
exercise intensities in people with type 1 diabetes (Turner et al., 2015, Yardley et al., 
2012, Yardley et al., 2013). There were three occasions where participants arrived at 
the laboratory with a blood glucose of <7 mmol/L on one trial so for safety reasons 
they ingested ~20g CHO before the start of exercise. This highlights the difficulty of 
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testing people with type 1 diabetes. However, excluding these participants from the 
statistical analyses made no difference to the results so their data were kept in the 
final analysis. Finally, the MICT was only 30 minutes in duration so we do not know 
the effects of prolonged (>30 minutes) MICT sessions as this may lead to eventual 
falls in glycaemia and risk of hypoglycaemia. However, 30 minute MICT sessions are 
in line with the current exercise recommendations of 30 minutes on 5 days of the 
week (Colberg et al., 2016).  
In conclusion, this is the first study to demonstrate that there is no increased 
risk of hypoglycaemia over the 24h period or nocturnal period following a single bout 
of HIT or 30 minutes of MICT in the fasted state, compared to a day of no exercise in 
individuals with type 1 diabetes. Secondly, blood glucose concentration is 
unchanged across HIT and MICT when undertaken following an overnight fast and 
having omitted short-acting insulin. Therefore, we recommend that in the fasted state, 
provided blood glucose starts between 7-14 mmol/L, carbohydrate ingestion is not 
needed during HIT or 30-minute MICT sessions. As HIT may offer a time-efficient 
and safe alternative for people with type 1 diabetes, future research should explore 
the efficacy of longer-term training programmes. 
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Chapter 7 High-Intensity Interval Training Improves 
Aerobic Capacity and Abolishes the Decline in Blood 
Glucose Observed During Moderate-Intensity 
Continuous Training Sessions in People with Type 1 
Diabetes 
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7.1. ABSTRACT  
OBJECTIVE: To investigate whether 1) six weeks of high-intensity interval training 
(HIT) induces similar improvements in cardio-metabolic health markers as moderate-
intensity continuous training (MICT) in people with type 1 diabetes, and 2) whether 
HIT abolishes acute reductions in plasma glucose observed following MICT sessions. 
RESEARCH DESIGN AND METHODS: Fourteen sedentary individuals with type 1 
diabetes (n=7 per group) completed six weeks of HIT or MICT 3 times per week. 
Pre- and post-training measurements were made of 24h interstitial glucose profiles 
(using continuous glucose monitors (CGMS)) and cardio-metabolic health markers 
(!̇O2peak, blood lipid profile and aortic pulse wave velocity; aPWV). Capillary blood 
glucose concentrations were assessed before and after exercise sessions 
throughout the training programme to investigate changes in blood glucose during 
exercise in the fed state.  
RESULTS: Six weeks of HIT or MICT improved !̇ O2peak by 14% and 15%, 
respectively (P<0.001), and aPWV by 12% (P<0.001), with no difference between 
groups. 24h CGMS data revealed no differences in incidence or percentage of time 
spent in hypoglycaemia following training in either group (P>0.05). In the fed state, 
the mean change in capillary blood glucose concentration during the HIT sessions 
was -0.2±0.5 mmol/L, whereas blood glucose change was -5.5±0.4 mmol/L during 
MICT. 
CONCLUSIONS: Six weeks of HIT improved !̇O2peak and aortic PWV to a similar 
extent as MICT. The finding that blood glucose remains stable during HIT in the fed 
state, but consistently falls during MICT, suggests that HIT may be the preferred 
training mode for people with type 1 diabetes. 
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7.2. INTRODUCTION 
Regular exercise is recommended for people with type 1 diabetes to maintain overall 
health and reduce the risk of macrovascular and microvascular complications, which 
are a major cause of mortality and morbidity (Chimen et al., 2012, Moy et al., 1993). 
The current guidelines for people with type 1 diabetes are to undertake at least 150 
minutes of moderate to vigorous aerobic exercise per week, spread over at least 
three days per week, with no more than two consecutive days without activity 
(Colberg et al., 2016). Benefits of exercise for those with type 1 diabetes include 
improved aerobic capacity (!̇O2max), insulin sensitivity, body composition, endothelial 
function and blood lipid profile (Chimen et al., 2012, Makura et al., 2013, Codella et 
al., 2017, Pang and Narendran, 2008). Despite the benefits, few people with type 1 
diabetes achieve exercise targets and many programmes designed to increase 
physical activity have failed (Brazeau et al., 2014, Bohn et al., 2015). In addition to 
the barriers to exercise cited by the general population, such as a perceived lack of 
time, work commitments and cost (Trost et al., 2002), people with type 1 diabetes 
face additional barriers including fear of hypoglycaemia, loss of glycaemic control 
and inadequate knowledge around exercise management (Lascar et al., 2014, 
Brazeau et al., 2008).  
 To overcome a perceived lack of time, high-intensity interval training (HIT) is 
purported as a time-efficient alternative to moderate-intensity exercise to improve 
numerous cardio-metabolic risk factors including !̇ O2max, insulin sensitivity and 
glycaemic control in people without type 1 diabetes (Hood et al., 2011, Little et al., 
2011). Furthermore, results from Chapter 6 show that a single bout of HIT does not 
increase the risk of hypoglycaemia in people with type 1 diabetes. Whether HIT 
offers a safe, effective and time-efficient training strategy to improve cardio-
metabolic health that reduces the risk of hypoglycaemia in people with type 1 
diabetes is yet to be investigated.  
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Here we investigated the hypothesis that six weeks of HIT would improve 
markers of cardio-metabolic health, including !̇O2peak, glycaemic control, blood lipid 
profile and vascular health in people with type 1 diabetes. A moderate-intensity 
continuous training (MICT) group was used as a control. During this 6-week training 
period capillary blood glucose concentrations were monitored before and after 
exercise sessions to provide further information on the acute effects of HIT and 
MICT on blood glucose concentration.  
 
7.3. METHODS 
Fourteen previously sedentary people with type 1 diabetes (10 men/4 women; see 
Table 5.1. for subject characteristics) on a basal-bolus insulin regimen completed six 
weeks of supervised HIT (n=7) or MICT (n=7) three times per week. Participants 
were pair-matched based on sex, age and !̇O2peak to the two training groups. 
Exclusion criteria were duration of type 1 diabetes <6 months, insulin pump therapy, 
significant history of hyper- or hypoglycaemia (determined from medical history), 
obesity (BMI >30 kg∙m-2), pregnancy or planning pregnancy, uncontrolled 
hypertension (>180/100 mmHg), angina, autonomic neuropathy, taking any 
medication that affects heart rate, major surgery planned within 6 weeks of the study, 
severe nonproliferative and unstable proliferative retinopathy. Testing took place in 
the laboratory of the School of Sport and Exercise Sciences at Liverpool John 
Moores University. The study was approved by the Black Country NHS Research 
Ethics Committee (West Midlands, UK) and all participants gave written informed 
consent to a protocol conforming to the Declaration of Helsinki.  
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Pre-Training Assessments 
Participants first performed an incremental exercise test to exhaustion on an 
electromagnetically braked cycle ergometer (Excalibur Sport V2.0, Lode, Groningen, 
The Netherlands) to determine maximal aerobic power output (Wmax) and !̇O2peak 
using an online gas collection system (MOXUS modular oxygen uptake system, AEI 
technologies, Pittsburgh, PA) as described in Chapter 3. Participants also completed 
a food diary over a minimum of three days in order to calculate habitual caloric and 
macronutrient intake. 
Three to 7 days after the incremental exercise test, participants attended the 
laboratory after an overnight fast (>10 h) for a second pre-training assessment 
session. Following 15 minutes rest, supine brachial artery blood pressure 
measurements were made in triplicate using an automated sphygmomanometer (GE 
DINAMAP Pro 300 V2). Aortic pulse wave velocity (aPWV) measurements were 
made using a semi-automated device and software (SphygmoCor, AtCor Medical, 
Sydney, Australia), as previously described by Cocks et al. (2016) and Chapter 3. A 
fasting blood sample was used to determine fasting plasma cholesterol and 
triglyceride concentrations, using a semi-automatic spectrophotometer (Randox RX 
Daytona™, County Antrim, UK).  
A Dexcom G4 Platinum (Dexcom, San Diego, CA, USA) CGMS was inserted 
subcutaneously on the abdomen. A habitual free-living 24h glucose profile was 
analysed at least 24 hours after the CGMS was inserted. Participants were trained to 
use the CGMS and instructed to calibrate the device a minimum of four times daily 
using capillary blood tests. Participants were provided with a standardised diet of 
three meals (breakfast, lunch and dinner) during the CGMS period (50% CHO; 30% 
fat; 20% protein) in accordance with their habitual calorie intake. Participants were 
instructed to consume these meals at pre-determined time points throughout the day. 
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No additional snacks were permitted and participants only consumed the food 
provided by the research team during this period, unless they needed to prevent 
hypoglycaemia (blood glucose <3.0 mmol/L) (International Hypoglycaemia Study 
Group, 2017). A food diary was completed to confirm that they had consumed the 
prescribed food at the correct times. Participants were instructed to avoid alcohol 
and caffeine, as well as exercise throughout the CGMS period.  
 
Exercise Training  
Training started ~72h after completion of the pre-experimental procedures. 
Participants trained three times per week for six weeks under researcher supervision 
on a Lode Corival cycle ergometer (Corival Lode BV, Groningen, The Netherlands). 
Following a 3-minute low-intensity warm-up, the HIT group performed repeated 1 
minute bouts of high intensity cycling at a workload equivalent to 100% !̇O2peak 
interspersed with 1 minute of recovery at 50 W, whereas the MICT group performed 
continuous moderate intensity cycling at a workload equivalent to 65% !̇O2peak. The 
number of intervals in the HIT group increased from 6 in weeks 1 and 2, to 8 in 
weeks 3 and 4 to 10 in weeks 5 and 6. The duration of the sessions in the MICT 
group were 30 minutes in weeks 1 and 2, 40 minutes in weeks 3 and 4 and 50 
minutes in weeks 5 and 6. 
 
Acute Change in Blood Glucose with Exercise 
Before starting and after completing each training session during the six-week 
training period, participant’s blood glucose concentrations were required to be 
between 7-14 mmol/L, in accordance with the Exercising for Type 1 Diabetes 
(EXTOD) guidelines (Narendran et al., 2017).  If blood glucose concentrations fell 
outside of this range corrective measures were taken; glucose was ingested if blood 
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glucose <7 mmol/L, and a light walk or insulin bolus was advised if glucose >14 
mmol/L, as well as checking blood ketones (Riddell et al., 2017). During the MICT 
sessions participants were advised to check their blood glucose concentrations part-
way through the exercise and to consume carbohydrate as necessary to prevent 
hypoglycaemia. Capillary blood glucose concentrations were recorded immediately 
before and after exercise. As such, over the course of the six weeks of training we 
gathered pre and post-exercise blood glucose concentrations from a total of 108 
MICT training sessions and 87 HIT sessions in the fed state. The proportion of total 
sessions that blood glucose was recorded was 86% in the MICT group and 69% in 
the HIT group. 
 
Post-Training Assessments 
Approximately 72h after the final training session, participants attended the 
laboratory on two occasions (separated by 72h) to complete a series of post-training 
assessments. These assessments were identical in all respects to those undertaken 
prior to training (pre-training assessments).   
 
Statistical Analyses 
The primary outcome variable to measure a significant training benefit was !̇O2peak. 
Previous research in our group (Shepherd et al., 2015, Shepherd et al., 2013a) has 
suggested a SD of 2.7-3.2 to detect a change in !̇O2peak of 3.5 ml·kg-1·min-1, which is 
a clinically significant increase in !̇ O2peak (Myers, 2003). A power calculation 
suggested that 7-9 participants were required in each group to detect a within-group 
difference with a paired t test with 80% power at a significance level of 0.05. 
Continuous glucose monitor data were downloaded from the device using Dexcom 
Studioᵀᴹ software (12.0.4.6) and analysed in accordance with the International 
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Consensus on Use of Continuous Glucose Monitoring (Danne et al., 2017). 
Glycaemic thresholds were defined as follows: target range (3.9-10 mmol/L), level 1 
hypoglycaemia (≤3.9 mmol/L), level 2 hypoglycaemia (≤2.9 mmol/L) and 
hyperglycaemia (≥10 mmol/L). The 24h period was defined as 08:00-08:00h and the 
nocturnal period was defined as 24:00-06:00h. All variables were analysed using a 
two-way mixed ANOVA, with the between factor ‘group’ (HIT vs. MICT) and repeated 
factor ‘training status’ (pre-training vs. post training), followed by Bonferroni post-hoc 
corrections. A two way mixed ANOVA, with the between factor ‘group’ and the 
repeated factor ‘time point’ (pre-training vs. post training) was used to assess 
whether there was an acute change in blood glucose concentration following HIT 
and MICT in the fed state over the 6 weeks of training. The CGMS did not work on 
one participant in the MICT group. Aortic PWV readings were obtained from five 
participants in the HIT group and six in the MICT group. All analyses were performed 
using IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. Data 
are presented as mean ± SEM and significance was set at P≤0.05. 
 
7.4. RESULTS 
By design, there were no differences in age (P=0.877), !̇O2peak (P=0.371) or duration 
of type 1 diabetes (P=0.291) between the training groups at baseline. BMI was, 
however, significantly higher in the HIT group compared to the MICT group 
(P=0.038). Pre and post-training variables are presented in Table 5.1. Training 
increased !̇O2peak (HIT 14%, MICT 15%; P<0.001) and Wmax (HIT 13%, MICT 14%; 
P<0.001), with no difference between groups (Fig. 7.1). Six weeks of training also 
improved aPWV (P=0.001) and there was no difference between groups. Systolic, 
diastolic and mean arterial blood pressure did not improve following training 
(P=0.219; P=0.476; P=0.268, respectively). There was no change in plasma 
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cholesterol or triglyceride concentrations with training (P=0.881; P=0.652, 
respectively). 
 
 
 
 
 
Figure 7.1. Effect of six weeks of high intensity interval training (HIT) and 
moderate intensity continuous training (MICT) on #̇O2peak. 
(A) Shows the mean responses and (B) shows individual responses in !̇O2peak with 
training. *Indicates a significant difference from baseline (P<0.05).  
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Table 7.1. General characteristics 
 HIT  MICT 
 Pre Post  Pre Post 
Age (years) 29 ± 3 -  29 ± 5 - 
Sex 5M/2F -  5M/2F - 
Duration of T1D 
(years) 
13 ± 3 -  9 ± 2 - 
Mass (kg) 90.0 ± 4.8 89.8 ± 4.8  76.7 ± 5.4 76.3 ± 5.3 
BMI (kg∙m-2) 29.2 ± 1.2 29.2 ± 1.2  25.3 ± 1.2 25.2 ± 1.2 !̇O2peak (ml∙kg-
1∙min-1) 
35.6 ± 2.6 40.5 ± 2.6*  32.1 ± 2.6 36.9 ± 3.2* 
!̇O2peak (L/min-1) 3.2 ± 0.3 3.7 ± 0.3*  2.5 ± 0.3 2.9 ± 0.4* 
Wmax (W) 245 ± 16 277 ± 19*  202 ± 22 231 ± 24* 
SBP (mmHg) 121 ± 3 119 ± 4  123 ± 4 122 ± 4 
DBP (mmHg) 65 ± 3 63 ± 3  70 ± 5 68 ± 4 
MAP (mmHg) 84 ± 3 82 ± 2  87 ± 4 86 ± 3 
aPWV (m/s) 6.1 ± 0.5 5.4 ± 0.7*  6.1 ± 0.4 5.4 ± 0.4* 
Cholesterol 
(mmol/L) 
5.07 ± 0.29 5.12 ± 0.35  4.81 ± 0.41 4.93 ± 0.41 
Triglycerides 
(mmol/L) 
0.94 ± 0.09 1.03 ± 0.25  0.70 ± 0.04 0.65 ± 0.06 
 
BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood 
pressure; MAP = mean arterial pressure; aPWV = arterial pulse wave velocity. Data 
are presented as mean ± SEM. *Denotes a significant change from pre-training to 
post-training (P<0.05). 
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Glycaemic Control 
Glucose data from the CGMS obtained over a 24h period pre and post training are 
presented in Table 7.2. There was no difference in the time spent in level 1 
hypoglycaemia (≤3.9 mmol/L) over the 24h period (P=0.727) or nocturnal period 
(P=289) with training. Similarly, there was no difference in time spent in level 2 
hypoglycaemia (≤2.9 mmol/L) with training over the 24h period (P=0.442) or 
nocturnal period (P=0.397). There were also no differences in the time spent in 
target range over the 24h (P=0.412) or nocturnal periods (P>0.382). Furthermore, 
there was no difference in the time spent in hyperglycaemia over the 24h (P=0.540) 
or nocturnal period (P=0.118). However, there was an interaction effect for the time 
spent in target range (P=0.034) and time in hyperglycaemia over the nocturnal 
period (P=0.039). Post hoc analysis revealed that the HIT group spent significantly 
less time in target glycaemia during the nocturnal period (P=0.038) which was due to 
a greater time spent in hyperglycaemia over the nocturnal period (P=0.016). The 
incidence of level 1 hypoglycaemia over the 24h period (P=0.675) and nocturnal 
period (P=0.363) was no different with training. There were no differences in the 
incidence of level 2 hypoglycaemia over the 24h (P=0.174) or nocturnal (P=0.549) 
with training.  
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Table 7.2. Summary of continuous glucose monitor data 
 HIT  MICT 
 Pre Post  Pre Post 
24h period      
Mean glucose 
(mmol/L) 
9.3±0.3 9.5±1.0  9.2±0.6 8.6±0.7 
CV (%) 42.6±3.6 38.2±2.6  37.9±3.6 36.9±4.0 
Time in level 1 
hypoglycaemia (%) 
6.1±2.6 5.4±3.1  3.4±1.5 2.8±1.9 
Time in level 2 
hypoglycaemia (%) 
0.2±0.2 0.5±0.3  0.9±0.5 0.0±0.0 
Time in range (%) 56.7±3.1 56.4±7.8  59.3±5.8 68.2±7.7 
Time in 
hyperglycaemia  (%) 
37.0±2.0 37.7±8.9  36.3±6.5 28.9±8.5 
Incidence of level 1 
hypoglycaemia 
1.8±0.6 1.2±0.5  0.9±0.5 1.4±0.6 
Incidence of level 2 
hypoglycaemia 
0.2±0.2 0.2±0.2  0.4±0.2 0.1±0.1 
Incidence of 
hyperglycaemia 
3.0±0.5 2.8±0.5  3.2±0.5 2.5±0.5 
Nocturnal period      
Mean glucose 
(mmol/L) 
8.8±1.3 11.7±2.0  8.0±1.2 7.4±1.1 
CV (%) 23.2±5.9 19.5±9.1  29.1±7.2 22.2±6.2 
Time in level 1 
hypoglycaemia (%) 
9.3±9.0 3.0±2.0  7.6±5.0 4.9±4.9 
Time in level 2 
hypoglycaemia (%) 
0.0±0.0 1.2±1.2  3.2±2.0 0.0±0.0 
Time in range (%) 57.4±15.5 32.6±14.3*  60.0±15.4 71.3±16.5 
Time in 33.3±16.7 63.0±16.3*  28.5±15.9 23.6±15.8 
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hyperglycaemia  (%) 
Incidence of level 1 
hypoglycaemia 
0.5±0.2 0.3±0.2  0.3±0.2 0.1±0.1 
Incidence of level 2 
hypoglycaemia 
0.0±0.0 0.2±0.2  0.3±0.2 0.0±0.0 
Incidence of 
hyperglycaemia 
0.5±0.2 0.8±0.2  0.5±0.2 0.3±0.2 
 
The 24h period was defined as 08:00-08:00h and nocturnal period as 24:00-06:00h. 
Level 1 hypoglycaemia (≤3.9 mmol/L), level 2 (severe) hypoglycaemia (≤2.9 mmol/L), 
target range (3.9-10 mmol/L) and hyperglycaemia (≥10 mmol/L). There were no 
differences in any of the variables with training (P>0.05). 
 
 
Acute Change in Blood Glucose during Training Sessions  
When quantifying the change in blood glucose concentration during exercise training 
sessions undertaken in the fed state over the six-week intervention, the mean 
change in blood glucose concentration in response to HIT was -0.2 ± 0.5 mmol/L 
(P<0.001) whereas blood glucose decreased by -5.5 ± 0.4 mmol/L in response to 
MICT (P=0.626; Fig. 7.2). 
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Figure 7.2. Change in blood glucose following exercise in the fed state 
Finger prick blood glucose concentrations were recorded immediately before and 
after exercise. As such, over the course of the six weeks of training we gathered pre 
and post exercise blood glucose concentrations from a total of 108 MICT training 
sessions and 87 HIT sessions in the fed state (86% and 69% of total possible 
sessions, respectively). Mean change in blood glucose concentration (A) and 
average change in blood glucose concentration during HIT and MICT over the 6 
week training period (B). *Denotes a significant change from baseline (P<0.05). 
 
 
7.5. DISCUSSION 
This study demonstrates for the first time that six weeks of HIT improves !̇O2peak and 
aPWV in people with type 1 diabetes to a similar magnitude as MICT. Secondly, we 
observed that blood glucose concentration remained stable during the HIT sessions 
performed in the fed state throughout the training programme, but there was a 
consistently large drop in blood glucose during MICT throughout the training 
programme, with participants at risk of hypoglycaemia. The CGMS data revealed 
that there was a decrease in the time spent in target range in the HIT group which 
was due to an increase in time spent in hyperglycaemia while there were no changes 
in glycaemic control in the MICT group. The fact that HIT improved !̇O2peak and 
aPWV to a similar extent as MICT but did not cause a fall in glucose during exercise 
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suggest that HIT may be a more practical exercise strategy for patients with type 1 
diabetes. 
Aerobic capacity improved to a similar extent following six weeks of HIT and 
MICT, despite the weekly time commitment being 54-90 minutes less for HIT than for 
MICT. The 14% increase in !̇O2peak observed in our investigation following HIT (a 
mean increase of 4.9 ml·kg-1·min-1) is high in comparison to other studies using 
similar protocols that tend to report changes of 7-10% in populations without type 1 
diabetes (Weston et al., 2014) and the only other study to examine the effect of 
sprint interval training in type 1 diabetics (repeated 30-second maximal cycling bouts 
interspersed with 3-4 minutes of rest 3 times a week for 7 weeks) reported a 7% 
increase in !̇O2peak (Harmer et al., 2008). This has clinical importance given that !̇O2max is reported to be the strongest prognostic marker of cardiovascular mortality 
(Myers, 2003) and improvements in	!̇O2max with exercise training are associated with 
a reduction in all-cause mortality risk (Lee et al., 2010). In fact, Myers (2003) found 
that there is a 8-17% reduction in all-cause mortality for each 1-MET (~3.5 ml·kg-
1·min-1) increase in !̇O2max. Although these correlations have not been specifically 
confirmed in people with type 1 diabetes, it is likely that the HIT programme used 
here induces clinically meaningful benefits to this population, which is especially 
important as they are at increased risk of cardiovascular disease compared to a non-
diabetic population (Chimen et al., 2012, Moy et al., 1993).  
In the present study there was a 12% reduction in aPWV following both 
training modes, which is greater than has previously been reported in other training 
studies in populations without type 1 diabetes (Slivovskaja et al., 2017, Horner et al., 
2015). To the authors’ knowledge, this is the first study to investigate changes in 
arterial stiffness following HIT and MICT in people with type 1 diabetes. The 
reduction in aPWV is of clinical relevance as increased arterial stiffness is associated 
with negative cardiovascular outcomes (Cecelja and Chowienczyk, 2009).  
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Neither training mode improved glycaemic control according to the CGMS 
data, measured as time spent in target range (euglycaemia) or hypoglycaemia or the 
incidences of hypoglycaemia. Previous studies using HbA1c and daily insulin dosage 
as a marker of glycaemic control have also failed to show overall improvements in 
glycaemic control with exercise training (Laaksonen et al., 2000, Lehmann et al., 
1997, Harmer et al., 2008), although studies reporting positive effects of training on 
glycaemic control do exist (Salem et al., 2010). There was a reduction in the time 
spent in euglycaemia in the HIT group which was due to an increase in the time 
spent in hyperglycaemia. Although increasing the proportion of time spent in 
hyperglycaemia during the nocturnal period is not desirable, it did reduce the risk of 
developing hypoglycaemia. This effect of HIT needs to be explored further as an 
increase in time spent in hyperglycaemia could increase the risk of long-term 
complications. It could be speculated that participants in the HIT group consumed 
additional carbohydrates before going to bed to prevent hypoglycaemia and as a 
result spent more time in hyperglycaemia. However, the study was performed under 
strict dietary control and participants in the HIT group did not report consuming 
additional snacks. The small sample size and the fact that just one 24h period was 
recorded pre and post-training in each individual is more likely to account for these 
differences. Although the use of CGMS in our investigation allowed a detailed 
analysis of glycaemic control, we acknowledge that longer duration exercise training 
programmes with larger sample sizes are needed to assess the effects of exercise 
training on long-term glycaemic control. Furthermore, the current guidelines suggest 
that a minimum of 14 consecutive days should be recorded when analysing CGMS 
data (Danne et al., 2017). Unfortunately, these guidelines were published after our 
data collection was completed so will be used in future studies. 
Before the training sessions, we recorded blood glucose concentration for 
safety reasons to prevent participants from exercising when glucose concentrations 
were too high or low based on the EXTOD guidelines (Narendran et al., 2017). Blood 
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glucose was also recorded after the sessions so that participants did not leave the 
laboratory while they were potentially at increased risk of hypoglycaemia. This meant 
that we collected pre and post-exercise blood glucose readings from up to 18 
training sessions for each participant over the course of six weeks of HIT or MICT. 
We found that blood glucose concentration remained stable during HIT throughout 
the training programme, but there was a consistently large drop in blood glucose 
during MICT, with participants at risk of hypoglycaemia. This was a consistent 
observation across all participants undertaking MICT (Fig. 7.2b). The changes in 
blood glucose concentration during the exercise we have reported here are striking 
and are the first of their kind in the literature over so many training sessions. 
Furthermore, they are supported by Garcia-Garcia et al. (2015) who conducted a 
systematic review and meta-analysis in which they aggregated results from 10 
studies to estimate rate of change of glucose concentration during and after different 
types of exercise in people with type 1 diabetes. Their results showed a rapid decline 
in glycaemia during continuous exercise (-4.43 mmol/L h-1 on average) while the 
results were more variable during intermittent high intensity exercise depending on 
the protocol.  
The drop in blood glucose concentration during the MICT sessions is likely 
due to the effects of short-acting insulin in the circulation. In healthy individuals, 
blood glucose concentration remains stable during moderate-intensity aerobic 
exercise because insulin secretion is suppressed progressively with exercise 
duration and there is a gradual increase in glucagon and adrenaline resulting in 
increased hepatic glucose production (Marliss and Vranic, 2002, Wasserman et al., 
1991). Therefore, contraction-mediated glucose uptake is matched by increased 
hepatic glucose production so that blood glucose concentration remains stable at 
~4.0-6.0 mmol/L (Marliss and Vranic, 2002). However, as insulin is supplied 
exogenously in people with type 1 diabetes, hyperinsulinaemia is likely to occur 
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because of increased blood flow and mobilisation of insulin from its subcutaneous 
depot, particularly if the injection site is in an exercised region (Marliss and Vranic, 
2002). This results in enhanced glucose uptake due to combined contraction-
mediated and insulin-stimulated GLUT4 translocation. The high insulin levels will 
also suppress the exercise-mediated increases in glucagon and adrenaline and their 
ability to stimulate hepatic glucose production (Guelfi et al., 2007a). As a result, 
muscle glucose uptake during MICT will exceed hepatic glucose production, leading 
to the large decreases in plasma glucose concentration observed in this study (Fig. 
7.2.). Hyperinsulinaemia has also been shown to suppress adipose tissue and 
intramuscular triglyceride (IMTG) lipolysis in healthy individuals (Coyle et al., 1997), 
which will reduce the contribution of lipids to the fuel mixture oxidised during exercise. 
The combination of insulin and exercise-mediated glucose disposal coupled with 
decreased hepatic glucose production and reduced lipolysis and lipid oxidation 
increases the risk of hypoglycaemia during MICT. On the other hand, the stable 
blood glucose concentrations during HIT are likely due to increased plasma 
catecholamines which offset the effects of hyperinsulinaemia through increased 
hepatic glucose output. Previous research has shown that addition of a sprint to a 
bout of moderate-intensity exercise in individuals with type 1 diabetes opposed the 
fall in glycaemia during exercise and this was associated with a rise in 
catecholamines (Bussau et al., 2006). Following a bout of HIT, it may be speculated 
that the greater catecholamine response compared to MICT may lead to stimulation 
of adipose tissue lipolysis and increase oxidation of the released fatty acids in the 
muscle during recovery (Watt et al., 2003).  
Another important observation, although not quantitatively reported here, was 
the number of training sessions in which participants had to prevent or treat an 
episode of hypoglycaemia by consuming fast-acting carbohydrate. During the MICT 
sessions, participants were advised to stop exercising at least once to check their 
blood glucose concentration in accordance with the EXTOD guidelines (Narendran 
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et al., 2017), correct accordingly with glucose if necessary, and then wait for their 
blood glucose to stabilise before recommencing the training. Many of the participants 
in the MICT condition found this frustrating and it would often mean that the already 
time consuming 50-minute cycling sessions were even longer while blood glucose 
was checked. The large drop in blood glucose concentration that we found during 
the MICT sessions highlights why the guidelines recommend that carbohydrate 
should be taken when doing more than 30 minutes of moderate-intensity exercise 
(Riddell et al., 2017).  
The main strengths of this investigation were 1) the strict dietary 
standardisation under free-living conditions during the CGMS period pre and post-
training, and 2) the monitoring of acute changes in blood glucose concentrations 
during exercise throughout the intervention. We also acknowledge that there are 
some limitations. The sample size of the study was small; however, the clear 
significant increases in !̇O2peak suggest that we have the power to conclude that HIT 
is effective at improving !̇O2peak in people with type 1 diabetes. Secondly, we did not 
record insulin dose before and after the training intervention. This would be useful to 
determine whether there is a change in insulin sensitivity as reduced insulin dosage 
is associated with decreased risk of cardiovascular complications in people with type 
1 diabetes (Schauer et al., 2011, Bergman et al., 2012a). 
In summary, this is the first study to demonstrate that six weeks of HIT leads 
to comparable improvements in !̇O2peak and arterial stiffness to MICT. HIT though 
may be the preferred exercise approach, as blood glucose remains stable during HIT, 
but falls substantially during MICT. We therefore recommend that HIT in the fed state 
is a safe, effective, flexible and time-efficient form of exercise for people with type 1 
diabetes. 
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Chapter 8 A Multi-Disciplinary Evaluation of Home-
Based High-Intensity Interval Training in People with 
Type 1 Diabetes: A Pilot Study 
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8.1. ABSTRACT 
OBJECTIVE: To use a multi-disciplinary approach to evaluate a home-based high-
intensity interval training (Home-HIT) intervention in people with type 1 diabetes. 
RESEARCH DESIGN AND METHODS: Eleven individuals with type 1 diabetes (4 
men/7 women; age 30±3 years; BMI 27.1±1.2 kg·m-2; !̇O2peak 2.5±0.2 L/min-1; 
duration of type 1 diabetes 10 ± 2 years) completed six weeks of Home-HIT. The 
effect of Home-HIT on !̇O2peak, blood pressure, insulin dose and glycaemic profile 
was assessed pre and post-training. Adherence and ability to meet target heart rate 
(HR) thresholds (compliance) were monitored using a HR monitor and mobile phone 
application. Change in glycaemia was measured pre, post and 1h post exercise 
sessions throughout the six-week period. A qualitative online survey was completed 
post-training.   
RESULTS: Training adherence was 95±2% and compliance was 99±1%. Six weeks 
of Home-HIT increased !̇O2peak by 8% (P=0.018), decreased insulin dose by 13% 
(P=0.026), but did not affect blood pressure (P=1.000). There was no change blood 
glucose from baseline immediately or 1h post Home-HIT sessions throughout the 
intervention. Qualitative responses about the programme were generally positive, 
providing support that Home-HIT removes barriers to exercise.  
CONCLUSIONS: This is the first study to combine physiological outcomes with a 
qualitative evaluation of a training intervention in people with type 1 diabetes. Home-
HIT resulted in high adherence alongside increased !̇O2peak and decreased insulin 
dose. Because Home-HIT is time-efficient and removes barriers to exercise including 
fear of hypoglycaemia, it may represent an effective strategy to increase exercise 
participation in people with type 1 diabetes. 
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8.2. INTRODUCTION 
People with type 1 diabetes are recommended to engage in regular exercise due to 
its recognised physiological and psychological benefits (Chimen et al., 2012, Moy et 
al., 1993, Wasserman and Zinman, 1994). The current guidelines for people with 
type 1 diabetes are to accumulate 150 minutes of moderate to vigorous aerobic 
exercise per week, spread over at least 3 days, with no more than 2 consecutive 
days without activity (Colberg et al., 2016). However, many people with type 1 
diabetes lead a sedentary lifestyle and fail to meet these guidelines (Makura et al., 
2013, Tielemans et al., 2013, Waden et al., 2008), with lack of time and fear of 
hypoglycaemia identified as key barriers to exercise (Lascar et al., 2014, Brazeau et 
al., 2008).  
Recent work from our laboratory has demonstrated that unlike traditional 
moderate-intensity continuous training (MICT), high-intensity interval training (HIT) 
does not cause acute reductions in blood glucose concentrations during exercise in 
people with type 1 diabetes (Chapter 7). Furthermore, 6 weeks of HIT in people with 
type 1 diabetes led to similar increases in !̇O2peak and aortic pulse wave velocity to 
MICT, despite training volume being 47-60% less (Chapter 7). However, during this 
study, HIT was performed under optimal conditions with high levels of researcher 
supervision and specialised equipment, meaning the “real world” effectiveness of 
HIT in people with type 1 diabetes is unclear. The HIT protocol did not address a 
number of other key barriers to exercise such as difficulties with access to facilities 
(including distance and cost) and embarrassment due to negative body image 
(Lascar et al., 2014). To combat these traditional exercise barriers, another study 
included in this thesis demonstrated the effectiveness of a novel home-based HIT 
(Home-HIT) programme in previously sedentary obese individuals with elevated 
cardiovascular disease risk (Chapter 4). This Home-HIT protocol, which could be 
performed without equipment in a place of the participant’s choosing, resulted in high 
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adherence, suggesting it successfully removed many of the aforementioned barriers 
to exercise. It was also effective at improving a number of cardio-metabolic health 
markers such as !̇ O2peak, insulin sensitivity, endothelial function and body 
composition. For people with type 1 diabetes, Home-HIT may offer an exercise 
strategy that reduces the two major barriers to exercise, lack of time and fear of 
hypoglycaemia, but is also inexpensive and requires no facilities, equipment or travel 
time to gyms.  
To date very little evidence has looked to qualitatively explore participant 
experiences of HIT (Kinnafick et al., 2018), and no studies have investigated the 
attitudes and barriers of HIT in people with type 1 diabetes in conjunction with an 
exercise programme designed to increase exercise participation. Therefore, the 
inclusion of a qualitative survey would allow a more in-depth exploration of 
participant experiences of the Home-HIT intervention to support the assessment of 
physiological effectiveness.  
The overall aim of this pilot study was to investigate the potential of Home-
HIT to be a practical and effective training method for people with type 1 diabetes. 
To achieve this aim, participants completed a 6-week Home-HIT intervention 
investigating 1) adherence and compliance (defined as ability to meet prescribed 
heart rates), 2) the effect of Home-HIT on !̇O2peak, 3) the effect of Home-HIT on 
insulin dose and glycaemic profile during the first and last week of training, and 4) 
the acute effect of Home-HIT on blood glucose concentration following each training 
session. Finally, participants completed an online survey to gain greater 
understanding of the barriers to exercise that people with type 1 diabetes face as 
well as participant experiences of the Home-HIT intervention. 
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8.3. METHODS 
Subjects 
Eleven previously physically inactive individuals with type 1 diabetes (6 on insulin 
pumps/5 on multiple daily injections) completed the intervention (see Table 8.1 for 
characteristics). Exclusion criteria were duration of type 1 diabetes <6 months, 
significant history of hyper- or hypoglycaemia, pregnancy or planning pregnancy, 
uncontrolled hypertension (>180/100 mmHg), angina, autonomic neuropathy, taking 
any medication that affects heart rate (HR), major surgery planned within 6 weeks of 
the study, severe nonproliferative and unstable proliferative retinopathy. The study 
was approved by the Black Country NHS Research Ethics Committee (West 
Midlands, UK) and all participants gave written informed consent to a protocol 
conforming to the Declaration of Helsinki. 
Table 8.1. Pre-training individual participant characteristics 
Characteristic Values Range 
Age (years) 30 ± 3 20 - 55 
Sex (M/F) 4/7 - 
BMI (kg·m-2) 27.1 ± 1.2 21.5 – 32.9 
Duration of type 1 diabetes (years) 10 ± 2 1 – 16 
Treatment (pump/MDI) 6/5 - !̇O2peak (ml·kg-1∙min-1) 32.4 ± 2.1 23.7 – 45.1 !̇O2peak (L/min-1) 2.5 ± 0.2 1.7 – 4.2 
Systolic blood pressure (mmHg) 126 ± 4 106 – 142 
Diastolic blood pressure (mmHg) 78 ± 4 62 – 95 
Mean arterial blood pressure (mmHg) 94 ± 3 78 - 111 
 
MDI = multiple daily injections. Data presented as mean ± SEM. 
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Pre-Training Testing 
Participants attended the laboratory at Liverpool John Moores University (LJMU) for 
one pre-training visit. Following 15 minutes supine rest blood pressure was recorded 
in triplicate using an automated sphygmomanometer (Dianamap; GE Pro 300V2, 
Tampa, Florida). Participants then completed an incremental exercise test to 
exhaustion on an electromagnetically braked cycle ergometer (Excalibur Sport V2.0, 
Lode, Groningen, the Netherlands) to determine !̇ O2peak using an online gas 
collection system (MOXUS modular oxygen uptake system, AEI technologies, 
Pittsburgh, PA). The test consisted of 3-minute stages starting at 60 W, with 
workload increasing by 35 W at each stage until subjects could not maintain a 
cadence of >50 rpm.	!̇O2peak was taken as the highest value obtained over a 15 
second recording period. 
 
Training  
The six-week home-based training programme started ~72h after completion of pre-
training testing. Training was completed in an unsupervised place of the participant’s 
choosing, outside of the LJMU laboratories and is fully described in Chapter 4. In 
brief, participants were asked to perform repeated 1 minute bouts of high intensity 
exercise interspersed with 1 minute of rest. Participants were advised to achieve a 
HR of ≥80% of their predicted maximum HR (220 – age) at some point throughout 
the intervals. The 1 minute intervals were composed of two 30-second simple 
bodyweight exercises with no rest in between. Participants were provided with 18 
exercises with 9 suggested exercise pairs which were detailed in an exercise pack. 
Participants were free to choose from all of these pairs during the sessions. 
To monitor training session completion rate (adherence) and exercise 
intensity achieved (compliance), participants were given a HR monitor which was 
Chapter 8 
168 
 
able to connect via Bluetooth to the participant’s smart phone (Polar Beat; 
www.polar.com/beat/uk-en). Following each training session HR data was 
automatically uploaded to a cloud storage site (www.flow.polar.com), which was 
monitored by the researchers to check adherence and compliance. Participants were 
aware that the research team were monitoring their training, but this software was 
not used to enforce adherence or compliance. Instead, participants were advised to 
complete 3 sessions per week and it was their responsibility to schedule and 
complete the sessions. The number of intervals increased from 6 in weeks 1 and 2, 
to 8 in weeks 3 and 4, to 10 in weeks 5 and 6. To avoid participant drop-out 
participants were contacted by text/email once every two weeks to enquire about 
progress and any general issues around training. If participants were observed to 
have missed consecutive training sessions their email enquired as to whether there 
was a specific reason, however no direct encouragement was given for them to re-
engage with training. 
 
Acute Effect of Exercise on Blood Glucose Control 
Participants were asked to record their blood glucose pre, post and 1h post each 
training session so that change in blood glucose could be monitored over the 18 
sessions. Participants were also asked to record whether they required additional 
carbohydrates or insulin during or following the session to adjust their blood glucose. 
Throughout the programme participants were asked to ensure that blood glucose 
levels were between 7-14 mmol/L, in accordance with the guidelines developed for 
the Exercising for Type 1 Diabetes (EXTOD) study (Narendran et al., 2017), 
meaning that they were safe to commence exercise. If blood glucose was outside of 
this range participants were asked to postpone the exercise.  
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Effect of Training on Glycaemic Profile and Insulin Dose 
During the first and final 7 days of the training programme participants were asked to 
monitor their blood glucose and insulin dose using an 8-point profile: before and 2h 
after each meal, just before bed, and at 2am. This was designed to provide 
information on whether the training programme had an effect on daily insulin dose 
and glucose control over the week. 
 
Post-Training Testing 
Approximately 72h after the final training session, participants attended the 
laboratory for a post-training visit. Here !̇O2peak and blood pressure were re-
assessed. Participants also completed a post-training qualitative survey. 
 
Qualitative Survey 
During post-training testing, participants completed an online qualitative survey 
(www.surveymonkey.co.uk) anonymously while alone in a quiet space. The survey 
included 7 open and 3 closed questions that asked participants’ about their barriers 
and facilitators to exercise, their experiences of the Home-HIT training programme 
and their intentions to exercise in the future (Table 8.2). Questions were developed, 
piloted within and revised by the research team using appropriate literature 
(Kinnafick et al., 2018). Participants were given the following instructions: “Please 
read the following questions and write your answers in the space provided. Give as 
much or as little information as you like”. 
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Table 8.2. Qualitative survey questions 
1. Prior to taking part in the Home-HIT study, how would you describe your activity 
levels? 
2. How did you feel about the level of activity you engaged in prior to the programme? 
3. Have you ever played team sports or exercised with others (for example at classes)? 
4. Are there any aspects of exercise (type 1 related or not) that you feel might prevent 
you from taking part? 
5. The current health recommendation is that we all undertake a minimum of 150 
minutes of exercise weekly as 30 minute sessions, five times a week.  
How do you feel about this? What may help or hinder you? 
6. Would any of the following encourage you to exercise? 
• Being given free access to a gym 
• Being given a programme that could be completed within your home 
• Attending an exercise group organised by the hospital or your GP 
• One to one advice outlining an exercise programme 
• Being provided with a mobile phone application detailing an exercise programme, 
with video examples 
• A leaflet outlining an exercise programme 
• One to one advice on each session and how to progress the programme 
• A mobile phone application that gives feedback on each session and how to 
progress the programme 
• Self-monitoring an exercise programme having being given advice in a leaflet 
7. How do you feel about HIT style exercise after completing this study? 
8. Please describe what you did and did not like about the programme. 
9. Are there any benefits or drawbacks to HIT at home? 
10. Would you consider continuing HIT at home? Or would you prefer to try something 
else? 
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Qualitative Analysis 
The answers from the qualitative survey were analysed using a framework approach 
(Ritchie and Spencer, 1994) as this is a flexible approach appropriate for multi-
disciplinary research teams (Gale et al., 2013). The analytical process was guided by 
Gale and colleagues’ (Gale et al., 2013) 7 stages of analysis (given that responses 
were already transcribed, the process started at stage 2). The  stages included; 
familiarisation with the interview, coding of the responses, developing an analytical 
framework to group and discuss codes (three of the researchers discussed this on 
two occasions); applying the analytical framework where agreed groups of codes 
were applied to the transcript; charting data to the framework where quotes were 
aligned to an appropriate group of codes; and finally interpreting the data where 
researchers discussed the meaning of quotes, consulted notes collected by F.K. 
during the analytical process and agreed on how they would be used to support the 
physiological data.  
 
Statistical Analysis 
Changes in !̇O2peak, blood pressure, glycaemic profile and insulin dose were 
assessed with paired samples t tests. Change in blood glucose concentration pre, 
post and 1h post exercise was assessed with a one-way ANOVA. Analysis was done 
using IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. 
Significance was set at P≤0.05 and data are presented as mean ± SEM.  
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8.4. RESULTS 
Adherence and Compliance to Home-HIT 
Mean training session adherence was 95 ± 2% (range = 83-100%) with participants 
achieving the 80% HRmax target in 99 ± 1% of sessions (range = 94-100%).  
 
Aerobic Capacity and Blood Pressure 
!̇O2peak increased by 8% (P=0.018) following 6 weeks of Home-HIT (Figure 8.1). 
There was no change in systolic (126 ± 4 vs. 125 ± 4 mmHg; P=0.975), diastolic (78 
± 4 vs. 78 ± 4 mmHg; P=0.967) or mean arterial (94 ± 3 vs. 94 ± 3 mmHg; P=1.000) 
blood pressure following training.  
 
 
Figure 8.1. Change in #̇O2peak following 6 weeks of home-based high intensity 
interval training (Home-HIT) 
A) The group mean response in !̇O2peak following training. *Indicates a significant 
change from baseline (P<0.05). B) Shows the individual changes in !̇O2peak with 
training. 
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Blood Glucose Control and Insulin Dose 
Blood glucose results pre, post and 1h post exercise are shown in Figure 8.2. Mean 
blood glucose concentration immediately post exercise and 1h post exercise were 
not different from baseline (P=0.070). Participants needed to correct their blood 
glucose concentrations with consumption of carbohydrates to prevent 
hypoglycaemia in 6 ± 3% of sessions (10 out of 188 sessions) and for 
hyperglycaemia with insulin in 2 ± 1% of sessions (3 out of 188 sessions). Everyone 
was able to complete every session without stopping mid-way to check their blood 
glucose concentration.  
The 8-point insulin diary showed that mean short acting insulin dose 
significantly decreased by 13% from 0.31 ± 0.06 to 0.27 ± 0.05 IU/kg/day post 
training (P=0.026). There was no change in mean blood glucose concentration per 
day (pre = 8.8 ± 0.5 mmol/L; post = 8.6 ± 0.4 mmol/L; P=0.457) and there was no 
difference in glucose variation, measured as coefficient of variation, pre and post 
training (pre = 34 ± 3%; post = 32 ± 3%; P=0.307). 
 
Figure 8.2. Change in blood glucose concentration during training sessions 
A) Shows the group mean blood glucose concentrations over the course of the 
training sessions. B) Shows mean blood glucose concentration for each participant 
over the 6 weeks of Home-HIT pre, post and 1h post training. There was no 
significant difference in blood glucose concentration across time points (P>0.05). 
Chapter 8 
174 
 
Qualitative Survey 
Three key themes, and sub-themes, were developed during analysis. These themes 
included; 1) Flexibility of Home-HIT with the sub-themes Type 1 Related Flexibility 
and Non-Type 1 Diabetes Related Flexibility, 2) Motivation, and 3) the Exercise 
Experience.  
 
Theme 1: Flexibility of Home-HIT 
Participants all agreed that Home-HIT provided them with flexibility not offered by 
other forms of exercise. Comments around flexibility centred on issues regarding 
their diagnosis and issues that were separate to their diagnosis.  
 
Type 1 Diabetes Related Flexibility:  
Participants disclosed that previously they had experienced difficulty in managing 
blood glucose during exercise, especially if it was over a long duration or in a 
competitive environment.   
 
“From experience exercise that requires stamina causes me to have a hypo 
during or after the activity.” (Participant 5) 
 
Three participants stated that Home-HIT appeared to reduce the number and 
severity of their hypos. These participants reported that the control over their blood 
glucose levels reduced the worry associated with a hypoglycaemic incident. 
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“I feel that HIT style exercises work very well for me in terms of improving my 
overall fitness and reducing the occurrence of hypos whilst exercising.” 
(Participant 8) 
 
“The even blood glucose levels are an absolute dream come true for exercise 
with T1. I'd even try it of an evening and go to bed less worried.” (Participant 
6) 
 
However, one participant said that Home-HIT made their hypos more frequent and 
severe.   
 
“Demanding physically, but particularly made blood sugar control more 
difficult and hypos more frequent and severe.” (Participant 9) 
 
Non-Type 1 Diabetes Related Flexibility: 
Common positives of the Home-HIT programme included the low time commitment, 
ease of doing the exercises at home, having a good variety of exercise, being able to 
monitor HR on their mobile phone and not having to go to the gym, all of which made 
Home-HIT more flexible. The small time commitment required during Home-HIT was 
mentioned in over half of the participants’ responses, with many saying it was easy 
to fit within a busy lifestyle because it could be done at home with no equipment. 
Just one person said they found it difficult to find the time to fit the training in 
because of their busy work schedule. Lack of time was identified as a major barrier 
to exercise before the programme with demanding work hours and family 
commitments being a major problem.  
“Time constraints are a massive barrier to achieving this (government’s 
physical activity guidelines) for me. I'd have to cut time off from other things 
and it would impact on my work/life balance.” (Participant 6) 
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“It was very easy to fit the workout sessions into my day, depending on what I 
was doing due (to) the time it took to complete.”  (Participant 8) 
 
One person also mentioned that at times they found it difficult to exercise at home 
because they would get distracted easily. Participants who expressed poor 
perceptions of body image, from weight gain, or low competence for exercise were 
grateful for the flexibility of being in the home where no one could see them and they 
did not feel judged. 
 
“Being able to complete the programme in my own flat, without feeling self-
conscious about people watching what I was doing.” (Participant 8) 
 
Theme 2: Motivation 
Participants’ responses to the survey described their motivation prior, during and for 
future engagement. A low level of motivation, and sometimes complete lack of 
motivation, were cited as reasons for not taking part in regular exercise prior to 
taking part in Home-HIT. In regards to Home-HIT, three people said that they 
particularly liked having the target number of intervals to complete each session. 
Four individuals responded that self-monitoring via the instant feedback of the HR 
monitor and mobile app and having a variety of exercises provided encouragement 
to continue. 
“I would consider doing HIT at home if I could view my progress through a 
monitor device like a HR monitor. It did not take long to complete each 
session and I feel as though my blood sugar control is better doing HIT x3 a 
week.” (Participant 5) 
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Wanting a source of social support was mentioned by several participants. One 
person said that they would have liked someone with them while doing the exercises 
to time the intervals to keep them motivated. Two participants explained that they 
liked being able to choose which exercises they completed and how the number of 
intervals increased as they progressed through the programme.  
 
“I liked the opportunity to choose which exercises to do during each session 
and that I was able to monitor my own progress through a heart rate monitor 
device through my phone. I also liked how throughout the programme the 
intensity increased and this became a challenge.” (Participant 5) 
 
Two participants explained that it would have been hard to motivate themselves to 
complete the programme unless they felt they were being monitored by the research 
team using the mobile app. 
 
Theme 3: The Exercise Experience 
When asked to provide information on barriers and facilitators to the programme, 
most participants provided details of their experiences of the exercise itself. 
Participants agreed that they liked the interval style exercises as they found they did 
not get bored. Three participants stated that they found the training programme very 
demanding, especially when it increased to 10 intervals. However, they 
acknowledged that it was rewarding when they had finished.  
 
“I liked the interval training as you do not get a chance to become bored if 
you have a set training program to follow.” (Participant 4) 
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“It was initially hard to complete but got better as the sessions continued and 
it was good to measure my heart rate and see if any progress was being 
made.” (Participant 2) 
 
Two of the individuals said they would have liked a greater variety of exercises, 
whereas others felt the variety was sufficient. When asked if they would consider 
continuing the Home-HIT programme after the study 10 out of the 11 said that they 
would. Eight of these said that they would continue the programme alongside other 
forms of exercise. 
 
“I would continue the HIT at home but would be interested in trying something 
new.” (Participant 8) 
 
8.5. DISCUSSION 
This is the first study to combine physiological data with qualitative evaluation of a 
training intervention in people with type 1 diabetes. We provide strong evidence that 
Home-HIT is an effective intervention with high adherence and compliance, leading 
to increases in !̇O2peak despite participants being unsupervised during the exercise. 
Home-HIT appears to reduce traditional barriers to exercise as well as fear of 
hypoglycaemia, which is the major barrier in people with type 1 diabetes. Therefore, 
Home-HIT may represent an effective strategy to increase exercise participation in 
people with type 1 diabetes.  
Six weeks of Home-HIT increased !̇O2peak by 8% (0.2 L/min-1). This is similar 
to previous laboratory-based HIT studies in healthy individuals (Weston et al., 2014); 
however, not as high as the 14% increase that we reported in our laboratory-based 
HIT study in people with type 1 diabetes (Chapter 7). Aerobic capacity has been 
shown to be a more powerful predictor of mortality than clinical risk factors such as 
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hypertension, smoking and type 2 diabetes (Myers, 2003) and training induced 
improvement in	!̇O2peak is associated with a reduction in all-cause mortality risk (Lee 
et al., 2010). The improvements in !̇O2peak following the Home-HIT intervention are 
therefore likely to be clinically meaningful. 
Insulin dose and glucose concentrations were recorded during the first and 
final weeks of the training programme using an 8-point scale over 24h. In the sixth 
week of the Home-HIT programme there was a 13% reduction in insulin dose, 
indicating increased insulin sensitivity. This is important because insulin sensitivity is 
linked with decreased risk of cardiovascular complications in people with type 1 
diabetes (Schauer et al., 2011, Bergman et al., 2012a). These results are in 
agreement with Salem et al. (2010) who also found significant effects of exercise 
training on insulin dose. We also recorded blood glucose levels using the same 8-
point scale but showed no change in mean blood glucose concentration or daily 
glucose variation between weeks 1 and 6. However, the use of capillary glucose 
measures makes this difficult to interpret as there are many factors that could 
influence blood glucose concentrations between the time points. Future research 
should investigate the effects of Home-HIT on glycaemic control using continuous 
glucose monitors and HbA1c as these are the main clinical measures (Danne et al., 
2017).  
 The survey responses support the previous findings of Brazeau et al. (2008) 
and Lascar et al. (2014) that fear of hypoglycaemia is the main barrier to exercise for 
people with type 1 diabetes. Therefore, development of strategies to reduce this 
barrier are critical to improve exercise participation. The training diary results show 
that blood glucose remained stable even up to 1h after the Home-HIT sessions (Fig. 
8.2B), supporting the findings from a previous study in our laboratory (Chapter 7) 
that showed that blood glucose concentration did not change during laboratory-
based HIT. This contrasts with MICT, which is recommended by the American 
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Diabetes Association (ADA), where there is a consistently large drop in blood 
glucose in people with type 1 diabetes (Chapter 7, (Garcia-Garcia et al., 2015, 
Davey et al., 2013b, McMahon et al., 2007). The blood glucose data in this study 
was supported by the survey responses, as participants said that they were 
comfortable doing Home-HIT at any time of day because they felt their blood glucose 
concentrations would remain stable. This emphasises the potential of HIT to reduce 
the major barrier of fear of hypoglycaemia which may increase exercise participation 
in people with type 1 diabetes. This is clinically relevant because Brazeau et al. 
(2008) found that individuals with greater perceived barriers to physical activity had 
poorer glycaemic control as measured by HbA1c. Although the data from this trial is 
promising, not all participants reported positive experiences, with one participant 
reporting that they felt their blood glucose was more difficult to manage. As such, 
future research should focus on understanding individual variation in blood glucose 
management during exercise, potentially leading to more personalised exercise 
prescriptions. 
 Fear of hypoglycaemia means people with type 1 diabetes regularly check 
their blood glucose concentration when performing traditional MICT recommended 
by the ADA (Colberg et al., 2016). The survey responses provide evidence that 
stopping to check blood glucose and correct accordingly with carbohydrate during 
exercise can be frustrating as it means that an already time consuming MICT 
session is even longer while they wait for their blood glucose to stabilise so they can 
recommence exercise. Despite the apparent importance of blood glucose correction 
during exercise this is the first study to quantify the number of training sessions 
during which participants had to prevent or treat an episode of hypoglycaemia 
through ingestion of carbohydrate. The participants in this investigation were able to 
complete every session without stopping to check their blood glucose concentration 
and out of the 188 Home-HIT sessions completed there were just 10 occasions 
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where participants had to ingest carbohydrate following exercise to prevent 
hypoglycaemia. This further highlights the time efficiency and ease of Home-HIT for 
people with type 1 diabetes. Importantly, the data on carbohydrate consumption and 
blood glucose concentrations during and after exercise would suggest that HIT may 
provide more stable blood glucose concentrations following exercise sessions, which 
may lead to better glycaemic control in the long term. Indeed, Kennedy et al. (2013) 
suggested that previous research may have failed to show glycaemic benefits of 
exercise because calorie intake and insulin dose around the time of exercise has not 
been controlled. The long term effects of Home-HIT on glycaemic control should 
therefore be investigated further. 
Adherence and compliance to Home-HIT were high and comparable to that 
of our previous study investigating Home-HIT in obese individuals with elevated 
cardiovascular disease risk (Chapter 4). In fact, adherence was higher than two 
recent supervised field-based HIT interventions where participants attended pre-
scheduled training sessions (Lunt et al., 2014, Shepherd et al., 2015). The 
responses to the survey strongly support our high adherence and compliance data 
suggesting that the Home-HIT programme was positively received, and 10 out of the 
11 participants said that they would continue to use Home-HIT as a means to stay 
physically active after the study. Stable blood glucose values during the exercise 
may have contributed to the high adherence levels as there was no change in blood 
glucose concentration up to 1h post exercise and the survey responses were mostly 
positive regarding blood glucose levels. Another positive of Home-HIT is that it is 
time-efficient, as this has been highlighted as a major barrier to exercise here and in 
previous studies (Lascar et al., 2014, Brazeau et al., 2008). Training sessions lasted 
between 12 and 20 minutes meaning that weekly time commitment of Home-HIT is 
at least 90 minutes less than the 150 minutes that are recommended in the 
guidelines (Colberg et al., 2016). The results from the survey confirm this point, as 
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many people saw the time efficiency of HIT as a major advantage and liked the 
convenience of not having to travel. Other positive factors that were highlighted 
about exercising at home were that it helps with body image problems of exercising 
in front of others and the interval style exercises reduced boredom. The survey 
responses also highlighted that lack of motivation is often a key barrier to achieving 
physical activity guidelines. Having an exercise programme to follow with instant 
feedback from the HR monitor and mobile app was viewed positively. For example, 
one person said that they liked the feeling of someone (or something) monitoring 
them during exercise because it increased their motivation to complete all of the 
sessions. Two people said that especially when the training got to 10 intervals in 
weeks 5 and 6 that they may not have been motivated to do the exercise unless they 
felt they were being monitored.  
The major strength of this study is the multi-disciplinary approach combining 
physiological data with qualitative evaluation of a training intervention. This is the first 
study to qualitatively assess the acceptability of an exercise-training programme in 
people with type 1 diabetes, and to the authors’ knowledge only the third study to 
investigate the barriers to exercise in people with type 1 diabetes (Brazeau et al., 
2008, Lascar et al., 2014). Inclusion of the survey allowed us to explore in more 
depth how effective Home-HIT was at overcoming perceived barriers to exercise and 
to provide contextual information for the physiological data. The current investigation 
was designed as a proof of concept study, and as such the sample size was small. 
However, the sample size is in line with other exercise studies that have been 
conducted in people with type 1 diabetes (Harmer et al., 2008) and the promising 
results strongly suggest that future trials should investigate Home-HIT in larger 
cohorts over longer time periods to investigate its effectiveness compared to 
traditional training interventions.    
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The results of this pilot study demonstrate that Home-HIT is an effective 
intervention for people with type 1 diabetes resulting in high adherence to training 
that leads to increases in !̇O2peak and reduced insulin dosage. Importantly Home-HIT 
did not reduce blood glucose concentrations and carbohydrate was not needed to 
correct blood glucose during exercise. This data in combination with qualitative 
feedback suggests Home-HIT is a safe strategy that, for most, reduces the major 
barriers including fear of hypoglycaemia and lack of time. We therefore suggest that 
Home-HIT is an effective strategy to increase exercise participation in people with 
type 1 diabetes. 
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9.1 Thesis Overview 
We are currently experiencing a global obesity epidemic with >650 million adults 
worldwide classified as obese (BMI ≥30 kg∙m-2), which is forecast to increase to 1.12 
billion by 2030 (Kelly et al., 2008, World Health Organisation, 2018). The World 
Health Organisation has identified physical inactivity as one of the leading global 
risks for mortality, and obesity has been shown to double the risk of all-cause 
mortality due to its association with cardio-metabolic pathologies such as 
cardiovascular disease (CVD) and type 2 diabetes (Berrington de Gonzalez et al., 
2010). The cost of prevention and treatment of chronic diseases resulting from 
inactivity in the UK has been estimated at a staggering £8.2 billion per year (both 
direct treatment and indirect costs e.g. sick absence), placing an enormous financial 
burden on the economy. Exercise prescription consisting of moderate-intensity 
continuous exercise, in line with the physical activity guidelines (Colberg et al., 2016), 
is an important first line strategy for the management of obesity and cardio-metabolic 
disease (Ismail et al., 2013). However, adherence to exercise programmes 
comprising continuous bouts of prolonged exercise is poor unless there is adequate 
supervision (Eriksson and Lindgarde, 1991, Faulkner et al., 2014). 
Many people attribute their inactivity levels to a number of common exercise 
barriers including limited access to facilities and appropriate equipment, difficulty with 
transportation or inadequate financial resources (Korkiakangas et al., 2009) and the 
most commonly cited barrier, a “lack of time” (Trost et al., 2002). High-intensity 
interval training (HIT) protocols have been developed to reduce the time required to 
achieve health and fitness benefits, thus overcoming this “lack of time” barrier (Little 
et al., 2011, Weston et al., 2014). A plethora of supervised laboratory-based HIT 
programmes have shown clear improvements in numerous cardio-metabolic risk 
factors including aerobic capacity, insulin sensitivity and glycaemic control to a 
similar degree as moderate-intensity continuous training (MICT) (Cocks et al., 2013, 
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Cocks et al., 2016, Bradley et al., 2014, Wisloff et al., 2007, Tjonna et al., 2008). 
However, current evidence for the efficacy of HIT originates from researcher-led 
laboratory-based investigations using specialised equipment under close supervision 
to ensure correct training thresholds are achieved (Shepherd et al., 2017, Little et al., 
2011, Gillen and Gibala, 2014, Weston et al., 2014). Furthermore, the applicability of 
current HIT programmes to the sedentary obese population has been disputed by 
public health experts (Biddle and Batterham, 2015, Hardcastle et al., 2014), who cite 
the strenuous nature and complex protocols as major barriers when targeted at 
sedentary, exercise-naïve individuals. Therefore, although time efficient, laboratory-
based HIT does not address the additional barriers to exercise outlined above, 
meaning that the majority of the population are unlikely to adopt HIT as a strategy to 
improve their health and fitness.  
The overall aim of this PhD was to provide evidence that practical HIT 
strategies can remove many of the major exercise barriers for obese individuals and 
people with type 1 diabetes, that could potentially be used to improve population 
health by increasing physical activity participation. Five studies were conducted that 
investigated the effects of HIT in these at-risk individuals. The physiological 
effectiveness of the HIT programmes, as well as adherence and compliance, were 
tested thoroughly throughout this thesis to provide a comprehensive evaluation of 
the exercise training programmes. Chapter 4 aimed to eliminate many of the 
common exercise barriers by modifying existing HIT protocols to create a new 
Home-HIT intervention tailored to individuals with low fitness and mobility. In 
Chapter 5, muscle biopsies were analysed from the Home-HIT intervention to 
investigate the structural and endothelial enzymatic changes in skeletal muscle 
microvasculature in response to the 12-week training programme. In Chapters 6, 7 
and 8 the focus shifted to people with type 1 diabetes, and the major barriers to 
exercise faced by this population of fear of hypoglycaemia and lack of time (Lascar 
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et al., 2014, Brazeau et al., 2008). Chapter 6 investigated the effects of a single bout 
of HIT on glycaemic control under laboratory-controlled conditions in people with 
type 1 diabetes. Chapter 7 then assessed the effects of six weeks of HIT on markers 
of cardio-metabolic health in people with type 1 diabetes. Finally, Chapter 8 
introduced Home-HIT to people with type 1 diabetes, as a potential strategy to 
reduce the remaining exercise barriers in this population. 
 
9.2. Importance of Home-HIT 
Since its development, many have touted HIT as the exercise mode that would 
increase exercise participation due to its effectiveness and time-saving potential in 
comparison to traditional MICT (Gibala et al., 2012, Weston et al., 2014, Gillen and 
Gibala, 2014). However, a large proportion of the population remain inactive 
suggesting further research is needed to develop more feasible strategies that can 
be adopted by the majority of the population. The overall aim of Chapters 4 and 5 
was to assess the physiological effectiveness of a novel Home-HIT programme 
tailored to obese individuals with low mobility and fitness that could be performed in 
their own home with no equipment. A wide range of physiological assessments were 
conducted including fasting blood lipid profile and oral glucose tolerance test, DXA 
scanning to assess body composition, aortic pulse wave velocity to assess vascular 
stiffness, flow-mediated dilation, !̇O2peak and biopsies to assess skeletal muscle 
adaptations. This comprehensive approach allowed a full assessment of Home-HIT 
in comparison to the fully supervised laboratory-based HIT (Lab-HIT) and home-
based MICT (Home-MICT) programmes. Altogether, the results of this pilot study 
provide robust evidence that Home-HIT is physiologically effective in obese 
individuals. The high adherence and compliance data in the Home-HIT group 
suggest that this sedentary obese group were able to maintain the programme for 12 
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weeks at the correct intensity without researcher supervision. Therefore, Home-HIT 
may represent a strategy to increase physical activity levels of the obese population. 
Another important finding from the Home-HIT intervention was that the 
physiological benefits of HIT continue for at least 12 weeks. Previously, little was 
known about the long-term benefits of HIT compared to endurance training as most 
studies only investigated short-term training up to 6 weeks (Little et al., 2011, Gibala 
et al., 2012, Burgomaster et al., 2008). Although HIT is effective in the short-term, it 
was not known whether this would continue over a period of months. In their review 
on HIT, Gibala and McGee (2008) posed the question of whether the intense nature 
of interval training may stimulate relatively rapid physiological adaptations, whereas 
adaptations induced by traditional endurance training may take longer but progress 
for longer. The only study to date that has attempted to answer this was conducted 
by Gillen et al. (2016), who compared the cardio-metabolic effects of 12 weeks of 
sprint interval training (SIT) to endurance training in lean sedentary individuals and 
found similar improvements with both training modes. In Chapter 4 the physiological 
adaptations to HIT were measured at weeks 4 and 12 to assess a time-course effect. !̇O2peak increased significantly by 9% following 4 weeks of Home-HIT, and continued 
to increase by a further 7% between weeks 4 and 12, providing evidence that !̇O2peak 
does not plateau for at least 12 weeks of training. Our data suggest that HIT, 
including Home-HIT, does have the potential as a long-term training strategy, at least 
in obese individuals with elevated CVD risk.  
 
9.2.1. Myocyte Adaptations 
In Chapters 4 and 5 immunofluorescence microscopy was used to assess the 
effects of 12 weeks of Home-HIT on adaptations in skeletal muscle using biopsy 
samples taken pre- and post-training. This analysis aimed to provide mechanistic 
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insight into the training-induced improvements in #̇O2max and insulin sensitivity. In 
Chapter 4, mitochondrial density, intramuscular triglyceride (IMTG) content and 
GLUT4 protein expression were assessed pre- and post-training, as these are 
classical markers of training adaptation. Chapter 5 aimed to investigate the effect of 
the 12-week Home-HIT programme on skeletal muscle microvascular density and 
skeletal muscle microvascular enzymes responsible for NO bioavailability (eNOS 
content and ser1177 phosphorylation, NOX2 and p47phox content) in comparison to 
Home-MICT and supervised Lab-HIT.  
Mitochondrial biogenesis is a major training adaptation that increases lipid 
and glucose fuel handling following exercise training, contributing to improvements in !̇O2peak and insulin sensitivity (Holloszy, 1967). Chapter 4 showed that Home-HIT 
increased mitochondrial content in both type 1 and 2 muscle fibres with no 
differences between the control training groups (Lab-HIT and Home-MICT). This 
suggests that Home-HIT is an effective means to increase mitochondrial content and 
supports previous research showing mitochondrial biogenesis in both fibre types with 
SIT (Shepherd et al., 2017) and HIT (Tan et al., 2018).  
The increased central IMTG content and lipid droplet number found following 
Home-HIT is a training adaptation that has been seen in previous SIT interventions 
in lean (Shepherd et al., 2013a) and obese (Shepherd et al., 2017) individuals. This 
adaptation is purported to allow increased turnover of the IMTG pool because IMTG-
containing lipid droplets have greater access to mitochondria for oxidation due to the 
increased surface area for interaction with lipases, suggesting improved metabolic 
flexibility and capacity for IMTG utilisation during exercise (Shepherd et al., 2017). 
There is a reorganisation of lipid droplets following training so that there is a higher 
fraction located in the intermyofibrillar space rather than the peripheral region. This 
appears to be an important adaptation for improved insulin sensitivity (Nielsen et al., 
2017). It could be speculated that this adaptation will result in a reduction in the 
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accumulation of lipid metabolites such as ceramides, LCFA-CoA and diacylglycerol 
that can impair insulin signalling at the insulin receptor substrate-1 and Akt/PKB 
(Shulman, 2014, Amati et al., 2011, Shaw et al., 2010), eventually leading to 
improved insulin sensitivity. 
The increase in GLUT4 expression likely contributed to the increased insulin 
sensitivity observed in Chapter 4. Increased GLUT4 protein expression was 
previously reported to increase following 6 weeks of MICT and SIT in lean sedentary 
males (Bradley et al., 2014). GLUT4 is the primary insulin-responsive glucose 
transporter in skeletal muscle, and experimental increases in skeletal muscle GLUT4 
expression in animal models have been shown to increase whole-body insulin 
sensitivity (Tsao et al., 1996, Ren et al., 1995, Hansen et al., 1995).  
Chapter 5 investigated the adaptations to the skeletal muscle 
microvasculature, as these are key mechanisms underpinning the increased insulin 
sensitivity and aerobic capacity. Obesity and sedentary behaviour lead to structural 
and functional impairments in skeletal muscle microvasculature that are associated 
with endothelial function loss and development of metabolic disease. Chapter 5 
demonstrated for the first time that 12 weeks of HIT in obese individuals with 
elevated CVD risk improves skeletal muscle capillarisation and the eNOS/NADPHox 
ratio of capillaries and arterioles, potentially improving skeletal muscle microvascular 
function. These data support previous work (Cocks et al., 2013, Cocks et al., 2016), 
that has shown exercise training to be effective at improving skeletal muscle 
microvascular health. Chapter 5 is the first study to demonstrate that two home-
based exercise interventions performed without supervision or equipment improve 
capillary density, capillary contacts and capillary-fibre perimeter exchange index to a 
similar degree to Lab-HIT. Increased capillarisation is an established adaptation to 
exercise training that contributes to increases in !̇O2max and insulin sensitivity (Saltin 
et al., 1998, Akerstrom et al., 2014). Twelve weeks of Home-HIT also increased 
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eNOS content within the microvascular endothelium of arterioles and capillaries of 
skeletal muscle to a similar degree to Lab-HIT and Home-MICT, which is in 
agreement with other training studies that have been conducted in lean and obese 
individuals (Hoier et al., 2013, Cocks and Wagenmakers, 2016, Cocks et al., 2013).  
Taken together, the immunofluorescence microscopy data in Chapters 4 and 
5 provide strong evidence that Home-HIT leads to improvements in a wide range of 
factors associated with insulin sensitivity and !̇O2max.  
 
9.3. High-Intensity Interval Training is a Safe, Efficient and Effective Form of 
Exercise for People with Type 1 Diabetes 
9.3.1. Glycaemic Effects of an Acute Bout of HIT and MICT 
Before and after the exercise training sessions in Chapters 6 and 7 blood glucose 
concentration was recorded for safety reasons to prevent participants from 
exercising when they were too high or low based on the Exercising for Type 1 
Diabetes (EXTOD) guidelines (Narendran et al., 2017). In Chapter 6, exercise was 
undertaken in the fasted state where participants had omitted their short-acting 
insulin, whereas in Chapter 7, participants were in the fed state. Taken together, 
these data enable a comparison of the acute change in blood glucose from pre to 
post-exercise in the participants that completed HIT and MICT, as well blood glucose 
responses to exercise undertaken in the fasted (Chapter 6) and fed state (Chapter 
7). From these comparisons, the most important observation was that HIT 
completely eliminated the fall in blood glucose concentration in both the fed and 
fasted state, removing the risk of acute hypoglycaemia (Figure 9.1). Blood glucose 
was also stable following MICT in the fasted state, but there was a consistently large 
drop of ~5.5 mmol/L following MICT in the fed state, with participants at risk of 
hypoglycaemia. These findings are clinically important because fear of 
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hypoglycaemia prevents many patients from taking part in exercise (Brazeau et al., 
2008).  
 
 
Figure 9.1. Change in blood glucose concentration following exercise in the 
fed or fasted state adapted from Chapters 4 and 5. 
(A) Shows the mean change in blood glucose concentration following the HIT and 
MICT sessions where the participants were fasted and had omitted their fast acting 
insulin from Chapter 4. (B) Shows mean changes in blood glucose concentration 
during HIT or MICT over the 6-week training programme (Chapter 5) in the fed state. 
*Denotes a significant change from baseline (P<0.05). 
 
 
The patterns reported here are striking and are the first of their kind in the literature 
over so many training sessions to compare blood glucose responses between the 
fed and fasted states. The high number of training sessions that were assessed 
demonstrates that the stability in blood glucose following HIT in both the fed and 
fasted state is consistent. Garcia-Garcia et al. (2015) conducted a systematic review 
and meta-analysis in which they aggregated results from 10 studies to estimate rate 
of change of blood glucose concentration during and after different types of exercise 
in people with type 1 diabetes. Their results showed a rapid decline in glycaemia 
during continuous exercise (-4.43 mmol/L h-1 on average) while there were more 
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variable results during intermittent high-intensity exercise, depending on the protocol. 
The findings from the studies presented here have important implications for people 
with type 1 diabetes who want to undertake exercise. The data suggest that people 
that want to perform MICT should try to do so in the morning before food and short-
acting insulin, but there is more flexibility with HIT as it can be performed in the fed 
and fasted state without a significant reduction in blood glucose concentration.  
In non-diabetic individuals, several counterregulatory mechanisms exist that 
occur in a stepwise and hierarchical fashion during moderate-intensity exercise that 
mean glucose uptake and production are precisely matched to maintain blood 
glucose concentration within a tight range of ~4-6 mmol/L (Cryer, 1997). At the onset 
of aerobic exercise in an individual without type 1 diabetes, endogenous insulin 
secretion is suppressed to below fasting levels via sympathetic innervation of the 
islets of Langerhans (Robertson et al., 1987). Concomitantly, there is an increase in 
glucagon secretion from the α islets in the pancreas into the portal vein which 
stimulates release of glucose from the liver, to match the rate of glucose uptake into 
the working muscles (Camacho et al., 2005). The decrease in insulin also sensitises 
the liver to glucagon which causes a rapid rise in cyclic AMP in the liver to stimulate 
glycogenolysis and gluconeogenesis (Vranic et al., 1976b, Vranic et al., 1976a, 
Zinker et al., 1994). Gluconeogenesis is crucial for preservation of hepatic glycogen 
stores and becomes increasingly important with intense, prolonged exercise. Other 
counter-regulatory hormones including adrenaline, growth hormone, cortisol, 
noradrenaline, aldosterone and adrenocorticotropic hormone are also released. 
These hormones stimulate hepatic glucose production and adipose tissue lipolysis, 
as well as inhibiting skeletal muscle glucose uptake in order to protect against 
hypoglycaemia (Marliss and Vranic, 2002).  
 However, as insulin is supplied exogenously in people with type 1 diabetes, 
hyperinsulinaemia is likely to occur during exercise because of increased blood flow 
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and mobilisation of insulin from its subcutaneous depot, particularly if the injection 
site is in an exercised region (Marliss and Vranic, 2002). This results in enhanced 
glucose uptake due to combined contraction-mediated and insulin-stimulated GLUT4 
translocation. The high insulin levels will also suppress the exercise-mediated 
increases in glucagon and adrenaline and their ability to stimulate hepatic glucose 
production (Guelfi et al., 2007a). As a result, muscle glucose uptake during MICT in 
the fed state will exceed hepatic glucose production, leading to the large decreases 
in plasma glucose concentration observed in Chapter 7. Hyperinsulinaemia has also 
been shown to suppress adipose tissue and IMTG lipolysis in healthy individuals 
(Coyle et al., 1997), which will reduce the contribution of lipid metabolism during 
exercise. The combination of insulin and exercise-mediated glucose disposal 
coupled with decreased hepatic glucose production and reduced lipolysis and lipid 
oxidation increases the risk of hypoglycaemia during MICT in people with type 1 
diabetes. 
During high-intensity exercise circulating catecholamines increase 14-18 fold 
compared to only 2-4 fold during moderate-intensity exercise. This increase in 
catecholamines is a strong stimulus for glycogenolysis, inducing a 7-8 fold increase 
in hepatic glucose production (Marliss and Vranic, 2002). Interestingly, Kreisman et 
al. (2003) showed that infusion of adrenaline and noradrenaline in healthy non-
diabetic males during moderate-intensity exercise resulted in augmented hepatic 
glucose output to the same magnitude as during intense exercise. Moreover, an 
increase in circulating catecholamines enhances glucose rate of appearance even in 
the presence of hyperinsulinaemia (Bally et al., 2016). This suggests that 
catecholamines are important in the regulation of glucose homeostasis and could 
explain the improved glycaemic stability during HIT in people with type 1 diabetes 
even in the fed state where they have injected insulin. Indeed, circulating insulin 
does not decrease as markedly during high intensity exercise in people without type 
1 diabetes, partly because the duration of the activity is typically shorter (Marliss and 
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Vranic, 2002). Increased epinephrine also inhibits muscle glucose uptake during 
exercise (Watt et al., 2001), which appears to be due to its stimulatory effect on 
muscle glycogenolysis and the subsequent increase in muscle glucose-6-phosphate 
(an inhibitor of hexokinase and glucose phosphorylation).  
Following a high-intensity exercise bout in non-diabetics, there is a small 
hyperglycaemic response that persists for up to an hour (Marliss and Vranic, 2002). 
Insulin secretion increases post-exercise to normalise the hyperglycaemia and to 
permit rapid recovery of muscle glycogen (Marliss and Vranic, 2002). The issue in 
those with type 1 diabetes is that the inability to increase endogenous insulin in early 
recovery of high intensity exercise can result in greater or more sustained 
hyperglycaemia, possibly increasing the risk of ketoacidosis or hyperglycaemia 
related complications. Figure 9.2 provides information about the hormonal responses 
before, during and after high and moderate intensity exercise in healthy individuals 
without type 1 diabetes.  
 Growth hormone and cortisol secretion also appear to play a minor role in the 
regulation of glucose homeostasis during exercise, albeit indirectly, as they 
contribute to stimulation of whole-body lipolysis. In normal, healthy individuals, 
carbohydrate ingestion during prolonged moderate intensity exercise supresses 
cortisol secretion (Deuster et al., 1992). In addition, carbohydrate ingestion 
immediately before and during the first hour of prolonged running has been shown to 
attenuate the normal increase in growth hormone alongside suppression of lipolysis 
(Tsintzas et al., 1996). These studies suggest that secretion of growth hormone is 
important for fatty acid mobilisation from adipose tissue and therefore indirectly for 
glucose metabolism. During MICT in the fasted state, there will be greater lipolysis 
than the fed state which would contribute to more stable blood glucose, as observed 
in Chapter 6.  
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Figure 9.2. Hormonal responses to high and moderate intensity exercise 
Comparison of plasma glucose and hormonal responses during 40 minutes of 
moderate intensity exercise (50% !̇O2max; black) and 15 minutes of high intensity 
exercise (87% !̇O2max; red) in healthy non-diabetic males. A rest period was followed 
by exercise at either high intensity (dark shading) or moderate intensity (light 
shading). Adapted from Marliss and Vranic (2002). 
 
 
Bally et al. (2016) aimed to investigate the metabolic and hormonal response to 
intermittent high-intensity exercise and continuous exercise in people with type 1 
diabetes. They used stable isotope techniques, non-invasive measurement of liver 
glycogen (magnetic resonance spectroscopy) and assessment of whole-body 
substrate utilisation during a 90-minute cycle at 50% !̇O2max either with or without 10-
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second sprint every 10 minutes. Glucose requirements were lower during the 
intermittent high-intensity exercise condition compared with continuous exercise 
alone which paralleled an increase in counterregulatory hormones and lactate. 
Unexpectedly, the lower glucose requirements during the last 30 minutes of exercise 
of the intermittent sprint condition were due to lower glucose disposal rather than an 
increase in hepatic glucose output. The higher lactate levels in the intermittent 
exercise suggest that there may be a shift to consumption of alternative substrates 
that reduce glucose disposal and therefore help maintain blood glucose levels. One 
limitation of our HIT studies (Chapters 6 and 7) is that we did not measure 
catecholamines, lactate or growth hormone concentrations which would help with 
interpretation of the results. Differences in lipid oxidation may also account for the 
differences in glycaemic response between HIT and MICT as a greater 
catecholamine response during HIT may trigger IMTG utilisation due to stimulation of 
hormone sensitive lipase (Watt et al., 2003).  
Another important observation in Chapters 6 and 7, although not recorded, 
was the number of training sessions in which participants had to prevent or treat an 
episode of hypoglycaemia by consuming fast-acting carbohydrate. During most of 
the MICT sessions, especially the 50-minute sessions, participants had to stop 
exercising at least once to check their blood glucose, correct accordingly with 
glucose, and then wait for their blood glucose concentration to stabilise before 
recommencing the training. However, all participants were able to complete the HIT 
sessions without interruption. Many of the participants in the MICT condition found 
this frustrating and it would often mean that the already time-consuming 50-minute 
cycling sessions were even longer while they checked their blood glucose. This 
further highlights the time-efficiency and ease of HIT for people with type 1 diabetes. 
Furthermore, the carbohydrates used to prevent hypoglycaemia are high in calories 
which may make it difficult for patients to manage their weight. This can be 
especially off-putting for people wanting to exercise to lose weight, which is a 
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common goal (highlighted in Chapter 8). Secondly, taking on carbohydrate during or 
after the session is likely to cause their blood glucose to rise rapidly meaning they 
would be more likely to have to increase their insulin dosage to prevent 
hyperglycaemia later on, making it more difficult to control and predict blood glucose 
after the exercise session. Because blood glucose remains stable during HIT, it 
reduces the need to take on corrective carbohydrate or insulin, making blood 
glucose concentrations more predictable.  
Based on the findings in Chapters 6 and 7, the protocol for Chapter 8 was 
designed so that blood glucose responses and insulin dose around exercise were 
recorded in greater detail. In Chapter 8, participants were asked to record their 
blood glucose concentrations immediately pre, post and 1 hour post training over the 
6-week training period so that change in blood glucose could be monitored over the 
18 sessions. Participants were also asked to record whether they needed to take 
additional carbohydrates or insulin during or following the session to adjust their 
blood glucose. In addition, during the first and final 7 days of the training programme, 
participants were asked to monitor their blood glucose and insulin doses using an 8-
point profile: before and 2 hours after each meal, just before bed, and at 2am. This 
was designed to provide information on whether the training programme had an 
effect on insulin dosage and glucose control over the week. 
The results from Chapter 8 support those of Chapters 6 and 7. Blood 
glucose remained stable during Home-HIT and 1 hour post-exercise and there was a 
low number of sessions that needed to be corrected with carbohydrate or insulin 
suggesting that HIT, specifically Home-HIT, does not increase the risk of acute 
hypoglycaemia. These results were supported by the qualitative survey responses, 
as a number of participants reported that they felt the Home-HIT exercises helped 
with blood glucose management. Overall, Chapters 6, 7 and 8 provide strong, novel 
Chapter 9 
199 
 
evidence that HIT in both the fed and fasted state abolishes the drop in glycaemia 
that is associated with MICT.   
9.3.2. Effects of HIT on Markers of Cardio-Metabolic Health in People with Type 
1 Diabetes 
The findings from Chapter 6 suggested that there is no greater risk of 
hypoglycaemia following HIT in comparison to a control day with no exercise, 
suggesting this training mode should be explored further. Chapter 7 tested whether 
six weeks of HIT improves markers of metabolic health, including !̇O2peak, glycaemic 
control and vascular health, in people with type 1 diabetes in comparison to MICT. 
Six weeks of HIT led to comparable improvements in !̇O2peak and arterial stiffness to 
MICT while being a time-efficient alternative that reduces the risk of acute 
hypoglycaemia. The two studies combined provide evidence that HIT is a safe, 
efficient and effective form of exercise for people with type 1 diabetes. 
 As discussed in Chapter 7, !̇O2peak and arterial stiffness improved with 
training. However, there was no change in fasting plasma cholesterol or triglycerides, 
blood pressure, or blood glucose control indicated by time in target range from the 
continuous glucose monitoring systems (CGMS). This suggests that longer term 
training programmes are needed to see effects in these variables. A potential 
limitation of Chapter 7 was that only one 24-hour CGMS period was recorded pre- 
and post-training to assess the effects of training on glycaemic control. At the time of 
study design, this single 24-hour period was in line with other studies that have used 
CGMS to assess the effects of exercise on glycaemic variables in people with type 1 
and 2 diabetes (Little et al., 2011, Maran et al., 2010, Yardley et al., 2012, van Dijk et 
al., 2013). However, after data was collected for Chapters 6 and 7, an international 
consensus on use of continuous glucose monitoring was published (Danne et al., 
2017) that provides clear criteria for collecting and analysing CGMS data for 
research. These criteria were used for the analysis of the data for Chapters 6 and 7 
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in regards to definition of glycaemic thresholds. However, the guidelines recommend 
that a minimum of 14 consecutive days of data are required to generate a report that 
enables optimal analysis, which is clearly much longer than the single 24-hour period 
analysed for the work in this thesis. The longer period of analysis would increase the 
reliability of the data and allow more information on individual variability, as although 
diet was controlled, there are many other factors that affect blood glucose 
concentration in people with type 1 diabetes (Riddell et al., 2017).  
 
9.4. Directions for Future Research 
9.4.1. Transferring Home-HIT into the ‘Real World’ 
The Home-HIT investigation (Chapter 4) was designed as a proof of concept study, 
and as such the sample size was too small to detect differences in responses 
between the training modes. Nonetheless, this promising pilot study provides strong 
evidence that our novel Home-HIT programme offers an effective strategy to improve 
physical activity participation in obese individuals with elevated CVD risk. The data 
strongly suggest that the Home-HIT protocol elicits significant improvements in a 
wide range of cardio-metabolic health markers, and therefore should be explored 
further using larger cohorts. The use of a novel heart rate monitor and mobile phone 
app system was an important addition that allowed objective measurement of 
whether participants completed the exercises at the correct intensity. The high 
adherence and compliance data would certainly support this. This was further 
supported by Chapter 8, as there were high adherence and compliance results in 
the people with type 1 diabetes.  
 At present, a number of UK councils offer exercise referral schemes for 
individuals that meet certain criteria (e.g. inactivity, obesity, risk of CVD) and are 
deemed likely to benefit from regular exercise by their general practitioner. For 
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example, the Liverpool Clinical Commissioning Group offers a 12-week programme 
whereby individuals are given gym access with a fitness instructor available to offer 
support and guidance. Unfortunately, these schemes are not suitable for many and 
there are high levels of dropout (Kelly et al., 2017). A number of the barriers to 
exercise remain because the individual still has to travel to the ‘intimidating’ gym 
environment and exercise sessions are time consuming meaning that lack of time 
remains as a barrier (Morgan et al., 2016). Therefore, a large-scale randomised 
controlled trial should be conducted to test the effectiveness of Home-HIT vs. the 
current exercise referral scheme. It would also be useful to include a 3-month follow-
up assessment after the intervention has finished, whereby physical activity, aerobic 
capacity, CVD risk factors, body composition and psychological well-being are 
reassessed. This study would provide evidence of whether Home-HIT can be 
transferred to the ‘real world’. Further information is also required to develop the 
progression of Home-HIT over the long term so that individuals can continue to 
achieve health benefits even years after the start of a programme. Researchers will 
therefore have to consider ways in which motivation can be maintained for the long 
term so that high compliance rates are maintained while making the sessions 
challenging and achievable. Beyond the 12 weeks, individuals are unlikely to want to 
increase the number of intervals beyond 10, as the training sessions will lose their 
time saving advantage over MICT. Therefore, individuals will look to increase the 
number of sessions per week, alter the exercises that they are doing or add 
additional forms of training to vary their workouts.  
A parallel large randomised controlled trial in people with type 1 diabetes to 
test the effects of Home-HIT against traditional care also seems appropriate. The 
findings from Chapter 8 suggest that 6 weeks of Home-HIT is an effective strategy 
to improve fitness and reduce insulin requirements. A longer Home-HIT intervention, 
lasting a minimum of three months, is now required in order to assess changes in 
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glycaemic control and HbA1c. Combining a long-term assessment of glycaemic 
control using CGMS as per the most recent guidelines (Danne et al., 2017) before 
and after a training intervention alongside a series of markers of cardio-metabolic 
health would provide strong evidence for Home-HIT in people with type 1 diabetes. 
Home-HIT may be particularly useful for people that have been recently 
diagnosed with type 1 diabetes. Kennedy et al. (2018) found that additional barriers 
to exercise tend to exist in newly diagnosed patients with type 1 diabetes. Around 
half of the people that took part in the investigation by Kennedy et al. (2018) reported 
a decline in their activity levels around the time of diagnosis. Many people in the 
study reported that there was a scarcity of information on blood glucose 
management around exercise. The findings in the study by Kennedy et al. (2018) 
suggest that a programme such as Home-HIT where individuals are given a blood 
glucose diary to complete alongside a training programme designed to reduce the 
major barriers to exercise may be particularly beneficial for people that are newly 
diagnosed with type 1 diabetes, as it may provide a supportive and educational 
programme that can be used to help the individual to better understand how exercise 
affects their blood glucose. 
 
9.4.2. Effects of Training on Insulin-Stimulated Microvascular Perfusion 
Increases in skeletal muscle microvascular blood flow that are seen in response to 
insulin infusion or a mixed meal are impaired in obesity (Keske et al., 2009, Clerk et 
al., 2006). The results from Chapter 5 and the study by Cocks et al. (2016) suggest 
that with exercise training there is an increase in endothelial eNOS content of the 
microvasculature in obese individuals which presumably would lead to increased 
capillary perfusion following insulin stimulation. A limitation of these investigations is 
that the fasted muscle biopsy data do not provide insight into the regulation of 
microvascular perfusion under postprandial conditions. It would be assumed that 
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with training there would be greater eNOS ser1177 phosphorylation following insulin 
stimulation however this has not been tested in humans. Therefore, it would be 
important to investigate the effects of exercise training on the insulin-stimulated 
endothelial response. This would provide insight into the functional relevance of the 
observed changes in the microvascular enzymes measured in Chapter 5, the 
impairments in obesity and the adaptations with training.  
In a previous investigation, Rattigan et al. (2001) found that endurance 
training in previously sedentary rats led to parallel increases in skeletal muscle 
microvascular perfusion and glucose uptake during a hyperinsulinaemic-euglycaemic 
clamp as measured using 1-methylxanthine clearance. However, to date this has not 
been done in humans. Future studies should use insulin clamps alongside contrast 
enhanced ultrasound (CEU) to measure microvascular recruitment. This could be 
done alongside the immunofluorescence techniques used in Chapter 5 to 
investigate insulin-induced activation of eNOS. CEU has previously been used to 
measure microvascular blood volume and microvascular blood flow in response to 
insulin stimulation (Vincent et al., 2006, Vincent et al., 2004). CEU involves infusion 
of ~8 µm microspheres filled with contrast agent which can be visualised using 
ultrasound. The acoustic intensity of the image is proportional to the concentration of 
microspheres within the volume of tissue being measured. A single pulse of 
ultrasound is administered to destroy all of the microspheres within the ultrasound 
beam and then the rate of microsphere replenishment reflects the microvascular flow 
velocity and the plateau level of microspheres reached after destruction reflects 
microvascular blood volume. CEU may allow the rate assessment of how changes in 
microvascular eNOS content and insulin stimulated ser1177 phosphorylation lead to 
increased muscle microvascular perfusion and microvascular blood volume with 
training.  
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A further idea would be to investigate the translocation of GLUT4 following 
insulin stimulation in obese individuals pre- and post-training. Previously, Bradley et 
al. (2015) used immunofluorescence microscopy to show that there was an increase 
in the number of large GLUT4 spots at the plasma membrane layer of myocytes 
following glucose ingestion in healthy lean males, suggesting increased GLUT4 
translocation. If glucose-stimulated samples were taken pre- and post-training, 
immunofluorescence microscopy could be used to assess the effects of training on 
GLUT4 translocation to provide further insight into the mechanisms of insulin 
resistance with obesity and inactivity.  
 
9.4.3. Mechanisms of Blood Glucose Response to Fed vs. Fasted Exercise of 
Differing Intensities in People with Type 1 Diabetes 
The protocol for Chapter 6 was designed so that participants attended the laboratory 
under fasted conditions before taking their short-acting insulin to allow maximum 
control. The findings that HIT and MICT in the fasted state do not increase the risk of 
post-exercise hypoglycaemia over the 24-hour period and overnight are important. 
The current exercise guidelines do not advocate fasted exercise as a strategy for 
people with type 1 diabetes. However, the findings presented here suggest that 
provided appropriate precautions are taken it is safe for people with type 1 diabetes 
to exercise fasted.  
The question that remains following Chapter 6 is whether there is an 
increased risk of nocturnal hypoglycaemia when HIT is performed later in the day in 
both the fed and fasted states. Future research should investigate the effects of HIT 
during differing nutritional states and at different times of day in people with type 1 
diabetes. It also remains to be determined whether longer duration MICT sessions 
are associated with a risk of hypoglycaemia as many people would wish to exercise 
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longer than 30 minutes. Furthermore, more research is needed to determine whether 
there is a long-term benefit of exercising in the fasted state on glycaemic control. 
Exercise strategies that produce more stable blood glucose levels may lead to long 
term improvements in glycaemic control determined by HbA1c and CGMS.  
 It is important to determine the mechanisms underpinning the maintenance of 
blood glucose levels during HIT, as this will help provide information on nutritional 
and insulin requirements. Investigating changes in hormones such as 
catecholamines, growth hormone and cortisol is a good starting point. For example, 
Marliss and Vranic (2002) assessed the hormonal profiles of high intensity and 
moderate intensity exercise in healthy individuals to provide insight into blood 
glucose response in people with type 1 diabetes (Figure 9.2). Muscle biopsies could 
be taken to provide information on muscle glycogen and IMTG utilisation during 
exercise. The use of glucose stable isotope tracers would enable investigation of 
rates of endogenous glucose production (rate of appearance), glucose uptake into 
peripheral tissues (rate of disappearance) and glucose oxidation during exercise. 
This work would be particularly useful if combined with magnetic resonance 
spectroscopy to study metabolic changes in the liver. In a comprehensive study, 
Bally et al. (2016) conducted a randomised cross-over study in which 12 individuals 
with well controlled type 1 diabetes completed a 90-minute cycle at 50% !̇O2max 
either with 10 second sprints interspersed every 10 minutes or without. 13C Magnetic 
resonance spectroscopy was used to quantify hepatocellular and intramyocellular 
glycogen during the exercise bouts. They also measured glucose kinetics using 
stable isotopes, hormones and metabolites. Bally et al. (2016) found that exogenous 
glucose requirements were significantly lower in the final 30 minutes of the 
intermittent exercise condition but this was not due to a difference in hepatic glucose 
output or glycogen utilisation. Instead, there was decreased glucose uptake which 
implied a shift towards alternative substrates due to the intermittent sprints. A similar, 
Chapter 9 
206 
 
comprehensive study using the HIT protocol employed in Chapter 6 would provide 
detailed information on the metabolic responses to HIT in people with type 1 
diabetes.  
 
9.4.4. Myocyte Adaptations to Exercise Training in People with Type 1 Diabetes 
Current understanding of the long-term impact of type 1 diabetes on the health and 
quality of human skeletal muscle is limited, and little is known about the effects of 
exercise training on myocyte adaptations in this population. A recent study by 
Monaco et al. (2018) provided the first assessment of skeletal muscle mitochondrial 
ultrastructure and bioenergetics in young adults with type 1 diabetes that met the 
physical activity guidelines. Their findings highlighted mitochondrial and autophagic 
differences within the muscles of young adults with type 1 diabetes and non-diabetic 
controls matched for age, sex, BMI and levels of physical activity. Transmission 
electron microscopy revealed that type 1 diabetes negatively affects skeletal muscle 
ultrastructure as shown by disorganised mitochondrial cristae and an increased 
presence of autophagic remants. Monaco et al. (2018) also observed a 20% 
reduction in mitochondrial oxidative capacity. These impairments in mitochondria are 
clinically important as skeletal muscle is the major site of fatty acid catabolism 
(Hargreaves, 2000), a key mediator of whole-body glucose homeostasis and a major 
determinant of whole-body insulin sensitivity (Jensen et al., 1997, Shulman et al., 
1990). Therefore, impairments in skeletal muscle quality could have important long-
term consequences to the development in diabetic complications (Soedamah-Muthu 
et al., 2006, Kilpatrick et al., 2007).  
A major clinical concern highlighted by Monaco et al. (2018) was that the 
mitochondrial alterations that they observed were in young adults with type 1 
diabetes that met the American Diabetes Association physical activity guidelines of 
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150 minutes of moderate-intensity exercise per week (Colberg et al., 2016). 
Furthermore, in an earlier investigation, Perseghin et al. (2003) showed that people 
with type 1 diabetes had higher IMTG content than controls without type 1 diabetes 
and this was associated with degree of glycaemic control. Therefore, investigation of 
the effects of exercise training on mitochondrial biogenesis and IMTG content in 
people with type 1 diabetes, perhaps using the immunofluorescence microscopy 
techniques described in Chapters 4 and 5 of this thesis, may be important to 
determine optimal strategies to improve these markers and reduce the risk of insulin 
resistance. Future research should investigate the myocyte characteristics of 
sedentary and active people with type 1 diabetes, as well as the effects of chronic 
exercise training to provide insight into the adaptions with exercise. This will help to 
develop optimal exercise training strategies for people with type 1 diabetes to reduce 
the risk of metabolic complications. 
 
9.5. Final Conclusions 
The work conducted over the course of this PhD provides strong evidence for the 
use of Home-HIT as a strategy to remove the major barriers to exercise in sedentary 
populations that in the future may increase exercise participation and therefore 
population health. Chapters 4 and 5 provide evidence that a novel Home-HIT 
protocol improves cardio-metabolic health and removes barriers to exercise in obese 
individuals with elevated CVD risk. The comprehensive range of physiological 
measures including blood analysis, body composition measures and muscle biopsies 
alongside the novel HR monitoring system provide clear evidence for the 
effectiveness. Chapters 6 and 7 demonstrate that HIT is a safe and effective training 
strategy for people with type 1 diabetes that removes the major barriers of lack of 
time and fear of hypoglycaemia. This is especially important as this population is at 
increased risk of CVD and a high proportion of this population fail to reach physical 
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activity guidelines. Finally, Chapter 8 successfully introduced Home-HIT to people 
with type 1 diabetes. Therefore, Home-HIT appears to be an effective and feasible 
exercise strategy to improve markers of cardio-metabolic health in the obese 
sedentary population and people with type 1 diabetes.  
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